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ABSTRACT 
It is a recognized fact that most well defined population groups 
have their own typical pattern of inherited disorders. The genetic 
conditions most commonly found in Greek persons are the thalassaemias, 
glucose-6-dehydrogenase (G-6-PD) deficiency and, to a lesser extent, 
certain of the haemoglobinopathies. The clinical and socio-economic 
consequences of these disorders are significant. In the homozygous 
state, alpha-thalassaemia is incompatible with life, while thalassaemia 
major (homozygous beta-thalassaemia) results in a severe anaemia with 
death usually occurring in the second or third decades. Treatment to 
prolong the life of these patients is very costly. Alpha- and beta-
thalassaemia, when heterozygous, may result in a mild anaemia or be 
asymptomatic. G-6-PD deficiency results in attacks of haemolysis on 
ingestion of certain medical preparations and is of far less importance 
than the thalassaemias. Haemoglobin Sis the commonest haemoglobino-
pathy occurring in Greeks and results in a severe clinical condition 
when homozygous, as with the thalassaemias. However, the gene frequency 
is far less than that of the thalassaemias. 
The high prevalence of G-6-PD deficiency and haemoglobin Shave been 
demonstrated to be due to the selective advantage they confer against 
malaria. This same mechanism probably applies to the thalassaemias but 
has not been proven. Thus, these disorders have been demonstrated to 
occur more frequently in low-lying areas and places where malaria was 
endemic in the past. Population movement has made this situation less 
clearcut in recent times. 
Cape Town has a Greek population numbering approximately 5000 persons. 
As the thalassaemias, particularly, cause a notable public health 
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problem in Greece, it could be expected that the position would be 
similar, but on a smaller scale in Cape Town. For these reasons it was 
decided to undertake a study in Cape Town to ascertain exactly what the 
position was and what reco1T1T1endations to make concerning management and 
prevention. 
The study involved the' random blood sampling of 5% "(250 individuals) of 
the Greek population. These blood samples then underwent full screening 
to diagnose any inherited anaemia, including ones not expected to be 
found in high prevalence. Where warranted, further examinations were 
performed on the blood to enable a diagnosis to be made. In addition, a 
brief medical history was obtained from all the respondents and a more 
detailed history and full physical examination with special emphasis on 
the haemopoietic system was undertaken in persons found to have any 
disturbance. Furthermore, family studies were done where possible. 
The second part of thts thesis concerns the presentation of detailed 
case reports of known cases of thalassaemia major, individuals with 
G-6-PD deficiency and subjects found to have hereditary spherocytosis. 
Included in this section are pedigree studies of families in which 
these various conditions occur. 
Results given include firstly, epidemiological data and thereafter 
details of the prevalence of the various genetic conditions. It was 








(this finding was unexpected) 
0,4% 
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Findings which are presented, analysed and discussed include personal, 
clinical and haematological data. 
As a result of this study important theoretical genetic data have been 
collected which will facilitate the necessary steps to be taken for 
education of the population at risk, genetic control, clinical treat-
ment and prevention of the serious consequences of these various in-
herited disorders. 
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"The modern haematologist, instead of describing in 
English what he can see, prefers to describe in Greek 
what he can't." 
Richard Asher, Lancet, 2: 359, 1959. 
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INTRODUCTION 
South Africa, a relatively large country, has a number of eth-
nically distinct population groups residing within its borders and 
provides great potential for epidemiological and genetic investigations. 
Groups as diverse as the tribal African and the European descendants of 
early immigrants contain smaller sub-groups each with their own par-
ticular pattern of inherited disorders and therefore furnish a rich 
field for study. 
The investigation which forms the subject of this thesis is concerned 
with inherited haematological disorders in the Greek population of 
Cape Town. It is well established that the genetic disorders which 
occur most frequently in Mediterranean peoples, including Greeks, are 
haematological. These are thalassaemia and glucose-6-phosphate dehy-
drogenase (G-6-PD) deficiency with a high incidence, and the haemo-
globinopathies with a lower incidence. It is now almost universally 
accepted that the high prevalence of these disorders is due to the 
selective advantage possessed by people with minor forms of these con-
ditions. These individuals were protected against malaria, which in 
the pre-quinine era was a potentially lethal disease. 
Haemoglobin is the oxygen-carrying component of the red blood corpuscle. 
It is made up of haem, the iron-containing part, and globin, the 
protein moiety. Globin in turn consists of four chains, 2 alpha-chains 
and 2 non-alpha chains. The 2 non alpha-chains are designated either 
beta, gamma or delta. 
Normal adults have 97% haemoglobin A (HbA) which consists of 2 alpha 
and 2 beta-chains, 1,5 to 3,0% haemoglobin A2 (HbA2) consisting of 2 
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alpha and 2 delta-chains, and less than 1,7% haemoglobin F consisting 
of 2 alpha and 2 gamma-chains. 
In fetuses and neonates HbF is the predominant haemoglobin. Shortly 
after birth, an ill-understood mechanism switches off the gene directing 
the manufacture of gamma-chains and turns on that for producing beta-
chains, with resultant increased production of HbA. The proportion of 
HbF thence decreases until it reaches adult quantities at about the age 
of 6 months, when HbA is the predominant haemoglobin. The relative 
amounts of the various haemoglobins are important as they are disordered 
in the thalassaemias and provide the most important diagnostic tool. 
THE THALASSAEMIAS 
The thalassaemias are a heterogenous group of disorders occurring as a 
result of a quantitative decrease in globin chain production. In beta-
thalassaemia there is a decrease in beta-chain synthesis, while in 
alpha-thalassaemia there is a decrease in alpha-chain production. There 
can also be disturbed delta-chain production which will be discussed 
more fully later in the text. 
Alpha-thalassaemias 
Homozygous alpha-thalassaemia, where there is no alpha-chain production, 
is incompatible with life and results in a hydrops fetalis. 
Heterozygous alpha-thalassaemia is often asymptomatic though it may give 




In homozygous beta-thalassaemia (thalassaemia major), the proportion 
of HbF and HbA2 are far greater than normal. The gross chain imbalance 
causes a haemolytic anaemia and significant ineffective erythropoiesis 
which results in a severe clinical and haematological disorder. Clini-
cally, the untreated patient is extremely anaemic, growth retarded, may 
have massive hepatosplenomegaly and classically has a "mongoloid" 
facies. The prognosis is poor in untreated cases who usually die in 
childhood of infections or cardiac failure. Treatment is essentially 
blood transfusion together with an iron chelating agent, as well as 
appropriate supportive measures. The treatment, however, is not with-
out complications as it adds to the problem of iron overload and resul-
tant haemachromatosis which is, in addition, one of the natural sequelae 
of the disorder. With this therapy prognosis is improved, but life 
expectancy is nevertheless limited to the second or third decade. The 
cause of death is usually cardiac failure occurring as a result of 
haemachromatosis affecting the heart and exacerbated by anaemia. 
Heterozygous beta-thalassaemia (thalassaemia minor, beta-thalassaemia 
trait) is a far less severe condition. It is often totally asympto-
matic though it may also result in an anaemia requiring active manage-
ment. At times of stress, such as during a concurrent illness, preg-
nancy or puberty in females, an anaemia may become apparent which on 
subsequent investigation proves to be thalassaemia minor. Asymptomatic 
individuals mar be diagnosed as having thalassaemia minor during 
haematological population surveys or during family studies. 
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Glucose-6-phosphate dehydrogenase (G-6-PD) deficiency 
G-6-PD is an enzyme occurring in the red blood cell and is important in 
maintaining red cell membrane integri ty. Red blood cells deficient in 
G-6-PD haemolyse under certain conditions which include the ingestion 
of fava beans and certain corrmonly used drugs such as acetyl salicylic 
acid preparations, certain anti-malarial medicines and some of the 
sulphonamide group of drugs. Haemolysis may also occur following cer-
tain infections, e.g. infectious hepatitis. G-6-PD deficient infants 
may have a severe neonatal bilirubinaemi a. 
Cape Town has a small but significant Greek population of about 5000. 
Considering that the prevalence of thalassaemia heterozygotes in 
Greece varies from 6-18% and that of G-6-PD deficiency from 1-41%, 
depending on the area surveyed, it could be expected that the Greek 
population of Cape Town would have incidences of these disorders 
occurring within the above ranges, depending on their origin in Greece. 
From the infonnation given above it can be seen that thalassaemia, and 
to a lesser extent G-6-PD deficiency, carry a notable mortality and 
morbidity. Furthermore, extrapolating from the prevalence in Greece, 
it could be expected that these disorders would occur in significant 
proportions in Cape Town. 
The knowledge to be gained from the haematological and genetic investi-
gation which was carried out would have important implications for both 
the medical authorities and the Greek co111T1unity of Cape Town. 
In summary, the practical value of such an investigation includes: 
1. Collection of factual data concerning the incidence of the 
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disorders; hence, the magnitude of the problem can be assessed. 
2. Any change in incidence of the disorders could be noted and 
discussed. 
3. Information as to the incidence and significance of other blood 
disorders could possibly be gained. 
4. Affected individuals could be counselled in terms of prophylaxis, 
treatment and prognosis. 
5. Couples at risk could be counselled concerning the risks involved 
in procreation, while those not at risk could be reassured. 
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SECTION I 
A REVIEW OF GREECE, ITS PEOPLE AND THEIR 




Greece is situated in south-eastern Europe and occupies the 
southernmost extremity of the Balkan peninsula and the islands of the 
Aegean sea, numbering about 400 as far south as Crete. It is 131 944 
sq. kilometres in area and has a population of approximately 9 million 
people. 
A. PHYSICAL GEOGRAPHY 
The physical geography, with special reference to the climate and 
vegetation, is of significance as it has influenced the nature and 
distribution of genetic disorders found in persons of Greek origin. 
Malaria was endemic in southern Europe where the physical geography 
allowed the vector to thrive. It has been postulated (as will be dis-
cussed further on in the text) that the inherited haematological dis-
orders found in Greeks have a marked prevalence due to the protection 
these disorders provided against malaria. 
The sea dominates Greece. The many anns and inlets result in numerous 
peninsulas and no region in Greece is situated far from the sea. The 
next most significant feature is the mountains, which cover three-
quarters of the surface of Greece. These fonn a network running from 
north-west to south-east : Finally, there are lowlands, consisting of 
a thin, broken coastal strip, narrow valleys, small plains and basins. 
There are striking regional variations in climate due to the physical 
diversity of the land. Basically, the climate is of the Mediterranean 
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type with the rains occuring in winter. Due to the situation of the 
mountain ranges, the Ionian coast has a heavier rainfall than the 
eastern sector. Summers are hot and dry almost everywhere with the 
average July temperature at sea level being about 27°C. However, the 
mountains of the interior have some summer rains and the coast is 
! 
subject to sea breezes. 
Vegetation is diverse due to the topographical variations of the land. 
The mountainous north has deciduous , trees, whereas southern Greece 
has largely scrub. The vegetation of the lowlands consists of trees 
and shrubs. 
B. ORIGIN OF THE GREEK PEOPLE 
The progenitors of the Greek people are the Minoans and Mycenaens, 
who came from Asia Minor or the Middle East to Greece between 3000 and 
5000 B.C. and developed the first civilizations of ancient Greece on 
Crete. In 1100 B.C. the Dorians, a bloodthirsty, violent people from 
the Danube valley, invaded the Peloponnese, the Greek mainland and 
Crete. This resulted in the indigenous Argives moving east and 
settling along the Ionian coast of Asia Minor where large cities and 
centres of artistic and scientific thought were founded. 
In the 6th century B.C. Dorian arms, Aegean galleys and Ionian 
business acumen combined to make Greece pre-eminent from Spain to the 
Black Sea. In succeeding centuries the Macedonians, Persians, Romans, 
Byzantines all cqnquered Greece. The warlike Macedonians came from 
the north under Philip and subsequently his son, Alexander the Great, 
founded an empire extending from India to North Africa. In the years 
after the birth of Christ, Greece was conquered by a variety of nations 
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Figure 1 - 1 Greek National Dress 
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including the Vandals, Huns, Slavs, Bulgarians, Franks, Catalans, 
Venetians, Genoans and Turks. In the Greek War of Independence 
which lasted from 1821 to 1829 Greece finally freed herself from 
Turkish domination and became an independent monarchy. It is probable 
that the various conquerors of ancient and modern Greece contributed 
to the gene pool of the present day Greek people. 
C. SOCIO-ECONOMIC BACKGROUND 
Fifty-five percent of Greece's exports are agricultural in 
nature, although foodstuffs still have to be imported. Greece is not 
important industrially or in international trade and individuals have 
a low per capita income. As a result of these poor economic conditions 
there is a constant emigration from Greece. During the nineteen 
sixties alone, it has been estimated that approximately one million 
Greeks emigrated, especially to America, Canada and Australia and to a 
lesser extent, to South Africa. 
The Eastern Orthodox Church is a strong unifying force amongst the 
Greek corrrnunity but not to the same extent as the family unit. Close 
bonds within the family extend into their business and economic 




The majority of the Greek population of Cape Town have their 
antecedents on the island of Lesbos. Lesbos is one of the five 
Greek islands situated in the northern Aegean Sea. The others are 
Lemnos, Chios, Samos and Icaria. 
A. PHYSICAL GEOGRAPHY 
Lesbos, also known as Mytelene, has an area of 1630 sq. kilo-
metres, a population of 117 400 and is the largest north-east Aegean 
island. The vegetation is diverse, varying from the luxuriant and 
wooded region in the south-east around Agiassos, to the barren wilder-
ness region in the south-west. The pine-covered coastal mountains 
are broken up by valleys containing lush olive groves. The climate is 
Mediterranean in type. 
B. HISTORY AND ORIGINS OF THE POPULATION 
The north-east Aegean islands have played an important part in 
and seen much of the early growth of western civilization. The 
islanders were originally descended from the Pelasgians and Ionians 
who fled the Greek mainland following the Dorian invasion of the 
Peloponnese. From the 8th to the 16th century B.C. Lesbos, together 
with the other north-east Aegean islands, were in the vanguard of 
Greek civilization and made important contributions to both science 
and the arts. However, the great cities which grew up in these 
regions were too individualistic and fiercely independent to unite 
even against a common foreign foe and as a result they were doomed 
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Fig. 2 - l Typical town on the island of Lesbos 




. tion to Lesbos Origins of m1gra 
- 14 -
to live under a succession of conquerors. They first fell under 
Lydian and Persian rule before falling to successive invading armies, 
including the Byzantines, Crusaders and Genoese. Finally, the Turks 
held Lesbos from the 15th century. These invaders all contributed to 
the culture of the islands and to the gene pool of the population. 
Although the islanders played a courageous and important role in the 
Greek War of Independence of 1821, it was not until 1927 that Lesbos 
became a part of Greece. 
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CHAPTER 3 
POPULATION GROUPS OF SOUTH AFRICA 
A. SOUTH AFRICA 
South Africa has a population of approximately 25,5 million 
people. This is made up of 18 million African Negroes, 3 million Cape 
Coloureds and Asiatics and 4,2 million Whites. Of this latter group 
approximately 60 000 are of Greek orig i n. 
The White section comprise peoples mainly of Dutch and British descent 
and to a lesser extent French, German, Portuguese, Greek and Italian. 
The first Whites from Holland arrived in South Africa in 1652 to 
establish a hospital and refreshment station for ships of the Dutch 
East India Company. In 1688 the French Huguenots fleeing religious 
persecution arrived at the Cape and in 1820, after the Napoleonic 
Wars, 5000 Britons settled in t he Eastern Cape. Italian, Greek and 
Portuguese people came in small numbers on their own initiative in 
the late nineteenth and early twentieth centuries. 
In the early nineteen sixties, when South Africa actively recruited 
immigrants, larger numbers of these Mediterranean peoples immigrated to 
South Africa. 
B. CAPE PENINSULA 
When the first White settlers arrived in the Cape in 1652 they met 
the Bushmen who were roving hunters and the Hottentots who were herds-
men. Blood of these peoples is still to be found in the Cape Coloured 
population, a group of mixed ethnic background. 
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The first Whites to settle in Cape Town were the Dutch, followed by 
the French Huguenots who were fleeing religious persecution in Europe. 
After British occupation of the Cape in 1806, many British subjects 
also settled. By virtue of the city being a major sea port, persons of 
many nationalities have passed through Cape Town, while others have 
left some of their genes behind. During South Africa's drive for 
immigrants in the 1960s Cape Town received peoples of different origins. 
The overall result is that the present day population is fairly cos-
mopolitan. 
Cape Town at present has a population of about 1,1 million. These are 
made up of 47% Cape Coloureds, 34% Whites, 10% African Negroes and 8% 
Asiatics. Included in the White population group are the Greeks, who 
number about 5000 and represent 1,3% of this group. 
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CHAPTER 4 
THE GREEKS IN SOUTH AFRICA 
A. SIZE OF POPULATION, DISTRIBUTION AND ORIGIN 
At present the Greek population in South Africa numbers between 
55 000 and 65 000, the greatest proportion of whom reside in the large 
centres. Johannesburg and the Witwatersrand have between 45 000 and 
50 000 Greek people. Approximately 20% of these individuals originate 
from Cyprus, while ~he rest come from the Peloponnese, the islands of 
Ithaca, Lesbos and Lemnos and to a lesser extent, the other islands. 
Durban has a Greek conununity of about 2000 individuals, as does Port 
Elizabeth and small numbers of Greek people.are scattered in most 
towns in South Africa. 
As previously mentioned Cape Town, with a population of just over one 
million people, has a Greek community of approximately 5000. Between 
70% and 80% of Cape Town's Greek population originate from Lesbos, 
while the remainder have their antecedants in Cyprus, Lemnos, Cephalonia, 
Athens, the Peloponnese and the other islands. The reason for the high 
proportion of people being from Lesbos is that one of the first Greek 
people to arrive in Cape Town was from this island and he, finding 
local circumstances to his liking, brought out his brothers. They in 
turn brought their cousins to the Cape. This practice snowballed, with 
individuals encouraging their family and friends to emigrate to Cape 








Fig. 4 - 1 Distribution of the Greek population in the major 















The Greeks in South Africa can be traced back to about 1850. The 
first visitors were seamen, most of whom did not stay long in Cap_e 
Town before returning to Greece. With the discovery of diamonds and 
gold, more Greek people (as with other population groups) were 
attracted to South Africa and by 1902 Cape Town's Greek community 
numbered about 1000. This population fluctuated as many went north to 
the goldfields of the Witwatersrand. 
In 1900 a Greek Orthodox priest from Crete was sent to Cape Town to 
establish a Greek community and thereafter the church played an im~ 
portant and leading role. In 1903 the constitution of the community 
was formulated and the foundation stone for the first Greek Orthodox 
church in South Africa was laid. The church was completed in 1904 
and is still in use today. In the following decade additional 
communities were established in Johannesburg and Pretoria. 
By 1915 there were about 1500 Greeks in Cape Town but with the 
coming of the First World War in 1914, many of Cape Town's Greeks 
returned to help defend Greece. The result was that by 1925 there were 
only approximately 250 Greeks in Cape Town. At this time the number of 
foreigners allowed into South Africa was restricted, which further 
depleted Cape Town's Greek population. 
The population subsequently numbered about 1000 by 1960. In 1961 
inmigration offices were opened in several European countries, including 
Greece, to find and recruit suitable immigrants for South Africa. The 
result was that Cape Town's Greek population grew rapidly from 1000 in 
1960 to about 5000 in 1975. 
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Fig. 4 - 2 Migration from Greece to South Africa 
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Fig. 4 - 3 Greek Orthodox Church, Cape Town 
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At present the Greek population is static, with few new ilTITligrants 
coming to Cape Town. The reason for this situation is that Anglo-
Saxon ilTITligrants are presently favoured, while South Africa's current 
political situation is not encouraging to potential immigrants. How-
ever, Cape Town has recently acquired some Greeks who have emigrated 
from Rhodesia as a result of that country's internal and external 
problems. 
C. LIFE STYLE 
Of the 40 Greek families in Cape Town in 1925, almost all owned 
tearoom businesses. The situation at present is far more diverse, 
with members of the Cape Town's Greek community being in the profes-
sions, in conrnerce and employed as artisans. However, a large propor-
tion still own cafes and work long, inconvenient hours. 
The main congregating places for members of the Greek community are 
the church on Sundays and at the Greek cinema. Greek films are shown 
weekly at a local cinema on Sunday evenings, which is very popular 
and a favourite meeting venue. 
Individuals of the Greek community tend to marry within the community 
and often marry spouses from the same island and town. There are 




A HISTORICAL REVIEW OF THE INHERITED 
HAEMATOLOGICAL DISORDERS KNOWN TO BE 




Although thalassaemia has only been defined relatively recently, 
it has been present as a clinical entity for a long time. Zaino (1964), 
after studying the skulls of ancient man and their radiographs and 
recognizing the characteristic changes of thalassaemia, has come to the 
conclusion that the condition originated over 50 000 years ago in the 
now inundated Mediterranean valley south of Italy and Greece and thence 
spread to the rest of the world. 
Cooley and Lee (1925) reported 5 children with anaemia, hepatospleno-
megaly, skin pigmentation, thickening of the long bones and skull, 
decreased red cell osmotic fragility and leucocytosis. While the 
heterogenous group of childhood anaemias had previously been grouped 
together under the genera 1 term "Van Jaksch I s anaemia 11 , Cooley, in 
writing a critical review of these in 1927, clearly defined those 
cases he. had investigated as a specific separate condition. 
Thalassa (ea>.cxcracx) means 11 sea 11 in Greek and on this basis Whipple and 
Bradford (1930) coined the term 11 thalassaemia 11 • They noted the 
Mediterranean distribution of the disorder and suggested that a meta-
bolic defect might be responsible. 
At about the same time cases of haemolytic jaundice with decreased 
osmotic fragility were reported in the Italian literature. They became 
known as "La malattia di Rietti-Greppi-Micheli 11 with the haematological 
aspects being emphasized to distinguish it from familial acholuric 
jaundice (Rietti, 1925; Greppi, 1928; Micheli, Rietti and Momigliano, 
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1935). 
The first claim that thalassaemia was inherited, followed a report of 
a child with thalassaemia major whose parents had mild red cell 
abnormalities (Caminopetros, 1938). Hereafter many cases of both 
syndromes were reported in the American and European literature. Win-
trobe, et al (1940) described a haemolytic anaemia which they considered 
to be a mild form of Cooley's anaemia in 14 members of 3 Italian 
families. 
Rietti (1946) in a review of the literature equated the Rietti-Greppi-
Micheli syndrome with the cases reported by Wintrobe. Subsequently, 
after formal genetic investigations, it was established that Cooley's 
anaemia represented the homozygous state of a partially dominant auto-
somal gene (i.e. heterozygotes may manifest some of the symptoms and 
signs of the disorder) and that the cases reported by Wintrobe, et al 
(1940) and the Rietti-Greppi-Micheli syndrome represented the hetero-
zygous state. Family studies now revealed that the parents of patients 
with Cooley's anaemia had grades of haematological abnormalities which 
varied from a moderately severe haemolytic anaemia to minor changes 
such as a slight increase in osmotic fragility (Silvestroni and Bianco, 
1949). Other names for the syndrome at this time included target cell 
anaemia (Damashek, 1940), familial microcytic anaemia (Strauss, Daland 
and Fox, 1941), Mediterranean haemopathic syndromes (Chini and Valeri, 
1949) and hereditary eliptocytosis (Convnittee for the clarification of 
the nomenclature, 1950). 
The discovery by Pauling, et al (1949) that sickle cell disease is 
caused by an inherited defect in the globin portion of the haemoglobin 
led to intensified study of the molecular basis of the haemoglobin 
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molecule in health and disease. The study of abnonnal haemoglobin 
variants associated with thalassaemia and of the various haemoglobin 
fractions led to the conclusion that thalassaemia is, in fact, a 
heterogenous group of genetic disorders of haemoglobin synthesis 
(Itano, 1957; Ingram and Stretton, 1959). 
As a result of the improved techniques in molecular biology, isolation 
of messenger ribonucleic acid (mRNA) has now become feasible and Benz 
and Forget (1971) and Nienhuis and Anderson (1971) have demonstrated 
that a defect of mRNA is responsible for decreased synthesis of beta-
chains in beta-thalassaemia. Similarly, Ottolengi, et al (1974) proved 
that a gene delection is usually the fundamental abnonnality in alpha-
thalassaemia. 
The most recent progress in the study of the thalassaemias has been in 
the application of the present status of knowledge. A major step has 
been made with the discovery that beta-chain synthesis is activated at 
a low level as early as 8 weeks gestation (Wood and Weatherall, 1973) 
and that the beta-thalassaemia defect is expressed during early life 
(Kan, et al, 1975). A second important development has been the im-
provement of techniques enabling fetal blood to be sampled (Hobbins 
and Mahoney, 1974; Kan, et al, 1974). This progress has now led to 
certain specialized centres being able to diagnose thalassaemia major 
antenatally early enough to terminate an affected pregnancy (Fair-
weather, et al, 1978). 
The present state of knowledge concerning the molecular basis of 




GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G-6-PD) DEFICIENCY 
The precipitation of haemolytic crises after exposure to certain 
environmental agents has long been recognized and it is likely that 
G-6-PD deficiency was known in ancient times. In the 6th century B.C. 
Pythagoras forbade his disciples to eat fava beans as he asserted that 
his grandfather had been reincarnated as a bean (Tingey, 1961). How-
ever, it is possible that he empirically recognized the problem of 
favism! In the 5th century B.C. favism was mentioned by Herodotus 
(Jacobs, 1950). At the present time older Greek physicians remember 
their teachers recommending that army recruits should not be issued 
with blankets until they were aired and free of the fumes of mothballs 
as they contain naphthalene which induces haemolysis in G-6-PD deficient 
individuals (Kirkman, 1971). 
As early as 1926 Cordes reported the occurrence of acute haemolytic 
anaemia amongst workers treated with plasmochin for malaria. In World 
War 2 when troops of different ethnic groups were given primaquine it 
was noticeable that the red blood cells of Negroes underwent haemolysis 
far more commonly than in other persons. This was further substantiated 
by Earle, et al (1948) who reported that 5 to 10% of American Negroes 
suffered from pamaquin-induced haemolysis, although this complication 
occurred rarely in Caucasians. Hockwald, et al (1952) made similar 
observations during an evaluation of the less toxic drug, primaquine. 
They also noted that the severity of the haemolysis was related to the 
amount of the drug administered. 
Using prison volunteers in a malaria research unit at Joliet, U.S.A. 
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Dern, et al (1954) showed that primaquine sensitivity is due to an 
intrinsic defect of the red blood cells. They removed blood samples 
from sensitive individuals, labelled their red cells with 51cr, a 
radioactive isotope of chromium, and then transfused them into a non-
sensitive person. Primaquine was then administered and hemolysis of 
the 51cr labelled (sensitive) red cells was shown to occur. A reci-
procal experiment in which 51cr labelled non-sensitive red cells was 
transferred into a sensitive individual who was then given primaquine, 
was perfonned. These cells did not undergo rapid hemolysis. It was 
thus proved that the defect in a sensitive person lay in the red cell 
itself. 
Dern, Beutler and Alving (1954) demonstrated that haemolysis is self-
limiting in that clinical recovery occurs even if the daily dose of 
the "trigger" drug is continued. 
Beutler and co-workers (1955) discovered the first biochemical ab-
normality in the drug-sensitive cells. This was a low content of 
reduced glutathione (GSH). Flanagan, et al (1958) found that the 
amount of GSH in the red cells of sensitive persons fell just before 
these red cells underwent destruction after the ingestion of primaquine. 
This observation, besides being an important clue to the biochemical 
basis of the haemolytic process, also led to an in vitro test for 
primaquine sensitivity (Beutler, 1957). 
Glutathione reductase and reduced nicotinamide adenine dinucleotide 
phosphate (NADPH) are necessary to maintain glutathione in the reduced 
state in the red cells of man. NADPH is generated in the erythrocytes 
by G-6-PD. Carson, et al (1956) demonstrated that the activity of 
G-6-PD is markedly reduced in the red cells of primaquine sensitive 
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individuals. This represents a double handicap in ability to generate 
NADPH, for the product of G-6-PD becomes the substrate for 6-phospho-
gluconate dehydrogenase (6-PGD), the other principal NADPH generating 
enzyme of human erythrocytes. 
Sansoni and Segni (1956) and Szeinberg, et al (1957) noted that drug-
induced haemolytic anaemia and favism tend to occur in the same persons 
and that their red cells had a low GSH content. Panizon (1958) demon-
strated that sulfanilamide had a similar haemolytic effect. Thereafter, 
other drugs including nitrofurantoin, azulfidine and acetanilid were 
found to cause haemolysis in sensitive individuals (Kirkman, 1971). 
Kimbro, Sacks and Torbert (1957) and Zinkham and Childs (1957) recorded 
that drugs causing haemolysis in sensitive individuals are either 
oxidation-reduction compounds or converted to oxidation-reduction com-
pounds during metabolism. 
The early investigation subjects were predominantly men (soldiers, 
prisoners and labourers) and it was only in 1958 that Childs, et al, 
demonstrated that the abnormality was transmitted in an X-linked 
pattern with intermediate dominance, which implies that some of the 
genetic heterozygotes might suffer to a variable extent the effects of 
the disorder. Males fell into two separate categories - those with 
high or low levels of G-6-PD; whereas females from affected families 
had levels which varied from the highest to the lowest male values. 
Some had values independent of their fathers' values, while daughters 
of affected males often had intermediate or low values and fully 
affected females had affected sons. Similar conclusions concerning 
the mode of transmission were drawn from work on Caucasians of 
Mediterranean origin by Zinkham, Lenhard and Childs (1958). 
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In 1960, Motulsky and Allison separately noted that the global geo-
graphic distribution of G-6-PD deficiency and falciparum malaria 
coincided and proposed that G-6-PD deficiency conferred some selective 
advantage against this type of malaria . This correlation has since 
been demonstrated in local areas in Greece (Stomatoyannopoulos and 
Fessas, 1964) and in Cyprus (Plato, Rucknagel and Gershowitz, 1964). 
The most comprehensive work illustrating this relationship was presented 
by Siniscalco (1966) on Sardinia, where malaria was endemic in coastal 
areas until the 1940s. The Sardinian population is relatively stable 
and these investigators found that individuals in the coastal areas 
have a far higher gene frequency of G-6-PD deficiency than people in 
the malaria-free higher altitude regions. The best evidence of the 
resistance of G-6-PD deficient cells to the malarial parasite was 
presented by Luzzatto, Usanga and Reddy (1969). Using the phenomenon 
of X-chromosome inactivation in females, they demonstrated that G-6-PD 
deficient red cells contain fewer malarial parasites than do normal red 
cells. Women who were heterozygous for G-6-PD deficiency (and thus had 
2 cell lines) and were infected with malaria, were found to have fewer 
malarial parasites in their G-6-PD deficient red cells than their 
normal red cells. 
At present more than 100 different types of G-6-PD have been recognized 
and in the majority defective activity can occur. Each year more of 
these are diagnosed but, apart from this progress, no particularly 
significant recent discoveries regarding this condition have been made. 
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SECTION I II 
A DETAILED REVIEW OF THE INHERITED HAEMATOLOGICAL DISORDERS 
FOUND IN THE GREEK POPULATION OF CAPE TOWN 
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THE THALASSAEMIAS - A CLASSIFICATION 
CLASSIFICATION 
1. Alpha-Thalassaemias 
A. Alpha-Thalassaemia 1 
B. Alpha-Thalassaemia 2 
C. Chain tennination mutants 
e.g. Haemoglobin Constant Spring 
2. Beta-Thalassaemias and delta-beta-Thalassaemias 
A. Beta+ Thalassaemia 
B. Beta0 Thalassaemia 
C. Delta-beta Thalassaemia 
D. Non alpha-chain fusion syndromes 
e.g. Haemoglobin Lepore 
3. Hereditary persistence of fetal haemoglobin 
A. With homogenous distribution of fetal haemoglobin 
B. With heterogenous distribution of fetal haemoglobin 




1. HISTORICAL INTRODUCTION AND MOLECULAR BASIS 
The alpha-thalassaemias are a distinct group of hereditary 
haematological disorders caused by a defect in alpha-chain production. 
All the haemoglobin is equally affected and there is no alteration in 
the relative amounts of haemoglo~ins A, A2 and F produced. This latter 
fact results in problems in the diagnosis of the carrier state of alpha-
thalassaemia and difficulty in defining the genetic transmission of 
these disorders. 
The initial reports on this disorder emanated almost simultaneously 
from Greece and the United States (Gouttas, et al, 1955; Rigas, Kaler 
and Osgood, 1955). Haemoglobin H was shortly thereafter demonstrated 
to be a tetramer of beta chains (Jones, et al, 1959). At about this 
time, a new haemoglobin variant, designated haemoglobin Bart's, was 
discovered in a baby at St. Bartholomew's Hospital, London (Ager and 
Lehman, 1958). This haemoglobin was characterized as being a tetramer 
of gamma-chains with a molecular formula (Hunt and Lehman, 1959). 
It was now suggested that y4 and 84 were formed as a result of 
decreased alpha-chain production, thus resulting in haemoglobin Bart's 
and haemoglobin H (Ingram and Stratton, 1959). The discovery that 
adults with haemoglobin H disease often have traces of haemoglobin 
Bart's in their red cells lent further weight to this hypothesis 
(Fessas, 1960). Finally, a decreased rate of production of alpha-
chains was demonstrated by studies of in vitro alpha- and beta-chain 
production by Weatherall, Clegg and Naughton (1965). 
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Haemoglobin Bart's and Hb H disease are the two main clinical dis-
orders resulting from a defect of alpha-chain production. These 
result from the interaction of the alpha-thalassaemia genes: 
(A) alpha-thalassaemia 1 gene, which results in complete 
abolition of alpha-chain synthesis; 
(B) alpha-thalassaemia 2 gene, a milder gene resulting in 
partial reduction in alpha-chain synthesis; 
(C) Hb Constant Spring, an alpha-chain variant synthesized 
in very low amounts. 
(A} Alpha-thalassaemia 1 
Infants with Hb Bart's hydrops syndrome produce no alpha-chains 
(Weatherall, Clegg and Wong, 1970). It has now been demonstrated by 
Taylor et al (1974) and Ottolenghi et al (1974) that the absence of 
alpha-chains in this syndrome is due to absence of functional alpha-
chain mRNA. Experiments involving hybridization of DNA prepared from 
the liver of an alpha-thalassaemia 1 homozygote with purified copy 
DNA probes made from normal globin mRNA, together with viral reverse 
transcriptase, showed that alpha-chain genes are absent from the 
chromosomes of the affected babies. 
In summary, therefore, alpha-thalassaemia 1 is the result of a gene 
deletion of the alpha-chain genes. 
(B) Alpha-thalassaemia 2 
Good evidence suggests that human alpha-chain genes are 
duplicated {Lehman and Lang, 1974, Rucknagel and Winter, 1974). If 
one considers that alpha-thalassaemia 1 results from a deletion of 
both of the genes, it is reasonable to assume that alpha-thalassaemia 2 
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is a deletion c;>f one of the genes. Thus, an individual suffering from 
Hb H disease would be heterozygous for both alpha-thalassaemia 1, where 
no alpha-chains are present, and for alpha-thalassaemia 2, where one 
functional chain gene (locus) is present. 
Experiments involving the measurement of alpha-chain mRNA in the cells 
of patients with Hb H disease have indicated that the amount of alpha-
chain mRNA is decreased in these individuals (Benz, Swerdlow and Forget, 
1973; Pritchard, et al, 1974) . Kan, et al (1973) demonstrated that the 
kinetics of hybridization of Hb H disease DNA are compatible with the 
loss of 3 out of 4 genes. Since alpha-thalassaemia 1 DNA has no alpha-
genes, this indicates that the alpha-thalassaemia 2 DNA is lacking one 
of the pair of alpha-genes on the affected chromosome:. 
(C) Chain Termination Mutants 
Patients with Hb H disease from various race groups have been 
found to have small quantities of an alpha-chain haemoglobin variant. 
This variant was first characterized in a family from Constant Spring, 
Jamaica, hence the name Hb Constant Spring. It has been found that 
patients with one alpha-thalassaemia 1 gene and the gene for Hb Constant 
Spring have typical Hb H disease. Thus, this mutation behaves in the 
same way as the alpha-thalassaemia 2 gene. Hb Constant Spring has an 
elongated chain with 31 extra residues at the C- terminal end, due to 
a single base change in the mRNA. 
As a result of different base substitutions, further haemoglobin 
variants with differing substitutions at position 142, but with the 
same additional amino acid residues in the rest of their chains have 
been recognised; hence Haemoglobin Icaria (Clegg, et al, 1974) and 
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Haemoglobin Koya Dora (De Jong, Khan and Bernini, 1975). Still other 
hypothetical variants remain to be discovered. 
As there is no alpha-Constant Spring chain synthesis in reticulocytes, 
it has been suggested (Clegg and Weatherall, 1976) that alpha-Constant 
Spring mRNA is relatively unstable. This would explain why chain-
tennination mutant haemoglobins are synthesized only in small quanti-
ties. 
2. CLINICAL ASPECTS 
(A} Haemoglobin Bart's Hydrops Fetalis Syndrome 
This lethal syndrome results from the homozygous alpha-thalassaemia 
1 state, in which no alpha-chains are produced. The infants, usually 
born prematurely, have low birthweights and 50% are stillborn. The 
remainder die within the first hour of life. The gross findings are 
those of generalized oedema, pallor, hepatosplenomegaly and ascites. 
As no cases of haemoglobin Bart's hydrops fetalis were found in the 
course of the survey, this subject will not be discussed in detail. 
(B) Heterozygous Alpha-Thalassaemia 
Individuals with this disorder may have haemoglobin H disease 
(described below) or be totally asymptomatic and only diagnosed on 
screening programmes. In this latter group, clinical and haemato-
logical findings may be minimal and diagnosis may prove to be ex-
tremely difficult. 
This disorder, like haemoglobin Bart's hydrops fetalis, has a par-
ticularly high incidence in South East Asia (Wasi et al, 1969), 
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Yeminite and Iraqi Jews (Zaizov and Matoth, 1972) and in Shiite Arabs 
(Pembrey, et al, 1975). Other high incidence areas include Greece and 
Cyprus (Fessas, 1969). 
Haemoglobin H disease is discussed below but it should be borne in mind 
that findings enumerated may occur in nil or varying degrees in those 
persons with heterozygous alpha-thalassaemia (i.e. carrying 1 or 2 of 
the implicated genes). 
(i) Clinical Manifestations 
The clinical expression of the disorder may be extremely 
variable, from a virtually asymptomatic state to the picture of homo-
zygous thalassaemia. The majority of patients, however, have the 
appearance of thalassaemia intermedia. Features include pallor, 
hepatosplenomegaly and, in a significant proportion, mongoloid facies 
and bone changes similar to that of homozygous beta-thalassaemia. 
(ii) Haematological Manifestations 
Haemoglobin varies from 3-139% but usually is in the 7-109% 
range. There is usually a moderate reticulocytosis, varying from 
4-5%. Peripheral blood smear reveals microcytosis, hypochromia, 
anisocytosis and poikilocytosis. 
Incubation of red cells with brilliant cresyl blue for 30 minutes at 
room temperature reveals inclusion bodies in some of the cells. This 
is precipitated haemoglobin Has a result of the redox action of the 
dye. In addition, numerous Heinz bodies are found after splenectomy 
(Weatherall and Clegg, 1972). 
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(iii) Haemoglobin Pattern 
On starch gel electrophoresis at alkaline pH, haemoglobin H 
moves at a speed similar to haemoglobin I and more slowly than haemo-
globin A. On electrophoresis at pH 6,5 haemoglobin H can clearly be 
distinguished from other haemoglobin variants by its anodal migration 
(Weatherall and Clegg, 1972). ·Most patients with haemoglobin H disease 
have an additional haemoglobin component. This component moves more 
slowly than haemoglobin Hat pH 8,6 and nearer to the cathode than 
haemoglobin Hat pH 6,5. This fraction is haemoglobin Bart's (Ramot, 
et al , 1959) . 
The total amount of haemoglobin Hin the red cells of patients with 
haemoglobin H disease varies from 4-30%. Wasi, et al (1969) in their 
series found an average of 8%. In addition, they found an average of 
4,8% haemoglobin Bart's in their subjects. 
A third component, consisting of delta-chains, has also been isolated 
from patients with haemoglobin H disease. This component has not been 
fully characterized (Dance, Heuhns and Beavers, 1963). 
The levels of haemoglobin H, Bart's and A2 vary greatly in haemoglobin 
H disease. Weatherall and Clegg (1972) have suggested that this may 
depend on the activity of the gamma locus. Alpha-chains have a greater 
affinity for beta- than gamma chains and thus the more active the gamma 
locus is, the more haemoglobin Bart's as compared to haemoglobin H will 
be present. 
(C) Chain Termination Mutants 
Haemoglobin Constant Spring, the most fully characterized chain 
termination mutant, is most frequently diagnosed in association with 
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alpha-thalassaemia 1 to produce ~ypical haemoglobin H disease clini-
cally (Clegg and Weatherall, 1976). 
In Thailand, 40% of haemoglobin H disease results from the interaction 
of an alpha-thalassaemia 1 gene and a haemoglobin Constant Spring gene 





In broad terms the beta-thalassaemias can be defined as a hetero-
genous group of inherited haematological disorders occurring as a result 
of decreased synthesis of the beta-globin chain. 
HISTORICAL INTRODUCTION AND MOLECULAR BASIS 
In 1954 Pauling first suggested a relationship between the clinical dis-
order, thalassaemia, and globin synthesis. Ingram and Stretton (1959) 
noting that some of the thalassaemias interact with some of the haemo-
globin variants, such as haemoglobin S, and have raised levels of 
haemoglobin F and A2, suggested that the defect may be in beta-chain 
production. They thus named this group of disorders the beta-
thalassaemias. 
From about this time, the great heterogeneity of the thalassaemia dis-
orders was noted. It was observed that there may be a total (beta0 ) or 
partial (beta+) deficiency of beta-chains. In addition, the synthesis 
of delta-chains may be involved, resulting in the delta-beta-thala-
ssaemias in which the HbA2 level is not raised. Finally, there may 
also be fusion of delta- and beta-chains, resulting in the haemoglobin 
Lepore syndromes. To make matters more complex, it has been discovered 
that the above broad groups can be further subdivided at a molecular 
level. For example, in beta0 -thalassaemia (Ferrara) beta-chain mRNA is 
present, though in small quantities, whereas in classical beta0 -thala-
ssaemia there is no beta-chain mRNA. 
Nevertheless, it is still further complicated by the claim that beta-
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chain synthesis can be induced in the Ferrara type by the ribosome-
free supernatant fraction from normal reticulocytes or by blood trans-
fusion (Conconi, et al, 1975). It has also been suqgested that 
although there is a total absence of mRNA in beta0 -thalassaemia 
(Pritchard, et al, 1974), at least in some cases a highly unstable 
mRNA is synthesized (Clegg and Weatherall, 1974; Weatherall and Clegg, 
1975). Studies have revealed that both the beta0 and beta+ genes are 
present in Greeks. However, it has not been ascertained whether the 
beta0 is of the classical or Ferrara type (Kattamis, et al, 1978). 
In sunmary, although important advances have been made in the under-
standing of the molecular basis of the beta-thalassaemias, the 
situation has not been fully clarified and much remains to be eluci-
dated. 
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I. THALASSAEMIA MAJOR 
This disorder was first known as Cooley's anaemia, and may also 
be termed homozygous beta-thalassaemia. When the term thalassaemia 
major is used in the text, the author will be referring to homozygous 
beta-thalassaemia or homozygous delta-beta-thalassaemia. 
At birth, infants with this disorder are completely nonnal. Their 
problems begin when haemoglobin A takes over from haemoglobin Fas 
the major component of haemoglobin at about 6 months of age. 
A. CLINICAL FINDINGS 
Initial presenting symptoms are failure to thrive, recurrent 
infections, diarrhoea, pallor and feeding problems. Later, anaemia and 
hepatosplenomegaly, per se, may be discovered at a physical examination 
for other reasons and suggest the diagnosis. If the physician has a 
high index of suspicion the diagnosis is often made in the first year 
of life. 
With increasing age, there will be stunting of growth which may, how-
ever, be avoided by early vigorous therapy. Pallor and jaundice are 
usually present and increased pigmentation may be a feature. Typical 
"mongoloid" facies develop as a result of bone marrow hyperplasia 
which Weatherall and Clegg (1972) have suggested might more appro-
priately be termed "thalassaemic" facies (Fig. 20 - 1), so character-
istic are the changes. There is bossing of the skull and prominence 
of the malar eminences with depression of the nasal bridge and hyper-
trophy of the maxillae, resulting in protrusion of the upper teeth 
(Logothetis, et al, 1971). Recently, digital clubbing has been 
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reported in a significant proportion of thalassaemia major patients. 
This appears to be related to the severity of iron overload and 
hepatic dysfunction (Sinniah, et al, 1978). 
8. RADIOLOGICAL FINDINGS 
The skeletal changes in thalassaemia major are due to overgrowth 
of the bone marrow. The erythroid hyperplasia is a response to in-
creased destruction of defective red cells. Marrow hypertrophy widens 
the medullary cavities and increased intramedullary pressure results 
in atrophy of the spongiosa and corticalis. The shafts of the long 
and short tubular bones are osteoporotic. The cortex is thinned and 
normal bone modelling is lost. The changes are usually most marked in 
the short tubular bones of the hands and feet and in the femora (Fig. 
20 - 6). 
In the skull, marrow hyperplasia results in widening of the diploic 
space and thinning of the outer table. The diploic trabeculae may 
assume a position perpendicular to the inner table, presenting a 
radial pattern and thus resulting in the characteristic 11 hair-on-end 11 
appearance (Fig. 20 - 11) (Mosely, 1962). 
Overgrowth of marrow in the maxillary, sphenoidal and temporal bones, 
besides leading to the mongoloid or rodent facies and maloclusion of 
the jaws, may result in significant underpneumatization of the para-
nasal and mastoid sinuses (Caffey, 1957). Due to expansion of the 
maxillae the orbits may be displaced laterally, producing hyper-
telorism. 
Changes in the vertebral column are usually limited to osteoporosis. 
Pathological fractures of affected bones may occur and may in fact be 
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the presenting symptom (Modell, 1976). 
Abdominal lymphangiography may reveal nodal filling defects in para-
aortic and iliac lymph glands. When correlated with histologic 
findings on nodes removed at splenectomy, these filling defects are 
demonstrated to be haemosiderin deposits and foci of extra-medullary 
erythropoiesis (Parsons, 1977). 
C. HAEMATOLOGICAL FINDINGS 
Untreated individuals are always markedly anaemic with a haemo-
globin of approximately 4 g/100 ml. The anaemia is a hypochromic, 
microcytic type with a low mean cell haemoglobin (MCH) and a low mean 
cell volume (MCV). Peripheral blood smear reveals hypochromia, aniso-
poikilocytosis, many mishapen microcytes, reticulocytes, basophilic 
stippling and characteristically many target cells. 
After splenectomy the red cell characteristically undergoes more 
severe morphological changes and takes on bizarre fonns (Nathan and 
Gunn, 1966). The anisopoikilocytosis is more marked, there are tear-
drop cells and more nucleated cells are present. After staining with 
methyl violet inclusion bodies are found in both reticulocytes and 
nucleated red cells (Fessas, 1963). Fessas has found that these in-
clusion bodies are probably denatured, aggregated alpha-chains (1966). 
Study of these inclusions has revealed that the amount of precipitation 
correlates well with the clinical severity of the disorder. 
There is usually a moderate leucocytosis and normal platelet count 
(Weather~ll and Clegg. 1972). However, the spleen may sequester plate-




The initial disturbance of growth, manifest in early childhood, 
occurs in the presence of grossly active bone marrow. The striking 
clinical feature is lack of muscle tissue, which gives the limbs a 
stick-like appearance. There is also decreased exercise tolerance and 
weakness at this stage (Modell, 1976). Retarded linear growth is 
significant at the aqe of aporoximately 9 years. The degree of 
anaemia shows only slight correlation with the severity of retarded 
height. Systemic abnonnalities, however, appear to reflect the growth 
retardation far more closely (Logothetis, et al, 1972). Secondary 
sexual characteristics have been found to be delayed or absent in 
patients with thalassaemia major. Some reported patients have had 
gonadal dysf~nction with normal pituitary function, whereas in others 
the gonadal dysfunction has been secondary to pituitary dysfunction 
(Lassman, et -al, 1974). 
The abovementioned endocrine abnonnalities are due to iron overload 
and result in haemachromatosis and iron deposition in endocrine organs. 
Further endocrine abnonnalities occurring via this mechanism include 
diabetes mellitus from iron deposition in the pancreas, hypopara-
thyroidism (Oberklaid. 1975), hypothyroidism and adrenal insufficiency 
(Lassman, et al, 1974). 
The cephalofacial deformities leading to the mongoloid facies usually 
become manifest after the first year of life. The maxillary hyper-
trophy leads to protrusion of the incisors and may cause significant 
dental malocclusion. Susceptibility to infections is commonly a 
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problem and rare organisms have been reported in an increased incidence 
(Blum, Viant and Duchy, 1969}. 
Splenic enlargement occurring as a result of increased worklo~d because 
of the splenic breakdown of defective red blood corpuscles and iron 
deposition may cause hypersplenism, followed by neutropenia and thrombo-
cytopenia. Platelet sequestration by an enlarged spleen will worsen 
the thrombocytopenia. Trauma to an hypertrophied spleen, with the risk 
of rupture, may result in a life-threatening situation. 
Now that patients with thalassaemia major survive into the second and 
third decade, the problems of haemosiderosis are bein9 met more 
frequently. The precise relationship between hypertransfusion regimes 
and development of haemosiderosis has as yet not been fully clarified. 
However, some investigators believe that hypertransfusion results in 
the earlier development of siderosis. The most serious complication of 
iron overload is iron deposition in the myocardium. This leads to 
gradual cardiac enlargement and eventual cardiac failure. Anaemia, too, 
is a contributory factor. Iron deposition in the liver may result in a 
diffuse nodular cirrhosis. Attacks of pericarditis, similar in type to 
acute benign non-specific pericarditis frequently occur (Weatherall and 
Clegg, 1972} especially after splenectomy. 
The most recent complications reported in this condition have been 
neurological. Eight cases of spinal compression found to be caused by 
regions of extramedullary erythropoiesis have been reported in the 
literature (Cross, et al, 1977). This has also occurred in the past in 
1 non-Greek patient in Cape Town (Goldberg, 1976). Transient motor 
seizures, including some associated with temporary hemiparesis, which 
have resolved rapidly and been thought to be due to cortical vein throm-
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bosis, have been reported (Sinniah, et al, 1977). These patients have 
usually been dehydrated as a result of vomiting or diarrhoea from an 
intercurrent illness. A neurological syndrome which is probably a side 
effect of blood transfusion has recently been described in the literature. 
This consists of hypertension, convulsion and cerebral haemorrhage (Wasi, 
et al, 1978). It has therefore been reco111T1ended that care be taken when 
giving rapid blood transfusion to patients adapted to longstanding anaemia. 
Psychological tensions often develop within the family of a patient with 
thalassaemia major. The patient may express resentment while the parents 
may experience guilt feelings. This puts considerable stress on the 
family unit. 
E. PROGNOSIS 
Before the clinical entity of thalassaemia was recognized and under-
stood, patients with thalassaemia major died in childhood. Death was 
usually the result of anaemia or infection. The use of antibiotics and 
blood transfusion has considerably increased the lifespan of patients 
with this condition. Presently the most commonly used regimes of hyper-
transfusion in association with chelating agents has added years to the 
life expectancy of these patients. However, they still eventually 
succumb in the second or third decades, usually as a cumulative result 
of iron overload. The most frequent cause of death, as mentioned 
previously, is cardiac failure. 
As the thalassaemia syndromes are so heteroqenous it is to be expected 
that there are individuals with a relatively mild form of thalassaemia 
major. There are reports in the literature of long survival in this 
disorder (Apostolid~s and Avgoustakes, 1973; Eichner, 1976). 
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F. BIOCHEMICAL FINDINGS 
There is almost invariably a raised bilirubin level in patients 
with thalassaemia major due to increased rate of haemolysis. It is 
usually in the l-3mg/100 ml range. Serum glutamic oxaloacetic trans-
aminase (SGOT} and lactic dehydroqenase (LOH) are also raised, probably 
reflecting hepatic damage. The serum iron is raised with a saturated 
iron binding capacity. Serum calcium as well as magnesium and zinc may 
be low (Erlandson, et al, 1964). 
G. HAEMOGLOBIN PATTERN 
The haemoglobin pattern in patients with thalassaemia major is 
characterized by decreased haemoglobin A and raised haemoglobins F and 
A2. The levels of haemoglobin F and A2 may show considerable variation. 
Patients possessing the beta0 thalassaemia gene appear to produce no 
haemoqlobin A. Their haemoqlobin is constituted solely of haemoglobin A2 
and F (Fessas and Karaklis, 1962) . 
Haemoglobin F, which is alkali resistant (Vecchio, 1946), occurs 
usually in the 10 to 90% range. Using the modified acid elution tech-
nique of Kleihauer. Braun and Betke (1957), it has been found that the 
fetal haemoglobin is heterogeneously distributed in the cells (Frazer 
and Raper, 1961). No relationship has been found between the level of 
fetal haemoglobin and the severity of thalassaemia major. The turnover 
of haemoglobin F has been demonstrated to be slower than that of haemo-
globin A and A2. This is probably due to the longer survival of cells 
with a high level of haemoglobin F (Nathan and Gunn, 1966). 
Haemoqlobin A2 levels may vary considerably in thalassaemia major. The 
range is usually from 1,4-13 per cent. The level of haemoglobin A2 does 
- 49 -
not parallel the severity of the disorder (Fessas, 1959). Low levels 
of haemoglobin A2 in patients with thalassaemia major, where the 
parents have raised haemoglobin A2 implies occurrence of the doubly 
heterozygous state for beta- and delta-beta-thalassaemia genes. In 
cases where there is high haemoglobin F, the haemoqlobin A2 may appear 
within normal limits, but there is nevertheless a decreased haemoglobin 
A/haemoglobin A2 ratio (Kunkel, et al, 1957). 
Fresh haemolysates prepared from patients with thalassaemia major con-
tai'n trace amounts of a haemoglobin, which moves more slowly than 
haemoglobin A2 and disappears on the addition of haemoglobin H (Fessas 
and Loukopoulos, 1964). This fraction probably consists of free alpha-
chains. 
In vitro experiments of haemoglobin production have demonstrated that 
the~e is decreased production of beta-chains in beta-thalassaemia. 
There is thus a relative increase of alpha chains which are unstable 
and precipitate rapidly to becon~ associated with the red cell membrane 
(Weatherall, et al, 1969; Model 1, et al, 1969). This latter fact is of 
great importance in considering the pathophysiology of the disorder. 
H. PATHOPHYSIOLOGY 
The anaemia of thalassaemia is a result of ineffective erythro-
poresis and shortened red cell survival. There is extensive intra-
medullary destruction of red cell precursors (Finch, et al, 1970), with 
a rapid turnover of haemoglobin A. The turnover of haemoglobin Fis 
far lower (Gabuzda, Nathan and Gardner, 1963). Red cell survival 
studies using 51cr labellin~ techniques indicate a reduced survival 
time ranging from 7 to 22 days (Sturgeon and Firth, 1957). The in-
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effective erythroporesis leads to gross erythroid hyperplasia, which 
in turn gives rise to many of the clinical features of the disorder. 
The problems at a cellular level are caused by globin chain inbalance. 
Decreased beta-chain synthesis leads to relative excess alpha-chains. 
These alpha-chains are unstable and precipitate to form inclusions 
which damage the red cell membrane. Cells with large inclusions have 
little haemoglobin and are broken down in the bone marrow. Red cell 
precursors, having relatively large amounts of gamma-chains, are 
largely protected from chain imbalance, as the gamma-chains combine 
with the alpha-chains to produce fetal haemoglobin. Under these con-
ditions the inclusion bodies will be small with little damage to the 
cell membrane. Inclusion containing red cells reaching the peripheral 
blood are sequestered in the spleen. In the spleen the inclusions are 
removed by splenic pitting and then returned to the circulation. 
Hence, in patients who have had a splenectomy, large numbers of red 
cells with inclusions may be seen in the peripheral blood. 
The problem of whether iron is absorbed from the gut in increased 
amounts or not has not yet been clarified. Nevertheless, iron appears 
to accumulate in the thalassaemic normoblast in larger than nonnal 
amounts. It takes the form of ferritin molecules or siderosomes 
(Fessas and Loukopoulos, 1974). Accumulation of iron in the mito-
chondria might interfere with their function in maintaining the energy 
metabolism of the normoblast and in participating in haem synthesis. 
An increase in potassium flux has been detected in inclusion bearing 
erythrocytes in thalassaemia major. This has also been found with 
haemoglobin H disease (Nathan, et al, 1969), This ph~nomenon has been 
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attributed to a selective penneability of the membrane to potassium 
following depletion of energy sources (Gunn, Silvers and Rosse, 1972). 
The altered potassium penneability appears to be less important than 
the noxious effect of haemoglobin precipitation to the red cells (Knox-
Macaulay, et al, 1972). 
I. TREATMENT 
1. BLOOD TRANSFUSION 
Before the early 1960's most patients with thalassaemia 
major were given blood transfusions only when their haemoglobin had 
reached the low level of approximately 5 g/100 ml, for fear of causing 
early iron overload and death. However, with this regime patients 
suffer all the problems of the disease as well as of the treatment 
(Modell, 1976). Wolman (1964} suggested that if a patient's haemo-
globin was kept in the normal range he could live a nonnal life without 
necessarily shortening his survival . This resulted in a general change 
of policy and the hypertransfusion regime is now practiced almost 
universally (Necheles, 1974). Thus patients who were debilitated and 
symptomatic are now normal until they are about 12 years of age, when 
they tend to show the signs and symptoms of iron overload. Patients on 
these regimes who were previously troubled by recurrent and serious 
chest infections no longer suffer these complications. Initial growth 
is normal (Hyman, et al, 1976), bone changes regress, heart size 
decreases and gastro-intestinal iron absorption is suppressed (Modell, 
1976). The patient's well-being plays a significant part in relieving 
the family of much stress. In addition, this regime suppresses bone 
marrow hypertrophy, thus promoting a more normal life without the 
facial stigmata of the condition {Weiner, et al, 1978). 
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The long tenn prognosis ultimately depends on the rate of progression 
of haemosiderosis. Iron overload as a result of high level trans-
fusion undoubtedly occurs. However, there is no evidence that 
toxicity appears earlier. As a possible reason it has been suggested 
(Necheles, Beard and Allen, 1969) that hypoxia potentiates the toxic 
effects of iron overload. It has also been suggested that the reduction 
in gastro-intestinal iron absorption offsets the increase due to high 
level transfusion. Recent reports indicate that iron overload can be 
significantly decreased by transfusing only the youngest 50 per cent of 
donor red cells and this will therefore further improve the outlook in 
this situation (Corash, et al, 1976). 
2. CHELATING AGENTS 
Desferrioxamine, produced by streptomyces piloxes, is the 
most widely used chelating agent in chronic iron overload. Desferri-
oxamine is only of use when a pat i ent is already iron overloaded. 
This usually occurs at the age of about 8 years, when approximately 100 
units of blood have been received. Modell (1976) recommends Desferri-
oxamine in doses of 0,5 g to 1 g intra-muscularly daily. However, 
Desferrioxamine can also be used intravenously (Retsky, 1976). About 
two-thirds of the iron bound by Desferrioxamine is excreted in the 
urine and one-third in the stool (Modell and Matthews, 1976). 
The most recent advances in the treatment of thalassaemia major have 
demonstrated that constant infusion of desferrioxamine either by the 
intravenous or subcutaneous route, is more efficient than when given 
in an intramuscular dose. When given intravenously this treatment is 
79 per cent as effective as subcutaenously and the latter route is 
- 53 -
now considered the treatment of choice (Graziano, et al, 1978). 
Desferrioxamine is given over an 8 hour period by subcutaneous in-
fusion with a pump and results in little inconvenience to the patient. 
This mode of treatment has been found to be 2,4 times as efficient as 
intramuscular treatment (Cohen and Schwartz, 1978). It has been found 
that this regime decreases inorganic iron absorbtion from the gut and 
that iron excretion is greater and occurs from an earlier age (Pippard, 
et al, 1977). This is compared to intramuscular treatment which is 
only effective from about 5 years of age when the patient is already 
severely iron overloaded (Necheles, et al, 1974; Modell, 1976). As a 
result of this progress it is now possible to approach iron balance in 
these individuals. However, it is not known yet whether cardiac 
siderosis is reversed (Weiner, et al, 1978). These recent advances 
will clearly improve the prognosis and increase the life expectancy of 
thalassaemic major patients. 
Vitamin C is usually given in conjunction with desferrioxamine, as it 
has been found that it enhances the excretion of iron in response to 
desferrioxamine (Wapnick, et al, 1969). In iron overload, increased 
catabolism of ascorbic acid has been reported. In addition to ascorbic 
acid deficiency it appears that there is some disorder of iron release 
(Charlton and Bothwell, 1976). Hence, increased efficiency of iron 
excretion is obtained by using desferrioxamine together with vitamin C. 
D.T.P.A. {diethylenetriaminepentaacetic acid), a chelating agent, has 
also been used in the treatment of iron overload. However, disadvan-
tages such as hyperpyrexial reactions {Letsky, 1976) and non-specificity 
for iron have been noted. As a result of this latter quality, other 
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possibilities of antenatal diagnosis. Fetal blood may be obtained from 
blind needling of the placenta or by aspirating blood fr001 surface 
placental vessels (Hobbins and Mahoney, 1974). Fetal blood cells are 
then analysed for the presence of beta-chain synthesis. This technique 
has been successfully applied by Kan, et al (1975). 
The most recent significant advances in the study of the thalassaemias 
have had important benefits in making antenatal diagnosis of the con-
dition possible. Th.e thalassa~mia model has been of use in DNA and RNA 
engineering and hence progress in this field has resulted in progress 
in the understanding of the molecular defect in the thalassaemias with 
practical applications in antenatal diagnosis. 
As mentioned above, homozygous beta-thalassaemia has now been success-
fully diagnosed antenatally (Fairweather, et al, 1978), but with a high 
risk of miscarriage or damage of about 10 per cent to the fetus. This 
risk is nevertheless acceptable compared to the tragedy of a child with 
the disorder. Alpha-thalassaemia has been shown to be due to a gene 
deletion. Cultured amniotic cells display this abnormality and, in 
fact, open up the possibilities of antenatal diagnosis by amniocentesis 
instead of fetal blood sampling. with the high associated risk. This 
has been successfully undertaken recently (Wong, et al, 1978). Ante-
natal diagnosis of sickle cell anaemia has recently been achieved by 
amniocentesis (Kan and Dozy, 1978) and it is hoped that in the future 
all the thalassaemias will be diagnosed in this very specialized way. 
It must be emphasized that although there is such spectacular progress 
in this field it is only large specialized centres that are able to 
undertake this work. This service, therefore, cannot at present be 
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cations such as magnesium and calcium are depleted. 
2,3-dihydroxybenzoic acid (2,3-DHB), an oral chelating agent, is at 
present under investigation. Initial reports suggest that it will be 
of use when administered in combination with desferrioxamine (Graziano, 
Grady and Cerani, 1974; Grady, 1976). 
3. SPLENECTOMY 
Judicious selection of patients for splenectomy is of great 
importance due to the associated risks of the surgical procedure. 
The most important indication for splenectomy is increase in blood 
requirements. Causative mechanisms are sequestration of red cells in 
a non-circulating splenic pool, dilutional anaemia as a result of in-
creased plasma volume and hypersplenism. The discomfort caused by a 
larqe spleen and risk of rupture following trauma are contributory 
factors. 
Risks associated with splenectomy include severe infection occurring 
post-operatively in the very young, increased iron load on the liver 
and increased incidence of recurrent pericarditis (Fessas and Louko-
poul os, 1974). 
4. PREVENTION 
In most centres, until recently, the only method available 
for the prevention of new cases of thalassaemia major was to recommend 
that two thalassaemia heterozygotes should not procreate. However, 
the discovery that abnormalities of the beta-chain can be detected by 
the study of haemoglobin synthesis (Kan, et al, 1972) opened up the 
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offered to all who need it, though it is envisaged that this will be 
possible in the not too distant future. 
5. FUTURE POSSIBILITIES 
i) Bone Marrow Transplantation 
This method of management is at present used in cases of 
resistant aplastic anaemias. However, the procedure still carries 
a significant morbidity and mortality, but if perfected it may well 
be an important tool in the treatment of thalassaemia major. 
ii) Gene Manipulation 
It has been demonstrated that sickle-cell anaemia in Saudi 
Arabs is clinically, as well as haematologically, a very mild dis-
order (Perrine, et al, 1978). It is thought this may be due to the 
protective effect conferred by the high concentrations of fetal 
haemoglobin (Hbf) found in the disorder amongst this population 
group (Perrine, et al, 1972). 
Relatively large amounts of Hbf have also been shown to be beneficial 
in beta-thalassaemia. Persons who have a gene for the hereditary per-
sistence of fetal haemoglobin as well as beta-thalassaemia have a 
milder condition than those who only inherit thalassaemia (Wood, 
Weatherall and Clegg, 1976). Furthermore, those forms of beta-
thalassaemia in which the defect results in increased levels of Hbf 
are generally milder than those in patients with limited Hbf production 
(Wood, Clegg and Weatherall, 1977). 
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The mechanisms regulating HbF production in these disorders are at 
present not clear but are of a genetic nature. It is not possible to 
switch on or off the genes for globin chain synthesis, but when this 
is achieved benefit may be derived from increasing the levels of HbF 
in individuals suffering from thalassaemia major. 
II. HETEROZYGOUS BETA-THALASSAEMIA 
Heterozygous ·beta-thalassaemia demonstrates the heterogeneity of the 
thalassaemia syndromes in that the clinical state, haematological 
findings and haemoglobin patterns may vary considerably. At one end 
of the spectrum patients have symptomatic anaemia and at the other end 
individuals are totally asymptomatic. The more severe fonns are more 
likely to occur in Mediterranean as opposed to Negro populations. 
A. CLINICAL MANIFESTATIONS 
Patients most severely affected have a chronic anaemia, which at 
periods of stress or pregnancy may require blood transfusion. They 
may present with symptoms of anaemia, jaundice or leg ulcers (Weatherall 
and Clegg, 1972). Upper abdominal pain might be the result of gall 
stones or perisplenitis (Bannennan and Callender, 1961). This form of 
the disorder is also known as thalassaemia intermedia. The milder 
symptomatic fonn of the disorder was known as "Malatia Rietti-Greppi-
Micheli" by the early Italian writers. The greatest proportion of 
individuals are asymptomatic and may never be diagnosed . 
• 
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B. RADIOLOGICAL MANIFESTATIONS 
Patients with thalassaemia intermedia. the most severe form of 
the heterozygous state, may have the roentgenographic findings 
characteristic of thalassaemia major, while those with a mild pheno-
typic expression of the gene have completely normal radiographs. 
C. HAEMATOLOGICAL MANIFESTATIONS 
Most thalassaemia heterozygotes are not anaemic. Character-
istically one finds a reduced mean cell volume (MCV), a low mean cell 
haemoglobin (MCH) with a somewhat raised red cell count. 
Osmotic fragility tends to be reduced to varying degrees, which is 
amplified by incubating for 24 hours. 
Peripheral blood smear findings vary from normal to changes similar to 
those seen in thalassaemia major . Red cell changes include hypochromia, 
microcytosis, poikilocytosis, basophilic stippling and the presence of 
tarqet cells. Abnormalities tend to be more severe in the Mediter-
ranean, as opposed to the Negro form of the disorder. 
Red cell survival time is unimpaired, though 51cr half-life times have 
been reported as marqinally below normal (Malamos, et al, 1961). 
0. COMPLICATIONS 
Complications occur essentially in the severely affected thalas-
saemia heterozygote. These include gall stones and chronic leg ulcers. 
Patients with thalassaemia minor may be significantly anaemic during 
pregnancy. Fol ic acid, as we 11 as iron deficiency, may exacerbate the 
natural tendency to anaemia. 
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E. PROGNOSIS 
The prognosis fqr most thalassaemia heterozygotes is complete 
normalit.v. In patients with thalassaemia intennedia the life span will 
be variably decreased. 
F. HAEMOGLOBIN PATTERN 
1. HAEMOGLOBIN A2 
The most specific and characteristic finding in beta-thalas-
saemia heterozygotes is a raised level of haemoglobin A2. This was 
first observed by Kunkel, et al (1957), who found a mean level of 
5,11% (± 1,35%) in 34 thalassaemia heterozygotes, as compared to 2,54% 
(± 0,35%) in 300 normal individuals . Raised haemoglobin A2 is found 
otherwise only in some of the unstable haemoglobinopathies and there-
fore this finding is an important diaqnostic parameter (Weatherall and 
Clegg, 1972). 
Iron deficiency has been found to reduce the haemoglobin A2 level which 
then rises on correcting the iron deficiency. This can thus mask a 
raised haemoglobin A2 (Wasi, Disthasonghan and Na-Nakorn, 1968). 
Following the investigation of chain variants, it has been found that 
there is increased delta-chain production at both loci in a patient 
heterozygous for beta-thalassaemia although only one of beta-chain loci 
is affected (Huisman, Punt and Schaad, 1961). 
Significant intrafamilial segregation for levels of haemoglobin A2 in 
beta-thalassaemia heterozygotes has been noted (Weatherall, 1964). 
This suggests a definite genetic factor in the level of haemoglobin A2. 
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It has been noted that there is no correlation between the haewoglobin 
A2 level and the total haemoglobin level. packed cell volume, red cell 
abnormalities, haemoglobin For any other associated haematological 
finding (Fessas, 1959). 
2. HAEtlOGLOBIN F 
Fifty per cent of thalassaemia heterozygotes have no in-
crease of haemoglobin F while the remainder have levels between 1,5-5%. 
However, occasional cases have been reported with haemoglobin Fin 
excess of 5% (Weatherall, 1964). 
The haemoglobin Fis distributed quite heterogenously within the red 
cells when assessed by the Kleihauer technique (Kleihauer, Braun and 
Betke, 1957). 
As with haemoglobin A2, there is no correlation between the haemoglobin 
F level and red cell morphology, severity of anaemia or level of haemo-
globin A2. There is also significant intrafamilial segregation for 
haemoglobin F values. 
DELTA-BETA-THALASSAEMIAS 
There is a defect of b9th beta and delta-chain synthesis in delta-beta-
thalassaemia. The diagnosis is thus dependent on haemoglobin F values 
and haematological parameters. The delta-beta-thalassaemias were 
fonnerly known as F-thalassaemia, normal haemoglobin A2 or beta-thalas-
saemia type 2. 
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III. HOMOZYGOUS DELTA-BETA-THALASSAEMIA 
A. CLINICAL FINDINGS 
This disorder is not as severe as homozygous beta-thalassaemia and 
survival into adult life can be expected. Clinically. one finds a 
moderate anaemia, mild jaundice and splenomegaly. These findings are 
not invariable. 
B. HAEMATOLOGICAL FINDINGS 
Moderate anaemia with a haemoglobin in the 9-12 g% range is 
typical. The MCV and MCH are reduced. Peripheral blood smear is 
similar to that of thalassaemia intermedia. 
C. HAEMOGLOBIN PATTERN 
There is no beta or delta-chain synthesis. The haemoglobin thus 
consists entirely of haemoglobin F. 
IV . HETEROZYGOUS DELTA-BETA-THALASSAEMIA 
Delta-beta-thalassaemia carriers are clinically normal. Haematologically 
they have the same mild abnormalities as in beta-thalassaemia hetero-
zygotes. 
A. HAEMOGLOBIN PATTERN 
Haemoglobin A2 is within normal limits. Haemoglobin Fis usually 
increased in the 5 to 20% range (Zuelzer, Robinson and Booker, 1961). 
As with the beta-thalassaemia there is intrafamilial segregation of 
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haemoglobin F levels. 
The diagnosis of this disorder, however, may be difficult as occasion-
ally individuals may not have the characteristic increase in HbF and 
have normal levels for both HbA2 and HbF (Weatherall and Clegg, 1972; 
Fessas and Loukopoulos, 1974, and Silvestroni, et al, 1978). These 
heterozygotes are usually diagnosed ultimately on alpha/beta chain 
ratio analysis during the investigation of a child with homozygous 
beta-thalassaemia. 
The following thalassaemia syndromes are found in association with 
abnormal haemoglobins: 
Heterozygosity for both delta-beta and beta-thalassaemia 
(Stomatoyannopoulos, Fessas and Papayannopoulou, 1969) 
Haemoglobin 5-beta-thalassaemia (Silvestroni and Bianco, 1946) 
Haemoglobin 5-delta-beta-thalassaemia 
Haemoglobin C-beta-thalassaemia (Dunston, et al. 1972) 
Haemoglobin E thalassaemia (Wasi, et al; 1969) 
Haemoglobin D-beta-thalassaemia (Hynes and Lehmann,1956) 
Haemo~lobin (Schwartz, et al, 1957) 
Haemoglobin J-beta-thalassaemia (Sydenstryker, et al, 1961) 
NON ALPHA-CHAIN FUSION SYNDROMES 
Haemoglobin Lepore is the classical example of the non alpha-chain 
fusion syndromes. It was discovered in 1958 (Gerald and Diamond) and 
defined chemically by Baglioni in 1962. Baglioni suggested that 
haemoglobin Lepore consisted of normal alpha-chain combined with chains 
comprising of both delta- and beta-chains. This he postulated resulted 
from unequal crossing at the closely linked delta and beta loci, 
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resulting in a delta-beta fusion gene. Haemoglobin Lepore is named 
after the Italian family in which it was first discovered. 
V. HOMOZYGOUS HAEMOGLOBIN LEPORE 
Clinical, radiological and haematological findings 
The clinical, radiological and haematological findings in patients with 
the homozygous state for haemoglobin Lepore are similar and indisting-
uishable from homozygous beta-thalassaemia. 
HAEMOGLOBIN ELECTROPHORETIC PATTERN 
On electrophoresis haemoglobin Lepore is slow-moving, migrating to a 
position similar to haemoglobin S. Characteristically, patients have 
70-90% haemoglobin F and 10-30% of haemoglobin Lepore. There is a 
total absence of haemoglobin A and A2. 
VI. HETEROZYGOUS HAEMOGLOBIN LEPORE 
Clinical and haematological findings 
Patients with heterozygous haemoglobin Lepore are asymptomatic. 
Haem~tologic changes are similar to those of mild heterozygous beta-
thalassaemia. 
HAEMOGLOBIN ELECTROPHORETIC PATTERN 
Individuals heterozygous for haemoglobin Lepore have 5-15% haemoglobin 
Lepore, 1,5-15% haemoglobin F and normal levels of haemoglobin A2. 
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HEREDITARY PERSISTENCE OF FETAL HAEMOGLOBIN 
Hereditary persistence of fetal haemoglobin (HPFH) was first described 
by Eddington and Lehmann in 1955. It is a condition characterized by 
the synthesis of haemoglobin Finto adult life without any major 
haematological abnormalities. It is presently felt that HPFH is an 
extremely mild form of thalassaemia with good compensation of decreased 
beta-chain production by gamma chains, resulting in minimal chain im-
balance (Weatherall and Clegg, 1972). 
VII. HOMOGENOUS DISTRIBUTION OF FETAL HAEMOGLOBIN 
Negro t.vpe HPFH 
Homozygous state 
Clinical findings 
Patients with this disorder are usually diagnosed when being treated for 
an intercurrent illness. They tend to be mildly polycythaemic. This is 
probably due to the increased oxygen affinity of haemoglobin F. 
HAEMATOLOGICAL FINDINGS 
Peripheral blood smear shows minor abnormalities. These include aniso-
poikilocytosis. microcytosis and many target cells. 
HAEMOGLOBIN PATTERN 
Haemoglobin consists solely of haemoglobin F with haemoglobins A and A2 
being totally absent. 
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Kan, et al (1975), utilizing cDNA x DNA hybridization studies, have 
shown HPFH results from a deletion of the beta-gene. 
VIII. HETEROZYGOUS STATE 
There are no clinical or haematological abnormalities associated in 
patients with this disorder. Individuals have levels of fetal haemo-
globin ranging from 15 to 35%. There tends to be intra-familial 
segregation of fetal haemoglobin levels. 
HPFH has been well reported in association with haemoglobin Sand C. 
There have been minimal clinical problems with these individuals. 
HPFH, in association with beta-thalassaemia, has resulted in the 
clinical and haematological picture of beta-thalassaemia minor. 
Ix.GREEK TYPE 
No patients have as of yet been reported in the homozygous state. 
HETEROZYGOUS STATE 
Individuals with this disorder are clinically and haematologically 
normal. Haemoglobin F levels range from 10 to 20%. A further 
difference from ' the Negro type is a high level of haemoglobin A2. 
HAEMOGLOBIN KENYA 
Haemoglobin Kenya has non alpha-chains consisting of the N-terminal 
residues of the ganma-chain fused to the C- terminal residues of the 
beta-chain. This has probably resulted from unequal crossing over, 
with the loss of the whole of the delta-chain locus and those portions 
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of _the garrvna- and beta-loci coding for the C- tenninal end of the 
ganvna-chain and the N- tenninal end of the beta-chain, respectively. 
Heterozygotes have about 10% haemoglobin F. 
X. HETEROGENOUS DISTRIBUTION OF FETAL HAEMOGLOBIN 
Individuals with this disorder have no clinical or haematological ab-
nonnalities. There is heterogeneity of the fetal haemoglobin among 
the red cells but no detectable globin-chain imbalance. 
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CHAPTER 9 
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 
Glucose-6-phosphate dehydrogenase (G-6-PD) is an enzyme occurring 
in many tissues including red blood cells, white blood cells, platelets, 
liver, spleen, adrenal cortex, lens and saliva. However, it is in red 
cells that a deficiency of this enzyme has important clinical impli-
cations and it will be discussed further only in this context. Studies 
on red cell G-6-PD are difficult, as although the level of activity of 
the enzyme is high, the enzyme itself constitutes less than 0,01% of 
the protein of human red cells. By contrast, haemoglobin fonns 96% of 
the red cell protein. 
A. PHYSIOLOGY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE 
In the normal red cell. 90% of glycolysis occurs through the 
anaerobic Emden-Meyerhof pathway wi th the production of the high energy 
product adenosine triphosphate. Reduced nicatinamide adenine dinucleo-
tide phosphate (NADPH}, a product of this pathway, supplies the energy 
for the reduction of methaemoglobin. The remaining 10% of red cell 
glycolysis occurs through the aerobic hexosemonophosphate (HMP) shunt 
pathway. This pathway has the only two reactions available to a cell 
without mitochondria (as in a mature red cell) for producing NADPH. 
The first r~action which involves the oxidation of glucose-6-phosphate 
(G6P) to 6 phosphogluconate (6PG), is catalysed by G-6-PD. The second 
reaction catalized by 6-phosphogluconate dehydrogenase (6PGD), cannot 
occur in the absence of the first. Thus a deficiency of G-6-PD will 
result in a reduction of NADPH from both sources. 
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Glutathione is a tripeptide Qf glutamic acid, glycine and the sulphy-
dryl-bearing amino acid, cysteine. The sulphydryl group of cysteine 
allows glutathione to exist in a reduced form (GSH) or an oxidised 
form (GSSG) when 2 molecules of glutathione are united through a 
disulphide bridge with the loss of 2 hydrogen molecules. 
Glutathione reductase, an enzyme, and NADPH. the co-enzyme which 
supplies the electrons, are necessary for the reduction of oxidised 
glutathione. Glutathione, a co-factor of glyoxylase, apparently plays 
an important role in maintaining both normal oxidation-reduction con-
ditions and the integrity of sulphydryl groups of proteins within the 
red cell. It is known that acute haemolysis in G-6-PD deficiency does 
not occur until GSH is nearly exhausted. It has been suggested that 
this haemolysis is associated with loss of membrane sulphydryl groups 
and the formation of haemoglobin denaturation products which appear as 
Heinz bodies (Jacob and Jandl, 1962). 
B. HETEROGENEITY OF G-6-PD DEFICIENCY 
The heterogeneity of glucose-6-phosphate dehydrogenase is well 
recognised. Numerous variants of G-6-PD have been reported which 
differ greatly in enzyme activity and other properties. By utilizing 
electrophoretic mobility, thermostability, catalytic properties, pH 
activity and the Michaelis constant (which is defined as the concen-
tration of substrate that allows the enzyme to function at half-
maximal velocity and is a measure of how lON the substrate concen-
tration must be without seriously impairing the function of an enzyme), 
more than 100 variants of G-6-PD have been detected. In this way, it 
has been found that individuals with the manifestations of G-6-PD 
deficiency may quantitatively have sufficient G-6-PD which is, however, 
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qualitatively at fault. 
Individuals with G-6-PD deficiency can be placed into two broad 
groups - those having G-6-PDA, the negro variety, and those having the 
Mediterranean type, G-6-PD Mediterranean. The first difference noted 
between the two was that the level of enzymatic activity was decreased 
to a far greater extent in the Mediterranean variety. These divisions 
are not exclusive to population groups, and occasionally people of 
Mediterranean origin may have the mild form of G-6-PD deficiency (the 
Negro variety). 
(1) NEGRO VARIETY - G-6-PD DEFICIENCY 
This entity was first recognised in Negroes of the American 
Military forces, who on receiving prophylactic antimalarial therapy, 
developed a sensitivity reaction. Classically, 2 to 3 days after 
receiving primaquine (an 8-aminoquinoline), the patient's haematocrit 
would begin to fall and they would develop signs and symptoms of 
varying severity. Problems ranged from minor symptoms to more severe 
haemolytic attacks characterised by abdominal pain, haemoglobinuria, 
jaundice and anaemia. However, even if the drug therapy was continued, 
it was discovered that the course of the disease was self-limiting and 
that it was only the older cell population which was haemolysed (Butler, 
Dern and Alving, 1954). A new steady state is reached in which the 
remaining red cells are gradually destroyed as they become older. 
Starch gel electrophoresis revealed 2 varieties of G-6-PD in non-
deficient American Negroes. These were designated G-6-PDA and G-6-PDB, 
the latter is the same type as that which occurs in normal individuals 
of all race groups, while G-6-PDA is largely confined to Negroes. It 
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moves faster electrophoretically and in distinction to G-6-PDB, has 
been demonstrated by amino acid analysis to have aspartic acid re-
placing asparagine (Yoshida, 1967). 
The varie~y of G-6-PD occurring in deficient American Negroes has the 
same electrophoretic mobility as G-6-PDA and hence has been designated 
G-6-PDA-. It was found that the enzymatic activity of G-6-PDB, A and 
A- is similar in reticulocytes but markedly different in older cell 
populations. Thus it has been suggested that G-6-PDA- may be analogous 
to some of the abnormal haemoglobins which, because of amino acid sub-
stitution, are less stable than normal haemoglobin molecules (Giblett 
and Eloise, 1969). 
(2) MEDITERRANEAN VARIETY 
G-6-PD deficiency of the Mediterranean type (G-6-PDB-) 
tends to occur largely in Southern European countries, the Middle East 
and countries of south east Asia (Allison, 1963; Szeinberg, 1963). 
Clinically, individuals in this group vary from being mildly affected 
on exposure to certain drugs, to those suffering from the more severe 
congenital non-spherocytic haemolytic disease (CNSHD). This latter 
group, besides suffering from acute haemolysis on exposure to the im-
plicated medicines, also tend to have a chronic haemolytic disease with 
chronic anaemia, jaundice and possibly gallstones and splenomegaly. 
They have marked decrease in red cell viability and elevated reticulo-
cyte levels. Differences between G-6-PD of the Mediterranean and 
Negro type include lower red cell G-6-PD activity in the Mediterranean 
variety, 2-7% of normal as opposed to 10-15% of nonnal in Negroes (Kirk-
man, Schettini and Pickard, 1964). Cells of all ages are destroyed on 
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ingestion of primaquine with the former but not in the latter; G-6-PD 
defi cienc.v ma.v be manifested in other tissues such as white ce 11 s, as 
oppo?ed to solely red cells, and patients with G-6-PD deficiency of the 
Mediterranean variety may suffer from favism and neonatal jaundice, 
whereas in the Negro variety this is unlikely. 
Favism, the acute haemolysis which occurs after ingestion of the bean, 
Vicia faba, as mentioned previously, occurs in patients with G-6-PD 
deficiency of the Mediterranean type . However, not all individuals 
with this variety of G-6-PD deficiency suffer from favism, which 
appears to have an additional genetic aspect (Stamatoyannopoulos, et al, 
1966). 
The electrophoretic mobility of G-6-PD in patients of Mediterranean 
origin is the same as those of normal Caucasians and Negroes, and hence 
has been designated G-6-PDB-. Through using specialized chromatography 
in a calcium phosphate gel column, G-6-PDB- has been separated from 
G-6-PDB (Yoshida, Stamatoyannopoulos and Motulsky, 1967). Doxiadis, et 
al (1964) have found on the island of Lesbos that the risk of severe 
jaundice of the newborn due to G-6-PD deficiency is increased in com-
parison to other areas in Greece. In addition the incidence of neo-
natal jaundice, not due to G-6-PD deficiency or ABO incompatibility, 
was significantly higher on Lesbos as opposed to other regions in Greece. 
This additional icterogenic factor has not been identified but it seems 
possible that it has a genetic basis. 
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C. GENETIC ASPECTS OF G-6-PD DEFICIENCY 
The pattern of inheritance of G-6-PD deficiency was not obvious 
when the intiial investigations into the disorder were being performed. 
The reason for this was that persons suffering from primaquine induced 
haemolysis were mostly men, namely: soldie~s and prison volunteers. 
Thus it was not until extensive family studies were undertaken that it 
became obvious that G-6-PD deficiency was inherited in an X-linked 
manner. 
As discussed earlier, there is great genetic heterogeneity within 
G-6-PD deficiency. This heterogeneity is illustrated by varying 
clinical expression of the disorder, not only between, but also within 
various population groups; differing levels of activity of the enzymes 
between Caucasian and Negro G-6-PD deficient individuals and variations 
in electrophoretic migration. Differences in thennostability, the 
Michaelis constant and catalytic function further help in categorizing 
the nature of the enzyme. 
In 1960, Motulsky noted that G-6-PD deficiency occurs in a wide belt of 
tropical Africa, the Mediterranean area, the Near East, India, south 
east Asia and the Phillipines. He further took cognisance of the fact 
that the geographic distribution of G-6-PD deficiency coincided with 
that of Plasmodium falciparum, the organism causing the most severe 
fonn of malaria, and sickle cell haemoglobin. Based on these findings, 
he made the reasonable suggestion that G-6-PD deficiency might provide 
some selective advantage against falciparum malaria. Allison (1960) 
came to similar conclusions, noting the high incidence of G-6-PD 
deficiency in East Africa where malaria is endemic. 
Within local areas in Greece (Stamatoyannopoulos and Fessas, 1964), 
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Cyprus (Plato, Rucknagel and Gershowitz, 1964), and Sardinia (Sini-
scalco, et al, 1966) the correlation between the gene frequency of 
G-6-PD deficiency and the endemicity of falciparum malaria has been 
well demonstrated. The work done by Siniscalco, et al (1966) on 
Sardinia was particularly illustrative as malaria was endemic there 
until recently, while the population has been relatively stable. A 
significantly higher incidency of G-6-PD deficiency was found in the 
coastal areas where malaria was endemic in comparison to the malaria-
free areas of higher altitude. Contributory evidence is the absence of 
G-6-PD deficiency in people occupying non-malarious regions of the 
world, and the demonstration that Plasmodium falciparum parasite rates 
and densities were lower in young African children with G-6-PD deficiency 
than in children with normal enzyme levels. 
Conflicting data has been reported by Kidson and Gonnan (1962) who 
noted the low incidency of G-6-PD deficiency in Malays and Indonesians, 
while the surrounding populations of Thailand, the Phillipines and 
coastal New Guinea have a high incidence. They therefore questioned the 
validity of the hypothesis that people with G-6-PD deficiency had a 
selective advantage over those with normal G-6-PD in malaria endemic 
areas. They then undertook population studies in New Britain and New . 
Guinea, and found that various linguistic groups living under similar 
conditions of nutrition and parasitic infestation, and living close to 
one another, had significantly varying incidences of G-6-PD deficiency. 
The most convincing evidence for the advantage of G-6-PD deficiency 
against falciparum malaria comes from Luzzatto, Usanga and Reddy (1969) 
who utilized the phenomenon of X chromosomal inactivation, to demonstrate 
that G-6-PD deficient red cells contain fewer malarial parasites than 
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normal cells. Due to X chromosomal inactivation, a female heterozygote 
for G-6-PD deficiency would have 2 cell lines - 1 G-6-PD deficient and 
1 normal. These workers examined females who were heterozygous for 
G-6-PD deficiency, and who had been exposed to malaria in natural 
circumstances, and demonstrated significantly higher parasitic counts 
in the normal compared to the G-6-PD deficient cells. 
G-6-PD has been extensively utilised for the demonstration of random 
X chromosomal inactivation in accordance with the Lyon hypothesis 
{Lyon, 1961). G-6-PD has been particularly valuable in this field as 
it can be measured quantitatively by electrophoretic techniques. 
Davidson, Mitowsky and Childs (1963) cultured fibroblasts from the 
skin of a female heterozygous for 2 electrophoretic types of G-6-PD 
and showed the expected mixture of two electrophoretic bands in the 
original culture. These workers then prepared a series of subcultures, 
each one having been derived from a single cell of the original cell 
population. Only 1 electrophoreti c type of G-6-PD was found in each 
clone. This experiment demonstrated that only 1 of the 2 X chromosomes 
was functional, as would be expected from the Lyon hypothesis. 
Linkage on the X Chromosome 
Good evidence exists that the locus for G-6-PD deficiency is closely 
linked to those for protan and deutan colour blindness. The G-6-PD 
locus may be at a recombination fraction of only 0,03-0,04 from the 
deutan locus (Porter, Schulze and ~cKusick, 1962; Siniscalco, Filippi 
and Latte, 1964) and 0,07 from the protan locus (Motulsky, 1968). 
In brief it seems that the region on the X chromosome containing the 
loci for G-6-PD haemophilia A and B, colour blindness and possibly X m 
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and the Hunter syndrome is distant from the region containing the loci 
for X g, X-linked icthyosis, occular albinism and possibly Fabry's 
disease (Kirkman, 1971). 
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CHAPTER 10 
SICKLE CELL HAEMOGLOBINOPATHIES 
A. HISTORICAL INTRODUCTION 
Letvnann and Huntsman (1974) noted that in 1910 a Chicago physician 
reported peculiar elongated and "sickle-shaped 11 cells in the blood of 
a West Indian student. They also commented that in 1927 Hahn and 
Gillespie discovered that sickling only occurred at a low oxygen 
tension. At roughly the same time Neel and Beet independently managed 
to show that sickle cell anaemia is the homozygous state, while the 
sickle cell trait is the heterozygous state. Subsequently the dis-
covery by Pauling, et al (1949) that haemoglobin S {HbS) had a dif-
fering isoelectric point from HbA, allowed Pauling to fonnulate the 
concept of molecular disease. By means of peptide mapping it was 
demonstrated that the chemical difference in haemoglobin S {HbS) is 
the substitution of valine for glutamic acid at the 6 position of the 
beta-chain (Hunt and Ingram, 1959). 
B. PATHOGENESIS 
The pathological and hence clinical features of sickle cell 
disease are dependent on the substitution of valine for glutamic acid 
in the beta-chain of the haemoglobin molecule. It has been suggested 
that the globin chain with the altered amino acid adheres to a comple-
mentary section on the alpha- or beta-chain of a neighbouring molecule 
(Hunt and Ingram 1959). Under conditions of deoxygenation crystals 
are formed which are similar in shape to sickled cells (Harris, 1950). 
As these crystals grow in length they form tactoids which disappear on 
reoxygenation (Perutz and Lehmann,1968). If this happens repeatedly, 
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irreversible sickling eventually occurs, with resultant cellular 
destruction. 
The level of haemoglobin S (HbS) in the red cell is important in 
detennining whether sickling will occur, and levels of less than 40% 
of the total haemoglobin are usually not associated with sickling 
(Weatherall and Clegg, 1972). Flow rate, and thus viscosity, are also 
important factors in initiating sickling. It takes 2 to 3 minutes for 
sickling to become fully established and with a further reduction in 
flow rate the oxygen tension will drop further, with resultant increase 
in sickling and viscosity, which in turn increases the stasis and de-
creases the flow rate. Thus a vicious circle is set up. In addition, 
a drop in pH which tends to occur with a sluggish circulation, enhances 
sickling. 
C. SICKLE CELL ANAEMIA (homozygous state) 
1. Clinical Features: 
Infants are nonnal until beta-chain synthesis is fully 
established at about 4 to 6 months. Characteristic early findings 
include pallor, mild jaundice and splenomegaly and frontal -bossing 
of the skull. Children are usually smaller than their nonnal 
peers but as their epiphyses fuse later than nonnal they develop 
an eunuchoidal habitus. 
2. Course and Complications: 
There is marked variability in the life span of patients with 
sickle cell anaemia, depending greatly on environment, though very 
few have a nonnal lifespan. In tropical Africa 50% of infants die 
in the first few'Years of life, while fewer than 10% reach adult-
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hood (Weatherall and Clegg, 1972). 
In childhood painful infarcts of the hands and feet may occur, 
while in older youths aseptic necrosis of the femoral head may 
develop and be misdiagnosed as Perthe's disease. Infarctions may 
also occur in the spleen, liver, lungs, intestine and central ner-
¥OUS system. Other complications include chronic leg ulcers, 
which occur in 50% of Jamaican patients(Lehmann and Huntsman, 
1974) and salmonella infections, particularly septicaemia and 
osteomyelitis. Haemolytic and aplastic crises are life threaten-
ing. 
3. Laboratory Findings 
The haemoglobin level is usually between 5 and 9 grams per 
100 ml. Packed cell volume lies in the 20 to 25% range and the 
reticulocyte count is markedly elevated in the 15 to 25% range. 
Peripheral blood smear shows some partially sickled cells with 
occasional target cells and nucleated red cells. 
Paper electrophoresis reveals predominantly the slow moving 
haemoglobin S with a nonnal haemoglobin A2 level and a variable 
haemoglobin F level which is usually in the 5 to 10% range. 
4. Treatment and Prophylaxis 
Management of a sickle cell infarctive crisis involves 
maintaining hydration, adequate analgesia, treating secondary 
infections and keeping the patient wann to avoid vascular stasis .. 
Magnesium sulphate given intravenously has been used with some 
success. Magnesium, a calcium antagonist in the clotting process, 
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partially delays the formation of thrombin. It also has a vaso-
dilatory effect and discourages sludging of sickle cells. 
Sickling prophylaxis is aimed at preventing factors which promote 
sickling from occurring. Keeping the blood pH as alkaline as 
possible by giving 2 to 3 grams of sodium bicarbonate in diluted 
I 
doses during the day, is of use. This is of added importance 
during infections, especially of the respiratory tract which may 
result in acidosis. 
Care is required during anaesthesia to prevent anoxia, dehydration 
and circulatory stasis by cooling. Likewise, pregnancy and labour 
must be supervised where possible at institutions where personnel 
are aware of the dangers facing the patient. 
Due to decreased red cell survival time and increased haemolysis 
an anaemia is usually present. As there may be problems due to 
iron overload and resultant haemachromatosis, the anaemia is best 
treated conservatively with folic acid. Where studies indicate 
iron deficiency this may be given. Blood transfusion is indicated 
in the occurrence of crises of an aplastic or ·sequestration nature 
(where red cells are sequestrated in an internal organ) and where 
there is a risk of pulmonary oedema and cardiac failure. 
D. SICKLE CELL TRAIT (Heterozygous for HbS) 
Individuals with the sickle trait are usually clinically asympto-
matic. However, under circumstances where there is decreased oxygen 
tension, sickling may occur. These include high altitude flying in an 
unpressurized aircraft, hurried, inadequate anaesthesia and, rarely, 
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severe pnelJTionia. Females may be discovered to have the sickle cell 
trait during pregnancy when they are found to have an unexplained 
anaemia. Haematological parameters and peripheral blood smear are 
nonnal in patients without complications. Paper electrophoresis 
reveals nonnal quantities of haemoglobins F and A2, haemoglobin A and 
the slower moving haemoglobin S. 
E. OTHER HAEMOGLOBINOPATHIES 
Haemoglobin Smay be found in association with other abnormal 
haemoglobins and thalassaemia. When HbS is found in association with 
some abnormal haemoglobin such as HbK, there may be no clinical or 
haematological abnonnality, whereas with HbC a moderate haemolytic 
anaemia will be present. 
Similarly, haemoglobin S occurring with the thalassaemia gene may give 
rise to a severe sickle cell anaemia or a completely symptom free state 




Hereditary spherocytosis (HS) is an hereditary haemolyti~ dis-
order characterized by a variable degree of anaemia, splenomegaly, 
spherocytosis and increased osmotic fragility of the red cells. 
Jaundice, often of a mild degree, which is unaccompanied by bile in 
the urine (acholuric) is an inconstant feature. 
A. HISTORY 
Vanlair and Masias (1871) were the first authors to report a 
patient with what was probably hereditary spherocytosis. They 
described an individual with anaemia, acholuric jaundice, splenomegaly 
and abnormally small erythrocytes and termed the disorder microcy-
thaemia. Wilson and Stanley (1890, 1893} reported a kindred in which 
six members had a chronic condition characterized by splenomegaly, 
and a predisposition to jaundice. Minowski (1900} gave a detailed 
description of hereditary spherocytosis and drew attention to the fact 
that the osmotic fragility of the red cells is increased in the dis-
order. This observation is now used as an important diagnostic para-
meter for hereditary spherocytosis. 
B. PREVALENCE 
Hereditary spherocytosis is probably the commonest haemolytic 
anaemia amongst people of northern European origin. The prevalence is 
quoted as 2,2 per 10 000 and about 25% of the cases are apparently 
sporadic (McKusick, 1975). Though found in the African Negro, the 
condition is rare amongst this group (Kline and Wolman, 1957; Metz, 
- 83 -
1959). 
Hereditary spherocytosis has been diagnosed soon after birth {Truceo 
and Brown, 1967), and at ages ranging through to old age. Diagnosis 
is most often made between 10 and 45 years . 
C. GENETICS 
Hereditary spherocytosis is inherited in an autosomal dominant 
fashion. Phenotypic expression is often extremely variable and in 
the same family some members may suffer from a chronic haemolytic 
anaemia while others may be asymptomatic and only diagnosed in 
population surveys or family studies. Homozygosity has been suspected 
in a family where of 13 affected children 9 were physically or men-
tally defective {Bernard as quoted by Wintrobe, 1974). 
0. CLINICAL MANIFESTATIONS 
Patients may suffer from a chronic haemolytic anaemia of moderately 
severe extent or have very mild symptoms. These two extremes may occur 
in the same kindred. Clinical findings include anaemia with mild 
icterus which increases with fatigue, cold, emotion and pregnancy 
{Wintrobe, et al, 1974). Periodically, the jaundice and anaemia may 
worsen acutely with episodes of vomiting, fever and abdominal pain 
which may last from 5 to 14 days. This is said to be a haemolytic 
crisis; however, findings in one study suggest that such attacks may be 
acute aplastic crises (Owen, 1948). 
The haemolysis results in a raised serum bilirubin level and increased 
pigment (gall) stone fonnation. For this reason, cholelithiasis is a 
common presenting symptom and this complication occurs in 43-85% of 
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people with hereditary spherocytosis (Wintrobe, et al, 1974}. Spleno-
megaly is found in about 80% of affected individuals and the spleen 
may be massively enlarged. Dermatological complications include a 
chronic dermatosis and ankle pigmentation as a result of chronic leg 
ulcers. 
E. RADIOLOGICAL FINDINGS 
Thickening and striations of the frontal and parietal bones with 
the characteristic tower skull ( 11 turmschadel 11 } are the corrmonest radio-
graphic findings. Skeletal changes of a less severe nature but 
similar to those found in sickle cell anaemia and thalassaemia may be 
present. Heterotopic bone deposition is occasionally found. 
F. HAEMATOLOGICAL FINDINGS 
The haemoglobin concentration is usually at about lOg per 100 ml, 
although during a crisis it may fall to very low levels. 
The MCHC is characteristically high (37 to 39g per cent). Reticulo-
cytes are usually increased in number and values usually range from 5 
to 20%. In the peripheral blood smear cells with a typical spherical 
configuration (spherocytes) are present in large numbers. 
G. LABORATORY FINDINGS 
Osmotic fragility of red cells in hypotonic saline is increased. 
This may occur only as a "tail" at low concentrations or after in-
cubation for 24 hours. 
Spontaneous autohaemolysis of blood after incubation at 37°C occurs to 
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a greater extent than in patients suffering from an auto-irrmune 
haemolytic anaemic or normal individuals. In patients with hereditary 
spherocytosis, this increased autohaemolysis is corrected by the 
addition of glucose (Selwyn and Dacie, 1954). The Coombs test is 
usually negative and serum bilirubin is increased. 
H. DIAGNOSIS 
The diagnosis of hereditary spherocytosis in its typical clinical 
and familial background is relatively easy. However, in its mild form 
it may pose a diagnostic problem and require relatively extensive 
laboratory investigation. 
Initial diagnostic features are anaemia, splenomegaly, unconjugated 
bilirubinaemia, increased urobilinogen (not bilirubin) in the urine 
and stools and reticulocytosis. 
Peripheral blood smear reveals spherocytes and osmotic fragility is 
increased. Autohaemolytic studies show increased autohaemolysis 
corrected by the addition of glucose. 
Recognition of the hereditary nature of the disorder provides 
additional diagnostic support. 
I. PROGNOSIS 
The prognosis varies with the severity of the disorder. Mildly 
affected patients have a normal lifespan and even individuals with a 
chronic anaemia may reach an advanced age. Death may occur during a 
crisis and may be related to cardiac decompensation or biliary tract 
disease (Diamond, 1938). 
- 86 -
J. TREATMENT 
Iron therapy is contra-indicated due to the risk of iron overload 
and resultant haemochromatosis. Similarly, blood transfusions should 
not be given except in the case of a haemolytic or aplastic crisis. 
Folic acid deficiency may complicate the disorder and in these circum-
stances folate therapy should be utilized. 
The single most useful procedure in hereditary spherocytosis is 
splenectomy. After splenectomy, the haemoglobin rises, serum bilirubin 
decreases, reticulocytosis decreases and red cell survival time in-
creases. The osmotic fragility remains high and the peripheral smear 
still reveals spherocytes. Splenectomy is especially advisable in 
patients who are continuously anaemic, icteric, having had an aplastic 
or haemolytic crisis or suffering from cholelithiasis. Cholecystectomy 
for gallstones complicating hereditary spherocytosis should not be per-
formed without splenectomy. However, this procedure is contra-indicated 
in infancy due to the increased risk of infection, and should be 
delayed until about 5 years of age {Burman, 1958). 
K. PATHOPHYSIOLOGY 
The precise nature of the membrane defect leading to increased 
haemolysis in hereditary spherocytosis has not been fully elucidated 
I 
but several ; important observations have been made. 
The spherical configuration of the red cells is similar to that of 
normal red cells which have been incubated in hypotonic saline and 
which are about to burst. However, in phlebotomized patients with 
hereditary spherocytosis whose red cells were hypochromic and thin, the 
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red cell survival time w~s not increased (Crosby and Conrad, 1960). 
The red blood cell requires a constant supply of glucose. If there is 
a lack of glucose in vitro, adenosine triphosphate (ATP) becomes 
depleted and the mechanism for maintaining membrane impenneability to 
cations is lost. In hereditary spherocytosis, there is an increased 
sodium flux into the red cells (Wiley, 1972) which stimulates the 
adenosine triphosphatase system, resulting in ATP breakdown to provide 
energy for pumping the sodium out of the cell (Mohler, 1965). Adenosine 
diphosphate (ADP) and phosphate (P) are released and glycolysis is 
stimulated. Thus the effects of decreased glucose are exaggerated in 
red cells of hereditary spherocytosis. However, the increased sodium 
flux does not explain the accelerated red cell destruction in vivo, as 
after splenectomy this defect persists although red cell survival is 
essentially normal (Wintrobe, et al, 1974). 
It has been noted that the total lipid content of red cells in hereditary 
spherocytosis is decreased while the proportions of the various lipids 
are normal (Reed and Swisher, 1966). After splenectany, this abnor-
mality is not as obvious (De Gier, et al, 1964). The increased loss of 
lipid has been said to be due to accelerated metabolism necessary for the 
more rapid pumping of sodium. Decreased lipid content results in 
diminished pliability of the red cells which renders them more liable to 
I . 
sequestration in the spleen. 
Although certain structural abnormalities of the red cell membrane have 
been demonstrated by various workers, the exact nature of these 
anomalies has not been fully elucidated. The chief problem is that not 
all researchers in this field have been able to reproduce the same 
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results. 
Evidence for an abnonnal red cell membrane protein has been presented 
by Jacob, Amsden and White, 1971, 1972). However, this work has been 
questioned recently by Engehard, et al (1974} who found the protein 
to be nonnal. Similarly, an excess of negative charges of the com-
ponent proteins has been implicated by some workers (Engelhardt, 
1976} and refuted by others (Boivin and Galand, 1976; Johnson, 1978}. 
Abnonnalities in the interaction of lipid and protein membrane have 
been shown by Kuiper and Livne (1972) but not by others (Zail and 
van der Hoek, 1975a}. Calcium concentrations have shown to be ab-
nonnal by Feig and Basilian (1974} but not Zail and van der Hoek 
(1976). 
The most recent direction of study has been into the role of membrane-
bound protein kinase, an enzyme which by virtue of its catalysis of 
the phosphorylation of several membrane polypeptides has been 
postulated to effect cell shape and deformability. A significant 
decrease in cyclic AMP-dependent protein kinase activity in hereditary 
spherocytosis erythrocyte membrane has been demonstrated by some 
(Greenquist and Shohet, 1976; Matsumoto, Yawata and Jacob, 1977) but 
not confirmed by others (Zail and van der Hoek, 1975b, Beutler, Guinto 








Historical information was obtained with the aid of the Greek Con-
sulate, Church and comnunity of Cape Town. Early history of the Greek 
population in Cape Town was obtained fran the teacher of the Greek 
community, together with a book written in 1923 on Greek peoples in 
Southern Africa (Nickolaides, 1923). In addition, older members of the 
c0111Tiunity were consulted as to their personal history and that of their 
peers and progenitors. Statistical data on the population size, its 
movements and distribution was given by the same sources. 
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ASCERTAINMENT OF RESPONDENTS 
A. REQUIREMENTS FOR STUDY OF GENE FREQUENCY 
A random sample of the Greek community of Cape Town was required 
for this part of the investigation. Blood samples of 250 individuals, 
i.e. 5% of the Greek community were to be analysed. It was essential 
that these individuals were not first degree relatives, i.e; not sib-
lings or parent/children. A major stumbling block proved to be the 
reluctance of members of the Greek community to accept venepuncture. 
Reasons for this appeared to be fear of pain, superstition, incon-
venience and indifference. 
SOURCE OF SUBJECTS 
1. A circular was sent under the auspices of the Greek community 
committee to the members of the Greek community, explaining the aims 
of the study, and requesting volunteers for testing. The response to 
the circular was poor. However, the circular enlightened the community 
as to the nature of the work and facilitated subsequent contact. 
2. Permission was granted by the Executive Committee of the Board of 
I 
the Faculty of Medicine of the University of Cape Town to use Greek 
volunteers from the student body in the survey. The response from the 
students was also indifferent. 
3. The South African Defence Force was approached, and the Surgeon-
General gave permission for Greek servicemen to be tested. 
4. Inpatients at Groote Schuur Hospital, excluding patients being 
treated or investigated for thalassaemia, and other haematological dis-
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orders were investigated. This study also allowed the author to 
ascertain if there was any special pattern of non-haematological 
genetic disease in Greek people in Cape Town. 
5. The Greek co111nunity of Cape Town come together on Sundays to 
watch Greek film shows. The author therefore decided this meeting 
would be a suitable occasion for him to speak to reasonably large 
numbers of Greek people. As a result, the author explained the 
reasons and aims of the study at 2 film showings. The results of this 
exercise were satisfactory. Thereafter, a slide was projected at sub-
sequent film showings to remind members of the survey. 
6. The largest number of people tested were randomly approached. 
Individuals thus tested would recommend friends and acquaintances who 
would be willing to be sampled. This process proved to be extremely 
time-consuming but worthwhile in terms of the results obtained. Much 
time was spent in travelling to subjects' homes, private businesses 
or place of work. 
7. The ecclesiastical authorities were approached concerning the 
possibility of their referring couples for premarital testing. This 
would not only have been for the duration of the survey but as a con-
tinuing service to the Greek community. The church expressed appre-
ciation of the work being done for the community but found itself 
unable to give practical assistance. 
B. PATIENTS WITH THALASSAEMIA MAJOR 
Two patients of Greek origin, with thalassaemia major, domiciled 
in Cape Town, were traced through the Peninsula medical services. 
These individuals were subjected to a full clinical, radiological and 
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haematological examination. In addition, cognisance was taken of 
special investigations which had been perfonned as part of their 
hospital investigations and management. Where possible, the families 
of these patients were investigated clinically and haematologically. 
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CHAPTER 13 
CLINICAL AND LABORATORY TECHNIQUES 
During the first meeting with the investigation subjects, a per-
sonal history including age, marit~l status, number of children and 
place of origin was elicited. A brief medical history was taken, with 
special note of details of previous anaemia, jaundice, gallstones and 
leg ulcers. A 20 ml specimen of blood was obtained by venepuncture 
from the antecubital veins and then taken within 2 hours to the Cape 
Provincial Blood Grouping Laboratories, under direction of Dr MC Botha, 
where it was analysed. 
In view of the difficulty in obtaining respondents and satisfactory com-
pletion rates the author concentrated on this aspect of the survey. In 
all, the field work involved one year's full time and effort. 
The author became fully conversant with the laboratory techniques which 
were used. However, in view of the amount of time and effort involved 
in obtaining the blood specimens and the logistics of the survey, the 
greatest proportion of the hi~hly specialized analyses was performed by 
qualified medical technologists. 
The following standard laboratory procedures were undertaken on the 
blood specimens: 
1. Peripheral blood smears 
(a) red cell morphology 
2. Supra-vitally stained preparations 
(a) reticulocytes 
(b) haemoglobin H inclusion bodies 
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3. Blood grouping, including the ABO, rhesus and Duffy systems. 
4. Red cell parameters -
(a) haemoglobin levels (Hb) 
(b) packed cell volume (PCV) 
(c) red cell count (RCC) 
(d) mean corpuscular haemoglobin concentration (MCHC) 
(e) mean corpuscular volume (MCV) 
(f) mean corpuscular haemoglobin (MCH) 
5. Osmotic fragility 
6. Electrophoresis 
(a) abnormal haemoglobins (Lehman and Ager, 1960) 
(b) quantitation of haemoglobin A2 (Black,et al, 1960) 
7. Quantitation of haemoglobin F (Singer, et al, 1951) 
8. Brilliant cresyl blue dye test (Motulsky and Campbell-Kraut, 1961) 
Laboratory investigations undertaken for special indications: 
9. Methaemoglobin reduction test for G-6-PD deficiency (Bruwer, et al, 
1960) 
10. Solubility test for haemoglob in S (Itano, 1953) 
11. Autohaemolysis studies if spherocytosis was suspected 
12. Alpha/beta chain synthetic rates where alpha-thalassaemia carrier 
status was considered (Weatherall, et al, 1969). 
Once individuals had been found to have a haematological abnormality, a 
more detailed history was obtained. Emphasis was laid on the family 
origins and' medical problems, with special reference to symptoms or past 
findings of an anaemia. Thereafter, the author carried out a thorough 
medical examination, with particular emphasis on the haematological 
system, including the spleen. Where possible, members of the family 
were examined and tested. However, this proved impossible at times as 
many family members were still domiciled in Gr~ece , 
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Details of the laboratory methods for the procedures undertaken are 






DEMOGRAPHIC AND GENERAL RESULTS 
The Greek population of Cape Town numbers about 5000 and of these 
250 were randomly studied. Haematological investigations were carried 
out in this way in approximately 5% of primarily non-related individuals 
of this COITITIUnity . 
A. AGE 
The ages of the respondents ranged from 17 to 73 years in the 
following distribution (see Fig. 14 - 1). 
10 - 20 years 13 respondents 
20 - 30 years 57 respondents 
30 - 40 years 67 respondents 
40 - 50 years 61 respondents 
50 - 60 years 31 respondents 
60 - 21 respondents 
8. SEX 
Of the 250 individuals 150 (60%) were male and 100 (40%) were 
female. 
C. OCCUPATION 
Persons from a cross section of the Greek society were investigated 
and included labourers, shop assistants, artisans, students, businessmen, 
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Fig. 14 - 1 Age distribution of respondents 
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D. DEMOGRAPHIC INFORMATION 
The majority of the respondents originated from the Greek islands, 
especially the north-eastern Aegean islands. At least 27% had their 
antecedents in Lesbos. The reason for this distribution has already 
been discussed under the topic of Greeks in South Africa (Section 1. 
Chapter 4). 
A detailed analysis of the origin of the subjects is shown below in 
Table 14 - 1 and illustrated in Fig. 14 - 2:-
TABLE 14 - 1 
AGE DISTRIBUTION OF RESPONDENTS 
Numbers Per cent 
1. North-eastern Aegean Islands: 92 37 
(a) Lesbos 67 27 
{b) Lemnos 14 6 
2. Centra 1 Greece: 39 15 
3. Peloponnese: 37 15 
4. Northern Greece: 12 5 
5. Asia Minor: 12 5 
6. Cyprus: 15 6 
7. Other Greek Islands: 44 17 
(a) South-eastern Aegean Islands 11 
(b} Ionian 18 
(c) Crete 10 
(d) Cyclades 5 
N.<3Rt:ECE 
~ 30-50% 








Fig. 14 - 2 
"' ' '- ....... 
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E. OTHER GENETIC DISORDERS IN THE GREEK POPULATION OF CAPE TOWN 
Whilst the haematological survey was being carried out, note was 
taken of the possible occurrence of other genetic conditions within 
the Greek population of Cape Town. One couple included in the survey 
had a child with Down's Syndrome. This child was the couple's first 
born and the mother was 18 years of age at the time of the birth. The 
mother subsequently gave birth to a normal child. 
Diabetes and hypertension, both disorders with a genetic component, 
were found in the survey group but with an incidence probably in the 
range of that occurring in the White population as a whole in Cape 
Town. 
No other genetic disorders were found in the Greek population of Cape 
Town. 
DIAGNOSTIC CRITERIA 
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CHAPTER 15 
ALPHA-THALASSAEMIA 
A. Homozygous Alpha-Thalassaemia 
The homozygous alpha-thalassaemia state results in hydrops fetalis 
and the diagnosis is straightforward where the clinician has a high 
index of suspicion. The gene for alpha-thalassaemia has a particularly 
high frequency in south-east Asia (Poortrakul, et al, 1970) and homo-
zygous alpha-thalassaemia is considered in any hydropic birth where the 
parents have antecedents from this area. Confirmation of the diagnosis 
is by analysis of the cord (umbilical) blood. 
B. Heterozygous Alpha-thalassaemia 
The heterozygote may be asymptomatic or have stigmata of varying 
degrees characteristic of alpha-thalassaemia. 
For laboratory confirmation of the diagnosis of the alpha-thalassaemia 
heterozygote the following are considered: 
1. Red cell morphological abnormalities 
2. Red cell parameter abnormalities, especially MCH and MCV 
3. Red cell haemoglobin H inclusion bodies 
4. Alpha/beta chain synthesis rate ratios 
5. Haemoglobin Bart I s in cord blood 
6. Presence of haemoglobin Hon electrophoresis 
The clinical severity of the disorder depends on the number of abnormal 
genes, which in addition influences laboratory findings (see Chapter 7). 
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Hence, it may be reasonably easy to diagnose haemoglobin H disease in 
which 3 out of 4 genes are involved, but not the alpha-thalassaemia 
trait where only a single gene is implicated. The red cell morphology, 
MCV and MCH may be clearly abnormal in haemoglobin H disease but only 
be marginally abnormal in persons suffering from mild alpha-thalassaemia. 
Haemoglobin electrophoresis will show haemoglobin Hin the fonner con-
dition but nothing in the mild carrier state of alpha-thalassaemia. 
A further indication that an individual may have heterozygous alpha-
thalassaemia is the presence of typical red cell inclusion bodies. How-
ever, this finding is not diagnostic because as few as 2 red cells with 
inclusion bodies per 10 000 red cells can occur in heterozygous alpha-
thalassaemia. Similarly, numerous inclusion bodies may be present in 
the absence of the disorder (Botha, 1977). 
The easiest, and in fact sometimes the only time to diagnose the alpha-
thalassaemia trait is at birth by demonstration of haemoglobin Bart's in 
the .cord blood. In difficult diagnostic situations, family studies may 
be of use in deciding whether an individual carries alpha-thalassaemia. 
Finally, in equivocal cases the only certain method of diagnosing mild 
heterozygous alpha-thalassaemia is to measure alpha/beta chain synthesis 
rate ratios in order to demonstrate a decreased production of alpha 
chains. 
INTRODUCTION 
The difficulty in diagnosing alpha-thalassaemia has been discussed above 
and will be c0111T1ented upon later. 
During the survey no patients with hydrops fetalis (the result of homo-
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zygous alpha-thalassaemia) were born and no history of a previous 
hydropic birth was obtained. Haemoglobin H disease, where 3 of the 4 
genes are affected, and which is diagnosed by finding a typical H-band 
on electrophoresis was also not encountered. 
However, in no less than 22 persons peripheral blood smear revealed 
typical haemoglobin H inclusion bodies. These ranged in number from 
1/10 000 to 60/10 000. These red cell . inclusion bodies are suggestive, 
but not indicative of heterozygous alpha-thalassaemia and therefore it 
was decided to undertake further studies in a proportion of these per-
sons. As the relevant analyses to be done were extremely time con-
suming it was possible to investigate only a limited number of subjects 
in this survey. These selected for further investigation had a high 
proportion of inclusion bodies (more than 10/10 000) or those having 
red cell anomalies suggestive of the thalassaemia trait (decreased MCV 
and MCH) as well as any red cell inclusion bodies. On this basis a 
further 6 respondents were reviewed and alpha/beta chain ratios esti-
mated to enable the diagnosis of heterozygous alpha-thalassaemia to be 
made. 
On this basis 3 persons were diagnosed as having the alpha-thalassaemia 
trait with a resultant prevalence of 1,2 per cent and a gene frequency 
of 0,006 in the Greek comnunity of Cape Town. The findings in these 3 
individuals will now be summarized below. 
1. Personal data 
Details of age, sex, marital status, offspring, occupation and 






TABLE 15 - 1 
PERSONAL DATA OF SUBJECTS WITH THE 
A[PR~-TR~[~55~r~IA TR~IT 
Marital 
Age Sex status Children Occupation Origin 
31 M M 2 Tax consultant Cephalonia, 
Ithaca 
41 M M 2 Cafe owner Lesbos 
26 F s nil Teacher Lesbos 
a) Age 
Persons tested varied in age from 26 to 41 years. This is of 
no significance. 
b) Sex 
Two males as well as one female were found to carry alpha-
thalassaemia. As the inheritance of alpha-thalassaemia is auto-
somal equal distribution between the sexes would be expected. 
c) Marital status and offspring 
The 2 males who carry alpha-thalassaemia were married while 
the female was single. The ability to find a marriage partner 
was not impaired by the disorder. Each marriage produced 2 
children demonstrating that the fertility of the affected indivi-
duals was not diminished in any way. 
d) Occupation 
Occupation was not influenced by the disorder. 
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e) Ori gin 
Two of the individuals with heterozygous alpha-thalassaemia 
originated from Lesbos, while the other subject's antecedents 
were traced to Cephalonia and Ithaca. This is of importance for 
although more persons from Lesbos were involved in the survey 
than from any other single place, the proportion from the rest 
of Greece as a whole was nevertheless higher. Extrapolating from 
this data it appears possible that Lesbos has a higher proportion 
of alpha-thalassaemia than the rest of Greece. However, the 
numbers are too low for any final conclusions to be drawn. Un-
fortunately at present there is no comparable data from Greece. 
2. Red Cell Parameters 
These findings are sunmarized in Table 15 - 2. 
TABLE 15 - 2 
RED CELL PARAMETERS OF RESPONDENTS WITH THE 
ALPHA-THALAssAEMIA TRAIT 
CASE Hb g per PCV MCHC 
% 
































The haemoglobin in the 3 subjects varied from 14,2 to 16,7 g 
per 100 ml, with a mean of 15,5 g per 100 ml and a standard deviation 
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(SO) of 1,3. Thus the levels were within the normal range. It can be 
seen that although alpha-thalassaemia can result in an anaemia, the 
minimally affected individual who has 1 or 2 genes involved may not be 
anaemic at all. 
B. Packed Cell Volume (PCV) 
The PCV in the affected individuals ranged from 43 to 55 per 
cent with a mean of 48 and SO of 6,1. These values, as expected, are 
within normal limits. 
C. MCHC 
The mean MCHC was 32,2 per cent which is also in the normal 
range and of no significance. 
0. Reticulocyte Count 
The reticulocyte count in the 3 affected subjects varied 
from 0,9 to 1,2 per cent with a mean of 1,0 and a SO of 0,2. Persons 
with haemoglobin H disease, where there are 3 of the genes involved, 
and who are more severely affected clinically and haematological, 
usually have a reticulocytosis in the 5 per cent range (Weatherall and 
Clegg, 1972). However, persons with fewer genes involved may not have 
an abnormal reticulocyte count as is demonstrated here. 
E. Mean cell volume (MCV) 
The MCV, one of the most reliable indications of the thalas-
saemias, varied from 70 to 89 fl with a mean of 77 fl and SO of 10. 
Normal values range from 78 to 98 fl. Thus, only 2 of the 3 affected 
individuals have evidence of this important diagnostic indicator of the 
thalassaemias. 
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F. Red Cell Count {RCC) 
The RCC ranged from 4,48 to 7,62 million per mm3 with a mean 
of 6,37 and SD of 1,44. Higher than normal red cell counts are expected 
in the thalassaemias. This is the case in 2 of the 3 subjects. 
G. Mean Cell Haemoglobin (MCH) 
The MCH, a usually dependable indicator of the thalassaemias, 
ranged between 20 and 30 pg, with a mean of 25 and SD of 3. The normal 
range is 27 to 31 pg and thus, as with the MCV, 2 out of the 3 affected 
individuals have this characteristic abnormality. 











TABLE 15 - 3 
LABORATORY DATA OF SUBJECTS WITH THE 
ALPAA-TAALASSAEMIA TRAIT 
Hbf HbA Osmotic HbH inclusion 
% % fragility bodies 
0,1 2,2 Slightly 25 
increased lo 000 
0,6 1,7 normal 4 
10 000 
0,6 2,2 normal 60 
1o 000 






The haemoglobin pattern in the 3 subjects was AA. It is 
significant that no H-band was demonstrated on electrophoresis. Quanti-
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tation disclosed that the level of haemoglobin F (Hbf) ranged between 
0,1 and 0,6 per cent, with a mean of 0,4 and a SD of 0,3. Haemoglobin 
~ (HbA2) ranged between 1,7 and 2,2 per cent with a mean of 2,0 and a 
SD of 0,3. These values are all within nonnal limits. 
B. Osmotic fragility 
In 2 of the 3 subjects, the osmotic fragility of the red 
blood cells was nonnal, whereas in 1 it was slightly increased. These 
findings are not typical of the thalassaemias where one expects there 
to be a decreased osmotic fragility. However, this picture is in 
keeping with individuals with I or 2 affected genes where the typical 
stigmata may be minimal or absent. 
C. Inclusion Bodies 
An important indicator of the alpha-thalassaemia carrier 
trait is the presence of the typical inclusion bodies found on incu-
bating the blood with brilliant cresyl blue and which are due to 
precipitated beta-chains. These were found is all of the cases diag-
nosed as having heterozygous alpha-thalassaemia and varied from 
4 60 "th f 30 10 000 to 10 000 w, a mean° 10 000 · 
The presence of these peculiar inclusion bodies (see Fig. 15 - 1), 
although occurring characteristically in alpha-thalassaemia, may also 
occur in normal individuals and the diagnosis of the alpha-thalassaemia 
trait can thus not be made on this basis even in the presence of other 
typical abnormal red cell parameters. This will be discussed further 
in Chapter 25. 
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Fig. 15 - 1 Haemoglobin H inclusion bod.v in the centre 
of the field of peripheral blood smear of a person 
carrying alpha-thalassaemia. 
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E. Alpha/Beta chain ratios 
The most reliable method of diagnosing the alpha-thalassaemia 
carrier state is by studying the relative rates of synthesis of the 
alpha and beta chains in vitro. It was on this basis that heterozygous 
alpha-thalassaemia was finally diagnosed in the 3 subjects being dis-
cussed. All 3 individuals had defective rates of synthesis of the 
alpha chains when investigated by the method of Weatherall and Clegg 
(1969). 
Normal values in this test are 0,91 to 1,18, the alpha-thalassaemia 
trait (where 1 or 2 genes are involved) 0,50 - 9,90 and haemoglobin H 
disease (3 out of 4 genes affected) 0,20 to 0,50. 
In cases 1 and 2 where the values are 0,85 and 0,83 respectively 
definite but not gross impairment of alpha-chains synthesis is exhibited. 
Subject 3 manifests a greater reduction in chain production with a value 
of Q,58. 
4. CLINICAL DATA 





TABLE 15 - 4 
CLINICAL DATA OF RESPONDENTS WITH THE 
ALPHA-TAALASSAEMIA TRAIT 
Symptoms Signs Affected kin 
Nil Nil Not tested 
Nil Nil Son 
Anaemia noted Slight Not tested 
in past Splenomegaly 
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A. Symptoms 
Cases 1 and 2, the males, had no symptoms referrable to an 
anaemia. The single female, No. 3, had previously had symptoms of an 
anaemia though not when seen by the author. 
B. Signs 
No signs of a haematological disorder were found in cases 1 
and 2. Subject 3 was not anaemic but her spleen was just palpable 
below the left costal margin. 
C. Affected kin 
After respondent 2 had been investigated, it was discovered 
that his family had been previously studied and that his son had the 
alpha-thalassaemia trait. 





A. HOMOZYGOUS BETA-THALASSAEMIA 
Homozygous beta-thalassaemia (thalassaemia major, Cooley's 
Anaemia), is relatively easy to recognize. The distinct clinical 
presentation together with the results of haemoglobin electrophoresis 
and family studies makes the diagnosis reasonably straightforward. 
However, individuals may have a clinical condition of intermediate 
severity and still have homozygous beta-thalassaemia diagnosed by 
laboratory means and family studies. The latter situation occurs most 
often in Negro patients. 
A clinical picture which resembles thalassaemia major may occur when an 
individual has a combination of heterozygous beta-thalassaemia and an 
abnormal haemoglobin. This situation can be clarified by haemoglobin 
electrophoresis. 
B. HETEROZYGOUS BETA-THALASSAEMIA 
Parameters used in the diagnosis of heterozygous beta-thalassaemia 
include: 
(1) haemoglobin A2 and F levels 
(2) mean corpuscular volume (MCV) 
(3) mean corpuscular haemoglobin (MCH) 
(4) peripheral blood smear 
(5) osmotic fragility 
(6) family studies 
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The most important single diagnostic tool in this investigation of 
beta-thalassaemia was haemoglobin electrophoresis and the demonstration 
of a raised level of haemoglobin A2 .and/or haemoglobin F was considered 
highly suggestive of heterozygous beta-thalassaemia. The nonnal values 
for haemoglobin A2 and Fin the laboratory undertaking the tests were 
1,5 to 3% for the fonner, and Oto 1,7% for the latter. The diagnosis 
of heterozygous beta-thalassaemia was further substantiated by the 
demonstration of a decreased MCV and MCH with a moderately raised red 
cell count. 
Weatherall and Clegg (1972) consider a decreased MCH to be the haemato-
logical finding which gives the best discrimination from normal. An 
abnormal blood smear was also taken into account. Typical abnormalities 
include target cells, microcytosis, anisopoikilocytosis and basophilic 
stippling. The blood picture may vary from almost normal to that 
resembling homozygous beta-thalassaemia with numerous target cells, 
marked hypochromia and microcytosis. 
A decreased red cell osmotic fragility which is amplified after incu-
bation for 24 hours is considered to be of diagnostic importance. How-
ever, in the author's laboratory, the normal distribution curve is 
probably shifted to the right. Thus, if a patient had a normal osmotic 
fragility but other parameters positive for thalassaemia, the diagnosis 
of heterozygous beta-thalassaemia was not invalidated. In equivocal 
cases with minor abnonnalities, family studies may provide the necessary 
confirmatory evidence for the diagnosis of heterozygous beta-thalassaemia. 
For the purpose of this study, the finding of a raised haemoglobin F and/ 
or haemoglobin A2 together with 2 other abnonnal parameters was con-
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sidered sufficient to substantiate the diagnosis of heterozygous beta-
thalassaemia. There is one exception to these criteria, namely, case 
23, whose findings were all normal except for haemoglobin H type in-
clusion bodies in his peripheral blood. When alpha/beta chain syn-
thesis ratios were undertaken it was found that he had heterozygous 
beta-thalassaemia. The tests were repeated and the findings sub-
stantiated. 
INTRODUCTORY RESULTS 
Twenty-three of the 250 subjects involved in this study were found to 
be heterozygous for beta-thalassaemia. This can be stated as a 
prevalence of 9,2% and a gene frequency of 0,046. 
1. PERSONAL DATA 
Details of age, sex, marital status, offspring, occupation and place of 
origin are shown in Table 16 - 1. 
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TABLE 16 - 1 
PERSONAL DATA OF SUBJECTS WITH HETEROZYGOUS 
BtT~-TRAL~55~t~I~ 
MARITAL 
CASE AGE SEX STATUS CHILDREN OCCUPATION ORIGIN 
1 25 M s Nil Doctor Athens, 
Salonica 
2 38 M D 1 Electrician Aigon 
3 47 M M 1 Teacher Cyprus, 
Chios 
4 51 M M 2 Cafe owner Pelasgia 
5 27 F M 2 Supermarket Lesbos 
partner 
6 44 M M 1 Cafe owner Lesbos 
7 40 M M 3 Shop owner Lesbos 
8 29 F M 1 Dry cleaner Cyprus 
9 38 M M 1 Businessman Cyprus 
10 20 F s Nil Secretary Tri polis 
11 65 M M 2 Retired Cyprus 
12 49 M M 3 Cafe owner Lesbos 
13 27 M M Nil Doctor Kalamata 
14 32 M M 1 Electrician Lesbos 
15 52 M M 1 Cafe owner Patras, 
Chios 
16 41 M M 2 Cafe owner Lesbos 
17 33 F i"1 2 Cafe owner Lesbos 
18 23 F s Nil Clerk Cyprus 
19 58 M M Ship's captain Athens 
20 35 M M Nil Businessman Hagios 
Efstaios 
21 46 M M 3 Factory Crete 
manager 
22 48 F M 3 Housewife Galaxidion 




The age of the beta-thalassaemia heterozygotes ranged from 20 to 
65 years with a mean of 42 years. The age distribution (see Fig. 
16 - 1) was as follows: 
0 - 20 years ............ Ni 1 respondents 
20 - 30 years 7 II ............ 
30 - 40 years 6 II ............ 
40 - 50 years 6 II ............ 
50 60 years 3 II ............ 
60 - 70 years ......... ... 1 respondent 
In each of these broad age groups except the under 20 1 s and over 
60's the inti dence is approximately 10%. 
From the above figures it is evident that lifespan is not compromised 
by heterozygosity for beta-thalassaemia. 
b) SEX 
Of the 23 heterozygotes 17 were male and 6 were female. Thus, as 
there were 150 males in the population screened, the percentage of 
male beta-thalassaemia heterozygotes was 11,3%, and as there were 
100 females in the group as a whole the percentage of beta-thalas-
saemia heterozygotes was 6%. 
No obvious reason is evident for the difference in incidence between 
males and females. 
c) MARITAL STATUS AND CHILDREN 
The fact of having the beta-thalassaemia trait does not mitigate 
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Fig. 16 - l Age distribution of subjects with 
heterozygous beta-thalassaemia 
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were single, and all 3 were in fact engaged to be married. 
Besides these 3, 2 others have no children. One has a decreased 
sperm count, while the other couple were still young and were 
deliberately postponing procreation. Thus, having beta-thalas-
saemia trait does not affect the ability to reproduce in any way. 
d) OCCUPATION 
The occupation of individuals with heterozygous beta-thalassaemia 
show no particular bias. Occupations vary from cafe owners and 
artisans to professional people. As previously mentioned, a 
large proportion of the respondents from the Cape Town Greek 








See Table 16 - 2 and Fig. 16 - 2. 
TABLE 16 - 2 
ORIGINS OF RESPONDENTS WITH HETEROZYGOUS 
BETA-TRALASSAEMIA 
PLACE CASES % 
North East Aegean 10 10,8% 
Islands 
Lesbos 7 10,5% 
'-
Centra 1 Greece 3 7,7% 
Peleponnese 3 8, 1% 
Cyprus 4 30,0% 
Crete 1 10,0% 









Fig. 16 - 2 
DISTR}BUTlON OF OR!C71NS OF lNDlVlDU~ 
WITH HE.T~OZ.Y60U5 13-THALA55AE.MlA 
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Seven out of the 23 heterozygotes originated from the following 
towns on the island of Lesbos: Plomarian, Vera and Madamados. 
These are all fertile, low-lying areas in which it is probable 
that malaria was endemic until fairly recently. 
A further 3 individuals had their antecedents on the North Eastern 
Aegean islands; 1 from Agios Efstratios, and the other 2 from 
Chios. These are both low-lying areas. 
From the above figures, it can be seen that the prevalence of beta-
thalassaemia in individuals in Cape Town who originated from the 
North Eastern Aegean islands is slightly more than 10%, and 10,5~ 
. 
for persons from Lesbos. 
Three individuals who originated from Central Greece, from the low-
lying towns of Galaxidion, Athens and Pelasgia also have hetero-
zygous beta-thalassaemia. A prevalence of 7,7% may be calculated. 
Three respondents coming from Tripolis, Kalamata and Aigion, have 
the thalassaemia trait. Tripolis is not low-lying as is the case 
of the other 2 towns. In addition, 1 of the parents of an individual 
with heterozygous beta-thalassaemia originates from Patras, in the 
Peleponnese. The prevalence in people from the Peleponnese is 8,1%. 
Four individuals, plus a parent of a further subject with hetero-
zygous beta-thalassaemia had antecedents from 2 low-lying coastal 
towns in Cyprus, namely, Paphos and Kyrenia. The prevalence in 
individuals originating from Cyprus and at present living in Cape 
Town is 30%. Finally, 1 of the 10 individuals from Crete and 2 of 
the 5 from Cephalonia has the thalassaemia trait. 
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2. LABORATORY FINDINGS 
Details of abnormal haemoglobin, percentage haemoglobin A2 and F, 
osmotic fragility and peripheral blood smear are given in Table 


























TABLE 16 - 3 
LABORATORY FINDINGS IN RESPONDENTS WITH 
RETEROZYG005 BET~-TR~[~55~E~I~ 


































3,5 norma 1 
5,3 decreased 
5,3 norma 1 
4,5 normal 
4,1 norma 1 
3,1 norma 1 
4,9 normal 
3,4 decreased 
3,9 norma 1 
5,7 decreased 




3,7 norm a 1 
2,6 norm a 1 
TC = Target cells 
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a) HAEMOGLOBIN ELECTROPHORESIS 
There were no haemoglobin structural variants occurring in 
association with heterozygous beta-thalassaemia in the 23 subjects. 
The haemoglobin pattern in every instance was AA. 
In 3 of the 23 beta-thalassaemia heterozygotes the level of HbF 
was raised, but not that of Hb A2. Normal values for HbF are up 
to 1,7%, and the values in the respondents varied from 2,5% to 
7,9%, with a mean .of 4,3%. In the 1 instance (subject 21) there 
were minor haematological abnonnalities, creating a diagnostic 
difficulty, whereas in the other 2 cases (1 and 4), the diagnosis 
was relatively clearcut. In a further 3 respondents the value of 
haemoglobin Fas well as that of haemoglobin A2 was raised. These 
were subjects 10, 11 and 17, in which the value of HbF ranged from 
2,2% to 4,1% with a mean of 3,3%. Hb A2 values ranged from 4,5% to 
5,7% with a mean of 5,1%. Diagnosis was clearcut in these cases. 
In considering the above 2 groups together, the HbF values ranged 
from 2,5% to 7,9% with a mean of 3,8% and a standard deviation of 
2,1. In 16 respondents haemoglobin A2 alone was raised, with a 
nonnal value for haemoglobin F and in a further 3 subjects (Nos. 
10, 11 and 17), who have been mentioned previously, the values for 
both haemoglobin A2 and F were increased. In all these individuals 
abnonnal red corpuscular parameters confirmed the diagnosis of 
heterozygous beta-thalassaemia. The mean haemoglobin A2 level in 
the 19 cases with a raised A2 level was 4,5% with a standard 
deviation of 0,75. The mean for Hb A2 in these cases was 4,2% with 
a standard deviation of 1,0. A nonnal level for haemoglobin A2 is 
1,5 to 3,0%. Subject 23, an exception, had nonnal levels of both 
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Hb A2 and HbF. 'He will be discussed at length later. The 
distribution of haemoglobins A2 and Fare shown in Figs. 16 - 3 
and 16 - 4. 
b) OSMOTIC FRAGILITY 
Table 16 - 3 demonstrates that osmotic fragility studies, as 
undertaken in the laboratories involved in this investigation, is 
only an aid to diagnosis and not an absolute diagnostic parameter 
and that it is unsuitable as a screening procedure in population 
studies. In 6 of the 23 respondents with heterozygous beta-
thalassaemia, the osmotic fragility was decreased initially, or, 
after 24 hours incubation, whilst in 17 cases it was normal. A 
decreased osmotic fragility curve is demonstrated in Fig. 16 - 5. 
c) PERIPHERAL SMEARS 
All of the 21 peripheral blood smears examined exhibited abnor-
malities to a greater or lesser extent, ranging from anisopoi-
kilocytosis to smears revealing many target cells, microcytes, 
ovalocytes,basophilic stippling and tear drop cells (as found in 
thalassaemia major). Subject No. 21, who had the most minor 
abnormalities of other haematological parameters, also had only 
minor changes consisting only of anisopoikilosytosis. However, 
in the rest of the respondents there was no clear correlation 
between clinical severity, magnitude of haematological abnor-
malities and changes evident in peripheral blood smear. A 
typical target cell is shown in Fig. 16 - 6. 
3. RED CELL PARAMETERS 
Table 16 - 4 gives details of haemoglobin, packed cell volume, 
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Fig. 16 - 5 Osmotic fragility curve demonstrating decreased 
fragility in a patient with heterozygous beta-
thalassaemia. 
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Fig. 16 - 6 Peripheral blood smear in beta-thalassaemia 
heterozygote. Characteristic target cell 
is in the centre of the field. 
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mean corpuscular haemoglobin concentration, mean corpuscular 
volume, mean cell haemoglobi~, red blood cell count and reticulo-
cyte count. Subject No. 11 had G-6-PD deficiency and stage IV 
carcinoma of the bladder, in addition to heterozygous beta-
thalassaemia. Some of the red cell abnormalities could therefore 
be attributed to his neoplasm and for this reason he is not in-
cluded in the statistics of red cell parameters which are given 
in the next section. 
- 132 -
TABLE 16 - 4 
RED CELL PARAMETERS IN SUBJECTS WITH 
HtTtROZ9G005 BtT~-TR~[~SS~t~I~ 
Hb MCV MCH RBC 3 RETI CULOCYTE CASE g/100 ml PCV % MCHC % fl pg mi 11 /mm COUNT% 
1 13,0 45 27 71 21 6,34 0,6 
2 11, 7 37 31,5 76 23 4,89 1,0 
3 14,0 45 31 70 28 3,41 0,7 
4 12,3 38 32 65 21 5,84 0,6 
5 11, 7 38 31 66 21 5,61 1,8 
6 12 ,8 43 29,5 68 20 6,32 0,9 
7 13,0 43 30 1,2 
8 11,8 38 31 70 22 5,42 0,3 
9 13,6 44 29,5 73 21 6,25 1,1 
10 11,5 39 29 63 19 6,19 1,9 
11 3,1 35 25,5 74 7 4,72 2,4 
12 12,8 44 28,3 72 21 4,12 4,7 
13 15,1 45 34 64 21 7,05 2,4 
14 13,7 46 30 69 20 6,69 2,2 
15 12,1 38 32 62 20 6,20 2 ,9 
16 14,4 37 30 65 20 5 ,61 3,0 
17 10,9 37 29 67 20 5,53 2,6 
18 12.7 42 30 79 24 5,30 2,0 
19 10,6 35 30 78 24 4,46 2,1 
20 13,4 43 31 67 21 6,38 2,0 
21 16,1 50 32 82 26 6,16 2,2 
22 11,2 37 37 58 20 6,33 1,8 
23 16 ,5 46 36 84 30 5,46 0,4 
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a) HAEMOGLOBIN 
Normal haemoglobin levels in males vary from 14-18% and, for 
females from 12-16%. The haemoglobin values in the 6 females 
having heterozygous beta-thalassaemia, are generally lower than 
those of the males with the same disorder, and vary from 10,9 g per 
100 ml-12,7 g per 100 ml with a mean of 11,6 g per 100 ml and a 
standard deviation of 0,6. The haemoglobin values in the 16 male 
subjects varies from 10,6 g per 100 ml-16,5 g per 100 ml with a 
mean of 13,2 g per 100 ml and a standard deviation of 1,4. Case No . 
19, a male with a haemoglobin of 10,6 g per 100 ml was recovering 
from an acute pancreatitis at the time that he was investigated, 
and it is probable that he had some degree of anaemia as a result. 
Case No. 21, with a haemoglobin of 16,1 g per 100 ml, is at the other 
end of the spectrum. His other haematological abnonnalities are of 
minor nature, consisting essentially of a decreased MCH and aniso-
poikilocytosis on peripheral blood smear. Excluding subject No. 19, 
on the basis of his dual pathology, the mean haemoglobin for the 
group as a whole is 13,4 g per 100 ml with a standard deviation of 
1,2. These statistics demonstrate the usually, but not always, minor 
degree of anaemia found in patients with thalassaemia minor. 
b) PCV 
The normal values for males varies from 40-54% and for females from 
36-47%. The values in the female varied from 37-42% with a mean of 
38,5%, with the majority of them being within the normal limits. 
The values of the males, excluding case Nos. 11 and 19, who had 
concurrent pathology, ranged from 37-50% with a mean of 42,7% and 
a standard deviation of 4,46. The males fell within normal limits, 
with the exception of subject 4. 
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c) MCHC 
+ . The normal values for MCHC are 34 _ 2%. The MCHC ranged from 27-
34% in the 21 cases in the series. The mean was 30,4% with a 
standard deviation of 1,5. Four of the cases, Nos. 4, 13, 15 and 
22 had values within normal limits, while the greater majqrity 
had values which were slightly lower than normal. 
d} MCV 
The MCV in normal persons varies from 78-98 fl (i.e. 88 ± 10 fl}. 
In the 21 heterozygous beta-thalassaemia subjects studied, the 
MCV varied from 58-84 fl (see Fig. 16 - 7) with a mean of 69,5 fl 
and a standard deviation of 6,0. Respondent No. 23, whose stig-
mata are of a minor nature, has the highest MCV (84 fl), whilst 
another 3 cases, Nos. 18, 19 and 21, had MCV values which were 
within normal limits. The remaining 17 cases all had abnormally 
low MCV levels. A decreased MCV is typical of thalassaemia minor. 
e) MCH 
Normal values for MCH vary from 27-31 pg (29 ± 2 pg). In the 21 
cases under consideration the MCH ranged between 19 and 30 pg 
(see Fig. 16 - 8), thus all except Nos. 3 and 23 were abnormally 
low. The mean for the 21 cases was 21,6 pg with a standard 
deviation of 2,1. Case 21 had a MCH of 26 pg at the lCMer end of 
the normal range, while subject 23 had a normal level of 30 pg. 
A low MCH is characteristic of the disorder. 
. ' 
f) RED CELL COUNT 
The mean overall red cell count for 20 cases (those excluded being 
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Fig. 16 - 7 Range of mean cell haemoglobin in subjects with 
heterozygous beta-thalassaemia 
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Nos. 11 and 21, who had concurrent significant illness, and No. 7 
on which there is limited available data), was 5,88 million/mm3 
with a standard deviation of 0,79. The normal values in the 
general population are, males 5,4 ± 0,8 million/mm3 , and females 
4,8 ! 0,6 million/nun3. In the male cases under consideration, the 
mean was 5,94 million/nm3 with a standard deviation of 0,92 and in 
the female cases, the mean was 5,74 million/nm3 with a standard 
deviation of 0,43. Thus, the values for the men tend to occur 
within the high limits of normal or are mildly increased, whilst 
those for the women are moderately increased. In the heterozygous 
beta-thalassaemia it is usual for the red cell count to be raised. 
g) RETICULOCYTE COUNT 
The normal value for reticulocyte count is less than 2%. In the 
subjects with heterozygous beta-thalassaemia the reticulocyte 
varied from 0,4-4,7% with a mean of 1,81% and a standard deviation 
of 1,03. 


























TABLE 16 - 5 





Tiredness ni 1 
Headaches nil 
Dizziness, ni 1 
ma 1 aise 












weakness, 2 cm 
malaise, spleno-
fatigue megaly 
nil 1 cm 
spleno-
megaly 

































The majority of the 23 persons with heterozygous beta-thal&ssaemia 
were virtually asymptomatic. Minor symptoms which could possibly 
be due to anaemia were found in 3 females, and 3 males. On 
questioning the men more fully, it is probable that their symptoms 
were, in fact, due to stress and pressure from work. In the case 
of the women, their symptoms were probably due to a mild anaemia. 
However, a relatively large proportion of normal women within the 
Greek population had similar complaints and in view of this little 
significance is placed on this finding. 
b) SIGNS 
Signs due to the thalassaemia trait were elicited in only 2 indivi-
duals. These consisted of splenomegaly in both subjects, and in 1 
there was in addition clinical detectable anaemia. 
c) CONCOMITANT ILLNESS 
Concomitant illness, both past and present, was evident in 6 of the 
23 cases. Case 11, who had stage IV carcinoma of the bladder and 
G-6-PD deficiency, and case 19, who was recovering from acute 
pancreatitis, had some laboratory results which were affected by 
their major illnesses. There was, however, sufficient evidence to 
enable the diagnosis of heterozygous beta-thalassaemia to be 
established. 
The occurrence of heterozygous beta-thalassaemia in association with 
G-6-PD deficiency is noteworthy. It is well recognised that both 
thalassaemia and G-6-PD deficiency occur with high frequencies in 
the Greek population, but no direct relationship between the 2 
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disorders is recognised. Thus, in the 250 persons screened we 






-r = 1,38 cases 
{This calculation is based on the knowledge of the relative 
incidence of the 2 disorders in Cape Town.) 
As the numbers studied in the series as a whole are rel&tively low, 
the discovery of 2 persons with both disorders out of 250 
respondents, is in accordance with this figure. 
Other illnesses and disorders encountered in persons with the 
thalassaemia trait have no practical or statistical significance, 
and therefore do not warrant further c0111T1ent. 
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CHAPTER 17 
GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY 
DIAGNOSTIC CRITERIA 
The diagnosis of G-6-PD deficiency is straightforward and 
essentially a laboratory matter, although a history of haemolytic 
episodes following the ingestion of fava beans or certain implicated 
medicines might arouse suspicion that an individual may be G-6-PD 
deficient. 
Laboratory tests perfonned in this survey to diagnose G-6-PD deficiency 
were:-
(i) The brilliant cresyl blue test of Motulsky and 
Campbell-Kraut (1961) 
(ii) The methaemoglobin reduction test (Brewer, et al, 1960) 
In the abnonnal brilliant cresyl blue test the dye colour change occurs 
after 40 minutes in a female and more than 44 minutes in a male (see 
Fig. 17 - 1). In G-6-PD deficient males the result is usually gr9ssly 
abnonnal and the diagnosis obvious, whereas in heterozygous females the 
test may only be marginally abnormal. In this situation the more sen-
sitive methaemoglobin reduction test was perfonned. An abnormal result 
is when more than 5% of the methaemoglobin persists. 
INTRODUCTORY RESULTS 
Fifteen subjects of the 250 involved in this survey were found to have 
G-6-PD deficiency. These were 10 men and 5 women. Thus, the propor-
tion of individuals suffering from G-6-PD deficiency is 6% amongst the 
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Fig. 17 - 1 Colour change completed in test tube on 
left in Motulsky test for G-6-PD deficiency 
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250 members in the Greek population of Cape Town. The prevalence for 
the males is 6,7% (i.e. 10 out of 150) and that for the females 5% 
(i.e. 5 out of 100). The discrepancy between males and females, though 
not large, may be explicable due to the fact that as G-6-PD deficiency 
is an X-linked inherited disorder, it may be difficult to diagnose in 
hemizygous females whose disorder may be asymptomatic and can therefore 
be missed during a simple screening procedure. Because of this dis-
crepancy, the gene frequency will be calculated from the male prevalence 
and is 0,067. 
1. PERSONAL DATA 
Details of age, sex, marital status, offspring, occupation and place of 
origin in the 15 subjects with G-6-PD deficiency are given in Table 17 -
1. 
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TABLE 17 - 1 
PERSONAL DATA OF SUBJECTS WITH G-6-PD DEFICIENCY 
MARITAL 
CASE AGE SEX STATUS CHILDREN OCCUPATION ORIGIN 
1 26 M s nil Baker Lemnos 
2 50 F M 3 Housewife 
3 36 M M 1 Ass. Consul Arta 
4 24 F M 2 Housewife Simi s 
5 29 F M 1 Cafe owner Lesbos 
6 27 M M 1 Cafe owner Lemnos 
7 41 F M 3 Cafe owner Lem nos 
8 20 M s nil Medical student Lesbos 
9 50 M M 2 Factory manager Evia 
10 45 M M 1 Artisan Smyrne 
11 46 F M 2 Housewife Cephalonia 
12 60 M M 3 Businessman Imroz 
13 32 M s nil Restauranteur Cephalonia 
14 65 M M 2 Retired Cyprus 
15 40 M M 3 Shop owner Lesbos 
a) AGE 
Persons diagnosed as having G~6-PD deficiency ranged in age frcm 
20 to 65 years with a mean of 40 years. The age distribution of 





















Fig. 17 - 2 Age distribution of subjects with 
G-6-PD deftciency 
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TABLE 17 - 2 
AGE DISTRIBUTION OF SUBJECTS WITH G-6-PD DEFICIENCY 
% OF AGE GROUP 
AGE NO. OF CASES WITH THE DISORDER 
0 - 20 1 7,6 
20 - 30 4 6,7 
30 - 40 3 4,3 _ 
40 - 50 5 8,3 
50 - 60 1 3,3 
60 + 1 5,0 
b) MARITAL STATUS AND CHILDREN 
As all but 3 of the 15 individuals with G-6-PD deficiency were 
married and had families of nonnal size, it is evident that 
fitness to reproduce is not affected by the disorder. 
c) OCCUPATION 
As with thalassaemia, G-6-PD deficiency does not influence 
financial status or social class. Occupations vary from artisans 
and cafe owners to members of the diplomatic corps, in subjects 
covered in this s~rvey. 
d) ORIGIN 
The places of origin of the G-6-PD subjects, except subject 2 whose 
origins are not known, is shown in Fig. 17 - 3 and Table 17 - 3. 
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TABLE 17 - 3 
ORIGIN OF SUBJECTS WITH G-6-PD DEFICIENCY 
% OF SUBJECTS WITH G-6-PD 
PLACE CASES DEFICIENCY AT EACH LOCALITY 
1) North east Aegean 7 7,5 
Islands 
a) Lesbos 3 4,3 
b) Lemnos 3 20 
2) South east Aegean 1 9 
Islands 
3) Ionian (West) Islands 2 11,8 
4) Asia Minor 1 9,9 
5) Centra 1 Greece 1 2,5 
6) Cyprus 1 6,6 
7) Peloponnese 1 2,7 
The majority of individuals in this survey with G-6-PD deficiency came 
from low lying areas where malaria was moderately endemic until recent 
times. This includes the North Aegean, South Aegean and Ionian islands 
which have a relatively high prevalence, ranging from 7,5% to 11,8%, 
whilst the Peloponnese and Central Greece have relatively low prevalence 
of 2,7% and 2,5% respectively. The 4,3% prevalence of G-6-PD deficiency 
found in respondents originating from Lesbos compares well with 4,6% and 
3,9% found in surveys undertaken on the islands of Lesbos by Doxiadis, 
et al (1964). Stamatoyannopoulos and Fessas (1964)
1 
investigating G-6-PD 
deficiency in 5 areas in Greece, noted a prevalence of 0,86-6,22% on 
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prevalence of G-6-PD deficiency is higher in areas where malaria was 
endemic recently and lower where it was not. These findings were 
similar in the Arta area where the prevalence ranged from 2,8% to 
16,4% in parallel with past malarial endemnicity. 
2. HAEMATOLOGICAL PARAMETERS 
Details of haemoglobin, packed cell volume, mean corpuscular haemo-
globin concentration, mean corpuscular volume, mean corpuscular 
haemoglobin, red cell count and reticulocyte count are given in 
Table 17 - 4. 
Subjects 2 and 14 will not be considered in this analysis as at the 
time of testing they were suffering from concurrent illnesses, which 
were the main contributory factors to their low haemoglobins and 
other abnormal laboratory findings. Respondent 2 was in chronic renal 
failure, and case 14 had terminal stage IV carcinoma of the bladder. 
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TABLE 17 - 4 
RED CELL PARAMETERS OF RESPONDENTS WITH G-6-PD DEFICIENCY 
g per 
MILL IONS/MM3 100 ml % % fl pg % 
CASE Hb PCV MCHC MCV MCH RBC RETICULOCYTES 
1 13,0 39 33 88 29 4,45 0,4 
2 6,6 24 27,5 103 28 2,3 0,3 
3 15,5 48 32 96 31 5,0 2,8 
4 12,4 42 29,5 93 28 4,54 1,8 
5 12,7 46 32 92 29 4,33 3,0 
6 14,7 45 33 94 31 4,77 2,8 
7 12,2 39 31 90 28 4,35 2,6 
8 13,8 45 31 92 28 4,87 1,4 
9 14,7 46 32 91 29 5 ,05 1,5 
10 15,5 34 35 87 31 5,07 0,!;i 
11 U,3 38 30 93 29 4,05 1,2 
12 16, 1 46 35 86 30 5,29 1,4 
13 14,3 41 35 92 32 4,48 3,5 
14 3,1 35 25,5 74 7 4 ,72 2,4 
15 13,0 43 30 1,2 
a) HAEMOGLOBIN 
The haemoglobin in the case of the females varied from 11,3%-
12,7 g per 100 ml with a mean of 12,2 g per 100 ml and a standard 
deviation of 0,6. The males haemoglobin values ranged from 
13,0 g per 100 ml-16,1 g per 100 ml with a mean of 14,5 g per 
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100 ml and a standard deviation of 1,1. It is evident that the 
haemoglobin levels in both men and women tended to be in the 
lower normal limits rather than in the higher normal limits. 
This suggests that they were chronically haemolysing their red 
blood cells. 
b) PACKED CELL VOLUME (PCV) 
The PCV (excluding cases 2 and 14) was normal in all but 1 of the 
subjects where it was marginally decreased - this was case 10 
where the PCV was 34%. The reason for this low value is not 
apparent. 
c} MEAN CORPUSCULAR HAEMOGLOBIN CONCENTRATION (MCHC) 
The MCHC was slightly decreased in 4 of the cases; however, the 
abnormality is not significant and does not warrant further 
c00111ent. 
d) MEAN CORPUSCULAR VOLUME (MCV} 
The MCV is normal in all cases except in subjects 2 and 14. In 
subject 2 the MCV was 103 fl and thus macrocytic. This patient 
had chronic renal failure. Case No. 14 is microcytic having an 
MCV of 74 fl, which could be due to the patient's concomitant 
carcinoma of the bladder, or his B-heterozygous thalassaemia. A 
normal MCV is expected in this condition unless it is complicated 
by iron deficiency anaemia. 
e) MEAN CORPUSCULAR HAEMOGLOBIN (MCH) 
The MCH in all cases was normal. 
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f) RED CELL COUNT (RCC) 
The RCC was normal in all cases except No. 2 where there was a 
complicating illness. 
g) RETICULOCYTE COUNT 
The reticulocyte count varied from 0,4%-3,0% excluding case 
numbers 2, 14 and 13. The latter subject was found to have 
hereditary spherocytosis in addition to G-6-PD deficiency, and as 
both could result in a reticulocytosis, it was decided to exclude 
these findings from the analysis. The overall mean reticulocyte 
count was 2,0% with a standard deviation of 0,9. The mean 
reticulocyte count for the females was 2,2% with a standard 
deviation of·.o~a, whilst the mean for the males was 1,5% with a 
standard deviation of 0,8. As G-6-PD deficiency is inherited in 
an X-linked manner, with the feamles carrying the disease, while 
the males suffer from the disorder, it is to be expected that 
the men would have a higher reticulocyte count than the women. 
However, this was not so in the survey cases. Similarly, males 
would be expected to haemolyse at a higher rate than the females, 
with a resultant higher compensatory reticulocyte count. There 
. was no obvious reason· for this anoma_ty. If haemolysis was 
occurring it would be expected that the reticulocyte count would 
be increased. 
3. DIAGNOSTIC PROCEDURES 
These results are sunmarized in Table 17 - 5. 
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TABLE 17 - 5 
DIAGNOSTIC PROCEDURES IN SUBJECTS WITH 
G-6-PD DEFICIENCY 
MOTULSKY METHAEMOGLOB IN OSMOTIC 
CASE (MINUTES) REDUCTION FRAGILITY 
1 240 Nonnal 
2 43 20,1% Nonnal 
3 300 Nonnal 
4 50 16,7% Nonnal 
5 48 78% Nonnal 
6 240 Nonnal 
7 52 Increased 
8 120 Nonnal 
9 59 Nonnal 
10 65 Normal 
11 60 Normal 
12 180 Increased 
13 300 Increased 
14 133 Normal 
15 300 Decreased 
The brilliant cr~syl blue dye screening test of Motulsky and Campbell-
Kraut was used in screening the population investigated. This test 
was adequ~te in diagnosing males with the disorder, but in certain 
heterozygous females the results of these tests were equivocal and a 
more sensitive test was required. For these reasons, the methaemo-
globin reduction test was performed on the females who had a slightly 
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increased brilliant cresyl blue dye test, 
Eight of the males with G-6-PD deficiency hqd grossly elevated 
brilliant cresyl blue tests of greater than 120 minutes. The remain-
ing 2 cases (Nos. 9 and 10) had values of 59 and 65 minutes respectively. 
These re5ults fall more into the pattern of the Negro variety of G-6-PD 
deficiency. However, as has been previously mentioned, there is great 
heterogeneity within G-6-PD deficiency and many variants (more than 100) 
of G-6-PD deficiency have been identified. 
A normal brilliant cresyl blue dye test in females is considered less 
than 40 minutes. The females carrying G-6-PD deficiency included in 
this survey had values of the above test ranging from 43-60 minutes. A 
methaemoglobin reduction test is considered abnormal when over 5%. In 
the females tested the results varied from 16,7% to 78%. Subject 7, 
with a brilliant cresyl blue dye test of 52 did not have a methaemo-
globin test performed as her daughter had already been proven to have 
G-6-PD deficiency. Respondent 11 had a very abnormal brilliant cresyl 
blue test (60 minutes) and for this reason the methaemoglobin reduction 
test was considered unnecessary. 
Osmotic fragility studies are not diagnostic tests for G-6-PD deficiency 
and are usually normal. Three of the respondents found to have G-6-PD 
deficiency had an increased osmotic fragility, while 1 had a decreased 
osmotic fragility. The decreased osmotic fragility in case 15 was due 
to concomitant he~erozygous beta-thalassaemia, while case 13 had an in-
1 
creased osmotic fragility as a result of concomitant hereditary sphero-
cytosis. 
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These results are summarized in Table 17 - 6. 
TABLE 17 - 6 
CLINICAL MANIFESTATIONS OF RESPONDENTS WITH 
G-6-PD DEFICIENCY 
SYMPTOMS SIGNS 
Dizziness following fava Hepatospleno-
bean ingestion megaly 
Weakness Nil 
Abdominal pain and Splenomegaly 
weakness following 
fava bean and Disprin 
ingestion 
Nil Ni 1 
Fatigue, malaise Nil 
Nil Nil 
Abdominal pain, Nil 
malaise 
Nil Splenomegaly 
Vague abdominal pain Ni 1 
Ni 1 Nil 
Nil Nil 
Nil Splenomegaly 
Abdominal pain Nil 
Nil Lower abdominal 
mass 
Previous abdominal Nil 
pain, anaemia 
following ingestion 
of fava beans 
CONCOMITANT DISEASE 
Nil 













tomy for stones 
Spherocytos is 





Of the 5 wom~n with G-6-PD deficiency, 2 (cases 5 and 7) had 
symptoms in the past attributable to an anaemia which would tend 
to be exacerbated by G-6-PD deficiency. Case No. 2 had symptoms 
of weakness and lassitude which were probably due to her under-
lying chronic renal failure. 
Three of the males (cases 1, 3 and 15) have suffered attacks of 
favism. In addition, case 3 is the only individual who has had a 
definite haemolytic crisis following the ingestion of drugs, in 
his instance acetyl salicylic acid. Case 9, who is allergic to 
carbacaine and belladonna, probably suffered from acute allergic 
reactions to these drugs and not haemolytic reactions. Cases 9 
and 13 had vague symptoms of abdominal pain. 
b) SIGNS 
Four of the men with G-6-PD deficiency had clinically enlarged 
spleens. In 2 of them (cases 8 and 12) the spleen was just pal-
pable, but in case 3 it was firm and extended 3 cm below the left 
costal margin. In addition, case 1 had a liver palpable 1-2 cm 
below the right costal margin. Case 14 had a large, firm, 
irregular lower abdominal mass which was due to his carcinoma of 
the bladder and was not related to his G-6-PD deficiency. In 
subjects undergoing chronic haemolysis splenomegaly is known to 
occur and therefore eliciting this sign clinically is expected in 
a proportion of case~. 
c) CONCOMITANT DISEASES 
The occurrence of G-6-PD deficiency in association with thalassaemia 
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is to be expected due to the high frequency of each in peoples of 
Greek origin. As calculated earlier in Chapter 16, 1, 38 indi-
viduals would be expected to have the 2 disorders concomitantly. 
The discovery of 1 case (13) and possibly a second (7) of G-6-PD 
deficiency occurring in association with spherocytosis is higher 
than expected in Greeks in Cape Town. Statistically, one would 
expect 0,07-0,192 cases. This is calculated with the knowledge of 
the prevalence of G-6-PD deficiency and hereditary spherocytosis 
in the population being studied. The occurrence of 2 is probably 
attributable to chance. 
Cases 12 and 15 who have previously had cholecytectomies for 
cholelithiasis, probably had this illness on the basis of their 
G-6-PD deficiency. Subject 12's osmotic fragility studies were 
increased but his autohaemolytic studies were normal, indicating 
that he was haemolysing at an increased rate due to some exogenous 
cause. As he had been taking disprin for headaches over a long 
period it is reasonable to suggest that he would not have an acute 
haemolytic episode but that he would haemolyse his older red cell 
population at a steady rate. This chronic increased rate of 
haemolysis could well explain his cholelithiasis and splenomegaly. 
The occurrence of carcinoma of the bladder, chronic renal failure 
and duodenal ulceration were found to occur in the Greek population 
of Cape Town at a frequency similar to the rest of the population 




HEREDITARY SPHEROCYTOSIS (HS) 
Diagncstic Criteria 
Patients with HS may present with the clinical findinqs of anaemia, 
jaundice and splenorregaly. 
Laboratory findings important in the diagnosis of HS include:-





spherocytes on the peripheral 
blood smear (see Fi~. 18 - 1) 
(4) an increased osmotic fragility 
of the red blood cells 
(5) increased autohaemolytic studies 
corrected by the addition of 
glucose 
A diagnosis of HS was made in this survey when a subject had an in-
creased osmotic fragility, raised autohaemolytic studies corrected by 
the addition of glucose, splenomegaly or spherocytes on the peripheral 
blood smear and a dominant pattern of inheritance was demonstrated. 
This last feature was insisted upon as the haematological abnormalities 
were minimal in the majority of the respondents considered in this 
section. It is, however. recognized that the mutation rate for the gene 
may be as high as 25%. 
INTRODUCTION 
A small but significant proportion of individuals were found to have an 
increased osmotic fragility which suggested a haemolytic disorder. As 
hereditary spherocytosis would be high on the differential diagnostic 
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Fig. 18 - 1 Peripheral blood smear in hereditary spherocytosis. 
Typical spherocyte in centre of field. 
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list, furt~er relevant investigations were instituted. In addition a 
full clinical historv was obtained with special reference to a history 
of anaemia. jaundice. gallstones a~d affected kin. Further blood 
samples were obtained for a Coombs test and autohaemolytic studies and 
where possible other members of the family were examined physically and 
haematologically. Eight patients fell into this cntegory, and of these 
a diagnosis of hereditarv spherocytosis was made in 3. The other 5 
respondents have a mild haemolytic disorder which possibly represents a 
minimal expression of the spherocytic gene and which would reauire com-
prehensive family studies for diagnostic confirmation. 
INTRODUCTORY RESULTS 
The patients whose findings are summarized in Tables 18 - 1, 18 - 2, 
and 18 - 3 and who are discussed below are those in whom a definitive 
diagnosis of hereditary spherocytosis was made. Those who may have HS 
but in whom there was not sufficient contributing evidence to confirm 
the diagnosis are also included. A positive diagnosis was made in 3 
cases, namely numbers 1, 4 and 7. However, it is quite probable that 
some, if not all, of the others included in the following tables have 
HS. 
In summary, therefore, the minimal prevalence of HS isl ,2%with a gene 
frequency of 0,006. However, the prevalence may be as hioh as 3,2% 
with a gene frequency of 0,016 in the Greek population of Cape Town. 
The findings summarized in the various tables are now discussed in a 
manner similar to that for thalassaemia and G-6-PD deficiency. 
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These findings appear in Table 18 - 1. 









' TABLE 18 - 1 
PERSONAL DATA OF SUBJECTS WITH 
HEREDITARY SPHEROCYTOSIS 
MARITAL 
STATUS CHILDREN OCCUPATION 
M 3 Company represen-
tati ve 
M 2 Cafe owner 
M 3 Cafe owner 
M 3 Cafe owner 
M nil Retired 
M 2 Housewife 
s nil Restauranteur 














The age of the subjects with proven and possible HS varies from 
32 to 62 and is of no special significance except to illustrate 
that the lifespan of these patients will probably not be com-
promised by the condition. 
B. SEX 
Of the 8 cases, 4 are male and 4 female. As HS is an autosomal 
dominantly inherited disorder, it is to be expected that there 
would be equal distribution between the sexes. This is in con-
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trast to G-6-PD ijeficiency, which is inherited in an X-linked 
manner and where there is thus a preponderance of males 
suffering from the condition. 
C. MARITAL STATUS AND CHILDREN 
Seven of the 8 individuals are married, and of these, 6 have 
families of normal sizes. This is as expected, as there is 
no reason that their fitness to reproduce should in any way 
be affected. 
D. OCCUPATION 
There is nothing of importance to note under this heading. 
E. ORIGIN 
The place of origin of these subjects is of a uniform nature. 
There is no increased tendency for anyone to come from any 
particular place, area or situation with particular geographic 
characteristics. This is in contrast to the situation found 
in thalassaemia and G-6-PD deficiency where there appeared to 
be an increased prevalence in persons originating fr001 certain 
islands and from the islands in general, when compared to the 
mainland. 
2. RED CELL PARAMETERS 





















TABLE 18 - 2 
RED CELL PARAMETERS OF SUBJECTS WITH 
HEREDITARY SPHEROCYTosts 
PCV MCHC MCV 
% % RETICS fl 
44 35 0,4 83 
50 32 0,7 83 
39 31 2,6 90 
43 30 1,6 88 
47 31,5 1,8 87 
38 31 3,3 85 
41 35 3,5 92 












The mean haemoglobin of this group was 14,1 g/100 ml with a 
standard deviation (SD) of 1,5. When further subdivided, the 
mean for the males was 15,2 g/100 ml, with a SD of 0,72, while 
that for the females was 13,0 g/100 ml with a SD of 1,3. 
These results are all within normal limits. Since hereditary 
spherocytosis results in a haemolytic anaemia, it would be 
reasonable to expect that those with the abnormal gene would 
tend to have a haemoglobin level below normal. However, it is 
recognised t~at although the haemoglobin level is usually 
' ; 
between 9 and 12 g/100 ml, an anaemia may not be present 
(Wintrobe, 1974). Evaluating the results as a whole, and 
especially in the 3 in whom the diagnosis of HS was confirmed, 
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it appears that the expression of the HS gene in these persons 
is indeed mild. This is also added evidence for the hetero-
geneity of the HS gene. 
B. PCV 
The mean PCV for the group as a whole was 43% with an SD of 
4,0, while in the males it was 45,5% with an SD of 3,9, and in 
the males 41,0% with an SD of 2,9. These levels are, as ex-
pected, within normal limits. 
C. MCHC 
The mean MCHC in the above subjects was 32,4 g/100 ml with an 
SD of 2,0. The normal range is 34 ± 2%. A characteristic, 
but not invariable finding in HS, is an increased MCHC usually 
in the range 37 - 39 (Wintrobe, 1974). Cases 1 and 7 who do 
have HS have upper limit of normal levels of MCHC. The value 
in both is 35% whereas that in the other 6 subjects is within 
the lower normal range. 
D. RETICULOCYTES 
The reticulocyte level varied greatly in the cases from 0,4 to 
3,5%. As a result the mean was 2% with an SD of 1,1. This 
pattern was also found in the 3 cases diagnosed as having HS 
where the respective values were 0,4, 1,6 and 3,5%. A usual 
feature of the disorder is an increased reticulocyte count. 
This feature too is not constant with levels varying from ex-
tremely low to extremely high values. Usual values are from 5 
to 15%. 
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E. , MEAN CELL VOLUME 
The mean MCV in the cases under discussion is 87 fl with an 
SD of 3,5 and all occur within normal limits. These findings 
are common. However, the MCV may be as low as 62 or as high 
as 125 fl (Wintrobe, 1974). The cases in which one expects 
macrocytosis are those with a severe anaemia and marked 
reticulocytosis. 
F. RED CELL COUNT 
The red cell count ranged from 4,46 to 6,00 million per mm3 
with a mean of 5,0 and SD of 0,6. These findings are nonnal 
and of no noteworthiness. 
3. DIAGNOSTIC CONSIDERATIONS 
Clinical, as well as laboratory findings, useful in the diagnosis 
of hereditary spherocytosis and which have not already been dis-
cussed are presented in this section. 





















































































































































































A. MEDICAL HISTORY 
The most important diagnostic feature offered in the cases 
studied, was the fact that cases 4 and 5 had had a chole-
cystectomy for gallstones. HS is classified as a haemolytic 
anaemia and in affected individuals the haemolysis which 
occurs may be rapid or slow and insignificant. In the former 
group significant bilirubinaemia is found, which may be 
clinically apparent and result in pigment stones being formed 
in the gall bladder. These may then become infected and 
result in an attack of cholecystitis. 
Case No. 4, who has HS, required surgical intervention for her 
cholecystitis while a young woman. However, as a diagnosis of 
HS was not made at the time, she did not have a splenectomy as 
is reconvnended. 
Case No. 5 had gall bladder surgery done at the age of 61 
years. However, there is insufficient evidence in his case to 
make a definite diagnosis of hereditary spherocytosis. 
B. SIGNS 
The clinical signs particularly sought for in the patients 
with possible HS were anaemia, jaundice, chronic leg ulcers and 
splenomegaly. The above are usually found in persons suffering 
I 
fr001 a symptomatic fonn of the condition while in individuals 
with a well c001pensated fonn of the disorder no clinical signs 
may be apparent. In only one (No. 4) of the 8 cases was there 
a definite finding of a finn spleen palpable 3 cm below the 
left costal margin. In a further 2 cases, Nos. 1 and 7, it was 
equivocal whether they had minor degrees of clinical detectable 
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splenomegaly. Cases No. 4 and 7, who are discussed at 
greater length later, had the most complete picture of HS. 
C. OSMOTIC FRAGILITY 
The single most important laboratory test for HS is the 
demonstration that the red blood corpuscles have increased 
fragility in hypotonic saline solutions. In all the 8 cases 
under consideration, there was a detectable and marked in-
crease in osmotic fragility. A further 2 cases were found to 
have a raised osmotic fragility, but on further investigation 
it was decided that they definitely did not have HS. However, 
the cause for this abnormality was not detennined. 
It was not expected at the outset of the investigation that 
there would be a significant proportion of individuals with 
hereditary spherocytosis. The first indication that this 
might be so occurred when it was found that there was a rela-
tively large number of cases with raised osmotic fragility 
studies. These persons and their families, where possible, 
were then further studied. An abnormal osmotic fragility 
curve typical of HS is shown in Fig. 18 - 2. 
D. AUTOHAEMOLYTIC STUDIES 
The laboratory that conducted the tests for the author, 
routinely performed autohaemolytic studies as a final diag-
nostic tool for hereditary spherocytosis. In this test, on 
the addition of certain reagents, it is demonstrated that 
significant autohaemolysis occurs. However, on the addition 
of glucose to the patient's serum this can be prevented from 
occurring and this is said to be typical for HS. It also 
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Fig. 18 - 2 Osmotic fragility curve demonstrating increased 
fragility more marked after 24 hours incubation in a patient 
with hereditary spherocytosis. 
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occurs in thalassaemia (Know-Macauly, et al, 1972) but the 
osmotic fragility is then decreased. Autohaemolysis of 4% and 
greater is considered to be significant and correction on the 
addition of glucose to 2% is said to be diagnostic of HS. 
In all the cases presented, abnormal autohaemolytic studies 
were demonstrated and on this basis, together with raised 
osmotic fragilities, they were included here. Autohaemolysis 
ranged from 4% to 16,3% with a mean of 11,7% and a SD of 6,7. 
When corrected with glucose, the range was 0,2 to 1,8% with a 
mean of 1,2 and an SD of 0,6. 
The range in the 3 cases with confirmed HS was also 4 to 16,3% 
with a mean of 11,7% and an SD of 6,7. On correction with 
glucose the mean was 1,2% and SD 0,6. 
It is apparent from these results that there is a correlation 
between clinical severity and abnormality of the autohaemo-
lytic studies. 
E. AFFECTED KIN 
To confirm the diagnosis of hereditary spherocytosis, the 
author considered it necessary to demonstrate the typical 
dominant inheritance of the condition. This was possible in 
cases 1, 4 and 7. In case 1, the father, one daughter and 
one son were investigated and the son and father were found to 
have the disorder. The son and daughter of case 3 were tested 
and found not to have HS. In case 8, two daughters were 
studied and found to be normal. In case 4, only one of three 
children was tested and found to have the disorder. The 
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mother felt that her other two children were too young and 
thus was unwilling to have them tested. However, it is im-
portant that they be investigated later as the presence of the 
condition may have an important bearing on future disease 
processes and also may cause problems per se. After a diag-
nosis of hereditary spherocytosis was made in case No. 7, the 
author, while perusing old laboratory records, discovered the 
rest of his family had been extensively investigated for a 
haemolytic anaemia in the past when his sister had a problem-
atical anaemia. During these studies, it was found that both 
his father and sister had HS. It was not possible to study 
the family of subject 2, and in the case of respondent 6, he 
had no living blood relatives. The 5 subjects whose families 
were investigated and found to be nonnal and whose families 
were not studied, were not diagnosed as having HS, as the 
typical pattern of inheritance could not be proven. However, 
it is nevertheless quite probable that some, if not all of 
these 5 subjects do have a mild form of HS. 
F. DIRECT COOMBS TEST 
A direct Coombs test was performed on all except 1 of the 8 
cases, to exclude ilTlllune causes of haemolysis. The result was 
negative in all 7 individuals. 
G. PYRUVATE KINASE ESTIMATION 
The 5 respondents not diagnosed as having HS had their pyruvate 
kinase levels estimated to ascertain whether a deficiency of 
this enzyme was the cause of their mild haemolytic tendency. 
The results in all 5 subjects was within nonnal limits which 
SUMMARY 
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therefore excluded pyruvate kinase deficiency as a cause of 
their other abnormal laboratory findings. 
From the above results, it would be reasonable to state that 3 of the 
respondents have hereditary spherocytosis. This indicates that the 
minimum prevalence of hereditary spherocytosis amongst persons of 
Greek origin in Cape Town is 1,2% with a gene frequency of 0,005%. 
The remaining 5 respondents have minimal clinical abnormalities. They 
also have increased osmotic fragility and abnonnal autohaemolytic 
studies which are highly suggestive of hereditary spherocytosis. How-
ever, without adequate family studies and because of the minor degree 
of stigmata characteristic of the disease, no finn conclusion can be 
reached, though it seems possible that these persons have a mild ex-
pression of the hereditary spherocytosis gene. Inclusion of these 
persons would result in a prevalence of 3,2% with a gene frequency of 
0,016. 
Therefore, in sunmary, the minimal gene frequency for hereditary sphero-
cytosis in the Greek community of Cape Town is 0,006% but it may be as 
high as 0,016%. 
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CHAPTER 19 
MISCELLANEOUS INHERITED HAEMATOLOGICAL DISORDERS 
A. SICKLE CELL TRAIT 
Diagnostic Criteria 
For the diaqnosis of the sickle cell trait the demonstration of 
the 11S11 band on both paper and agar electrophoresis was considered 
necessary (see Fig. 19 - 1). Thereafter, decreased solubility of the 
11 $ 11 chain was required to be demonstrated by Itano's test. 
One of the 250 respondents included in the survey was found on 
laboratory testing to have the sickle cell trait (i.e. HbS}. He was 
a cafe owner aged 44 years who was born at Nafplion in the Peloponnese, 
where his famil.Y had their origins. From this data the prevalenc~ of 
the sickle cell trait is 0,4% with a gene frequency of 0,002 in the 
Greek population of Cape Town. 
He had neither symptoms nor signs of an anaemia and had never suffered 
any complications to suggest that sickling of his red blood cells had 
ever occurred. In addition, he had no chronic leg ulcers. From his 
past medical history it was ascertained that he had diabetes mellitus 
and a mildly elevated serum cholesterol. 
Results of laboratory investigations 
Hb: 16,0 g per 100 ml 
PCV: 47% 
MCHC: 34% 
MCV: 96 fl 
MCH: 33 pg 
Red cell 
4, 89 mi 11 /rrm3 count 
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Fig. 19 - 1 Haemoglobin electrophoresis. Patient at top 
with 11 S11 band, middle is normal control and patient at 






Motulsky: 30 minutes 
Haemoglobin 
pattern: AS 
Haemoglobin F: 0,8% 
Haemoglobin A2: 1,7% 
In summary his laboratory findings reveal that he was not anaemic, his 
red cell parameters were normal and did not manifest the features 
typical of the thalassaemia syndrome. Haemoglobin A2 and F were within 
normal limits. The only abnormality was the demonstration of the 11 S11 
band typical of the sickle cell traits. In addition this 11 S11 chain was 
demonstrated to have decreased solubility when Itano's test was applied. 
B. HAEMOGLOBIN LEPORE 
One of the respondents who volunteered for the survey was found to 
have an abnormal haemoglobin which had previously been diagnosed in 
Greece as being haemoglobin Lepore. 
The subject was a 28-year-old male doctor who had antecedents in St. 
George, Central Greece. He had never had any symptoms or signs 
referrable to the haemopoietic system and had been incidently diagnosed 
as having haemoglobin Lepore while being routinely screened in the Greek 
army during national service. Physical examination revealed no abnor-
ma l ity. 








MCV: 69 fl 
MCH: 22 pg 
Red cell 





Motulsky: 30 minutes 
Haemoglobin 
pattern: A Lepore 
Haemoglobin F: 9,5% 
Haemoglobin A2: 2,1% 
COMMENT 
This individual has the characteristic findinqs of haemoglobin Lepore. 
He was asymptomatic, as is typical, and had no physical signs. However, 
patients with the disorder may have minor physical signs. His blood 
picture too was characteristic of this disorder, with findings similar 
to the thalassaemia trait, i.e. MCV 69 fl, MCH 22 pg and Hb 12,2 g per 
100 ml. His haemoglobin electrophoresis had a band which moved slowly 
in a position similar to haemoglobin S which could not be characterized 
in the laboratory undertaking the investigations, but which had pre-
viously been delineated in Greece. His haemoglobin F was 9,5% and 
haemoglobin A2 2,1%. The latter finding is nonnal while the former 




CASE REPORTS AND PEDIGREE STUDIES 
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INTRODUCTION 
This section provides: 
1. Detailed clinical and laboratory reports on the 2 patients 
previously known to have thalassaemia major. (No separate 
details on subjects with the thalassaemic trait have been 
included as these respondents were found to be essentially 
normal clinically with minor haematological abnormalities.) 
2. The medical history and clinical findings together with 
laboratory results in certain respondents with G-6-PD deficiency. 
3. The clinical and laboratory data of the 3 patients with here-
ditary spherocytosis, as well as the details of the equivocal 
cases who were not positively diagnosed as having HS. 
4. Pedigree studies showing the typical inheritance of the major 






The patient was born in Cape Town on 10th July, 1966, and both 
his parents originated from Lesbos. He was irritable from birth, 
and pale when unwell. At 2 years of age he developed acute 
gastroenteritis requiring admission to the Children's hospital. 
It was then noted that he was anaemic with a haemoglobin of 6,8 g 
per 100 ml and had a 1 cm splenomegaly of unknown origin. In-
vestigations indicated a diagnosis of thalassaemia major which 
was confirmed by family studies. Complications hereafter include 
numerous incompatible blood reactions, careous teeth and chronic 
leg ulcers. In 1973, he presented with haematemesis, when a 
diagnosis of infectious hepatitis was made. Psychological 
problems manifesting as enuresis and aggressive behaviour required 
referral to the psychiatric department. 
B. EXAMINATION 
The patient was anaemic with facies typical of thalassaemia major. 
He had prominent malar eminences, a depressed nasal bridge and 
protuberant upper teeth as a result of maxillary hyperplasia, all 
resulting in the typical "mongoloid" facies (Fig. 20 - 1). 
Examination of his cardiovascular system disclosed a haemic murmur 
over his praecardium, while abdominal examination revealed a 7 cm 
hepatomegaly and 13,5 cm splenomegaly (Fig. 20 - 3). He also had 
evidence of chronic leg ulcers. 
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Fig. 20 - 1 The thalassaemic facies. Views showing the defonnity 
of the maxilla and protrusion of the . teeth, flattening of the 
nasal bridge, and wide-set eyes. 
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Fig. 20 - 2 Patient 1. Views demonstrating the thalassaemia 
facies and the patient's hepatosplenomegaly. 
Fig. 20 - 3 
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Views showing the hepatosplenomegaly characteristic 
of thalassaemia major. 
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Radiological studies of the chest displayed an increased trans-
verse diameter of heart with gross decalcification of the thoracic 
cage. The typical 11 hair-on-end 11 appearance was present in the 
calvarium, while the femur, lumbar spine, feet and hands showed 
osteoporosis with broad trabeculation and some defect in modelling 
(Figs. 20 - 4, 20 - 5, 20 - 6). 
C. LABORATORY INVESTIGATIONS 
At 2 years of age, when thalassaemia major was diagnosed, he had 
haemoglobin of 6,8 g/100 ml and peripheral blood smear demon-
strating microcytosis, hypochromia with anisocytosis, polychromasia 
and bizarre forms. Haemoglobin analysis revealed a fetal haemo-
globin of 89,5% and an inconclusive level of haemoglobin A2. 
At 11 years of age his red cell parameters were as follows: 
Hb 8,8 g/100 ml 
PCV 30% 
MCHC 36% 
MCV 78 fl 
Retie. count 2,5% 
Red cell count 3,11 million per cu. lllTI. 
Peripheral smear Target cells+, microcytosis +, 
anisopoikilocytosis and basophilic 
stippling present 










Fig. 20 - 4 Roentgenological findings in patient 1. Typical 
"hair-on-end'' appearance of the skull. 
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Fig. 20 - 5 Radiological appearance of vertebrae of patient 1 
demonstrating rarefaction of the bones. 
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Fig. 20 - 6 Radiological appearance in thalassaemia major. 
Hands and feet show rarefaction with early 









6 880 ug/L 
Iron studies revealed that percentage saturation in 1973 varied 
from 50-90%. In 1974 it was 54%; in 1975, 76,4%, and in 1976, 
34%. 
Australian antigen was reported as being positive in 1973, but 
negative on several subsequent occasions. Serum immunoglobulins 
were norma 1 . 






HbA2 3 ,9% 
Red cell parameters and peripheral blood smear were typical of 
the thalassaemia trait in both parents. 
E. TREATMENT 
Since the diagnosis of thalassaemia major has been made he has 
been treated with intravenous packed cells aimed at keeping his 
haemoglobin at ~bout 10 g per 100 ml. His monthly blood require-
ments have been 2 units of blood given when his haemoglobin has 
dropped to 6-8 g/100 ml. This has then brought his haemoglobin 
up to about 12 g/100 ml. In addition, with each unit (500 ml) of 
blood he receives 5 g of desferrioxamine and 100 mg of vitamin C 
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intravenously, and vitamin C 50 mg and folate 1 mg daily per 
mouth. 
2. P. c. 
A. HISTORY 
P.C., a male, born in 1952, was found to be anaemic and required a 
blood transfusion when approximately a year old, during an in-
fluenza-like illness. As an infant and child he intermittently 
required blood transfusions, and at the age of 6 years a firm 
diagnosis of "Cooley's anaemia" was made. Over the past 5 years 










Recurrent viral pericarditis 
Yersinia enterocolitica septicaemia 
Uric acid nephropathy which required dialysis 
Effusion of left hip joint which resulted in 
sciatic nerve compression 
Post-transfusional hepatitis 
Pleural effusion and atelectasis due possibly 
to a pulmonary embolus (though never proven) 
Arthritis of the left ankle 
Bone pain 
On examination in 1976 he was anaemic, slightly jaundiced and had 
increased pigmentation in his skin creases. Paucity of secondary 
sexual characteristics resulted in an inappropriate youthful 
appearance. In addition, he had a mild mongoloid facies due to 
midf.acial hyperplasia (F ig. 20 - 7). 
A soft, pansystolic murmur of grade 2/6 intensity was audible over 
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Fig. 20 - 7 Patient 2 aged 24 years. View demonstrating 
inappropriate youthful appearance, mild thalassaemia facies, 
increased facial skin pigmentation and massive hepatospleno-
megaly. 
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the praecordium but no further abnormality was demonstrated in 
the cardiovascular system. Abdominal examination revealed a 10 cm 
hepatomegaly and massive splenomegaly extending into the left 
iliac fossa (Fig. 20 - 8). His testes were hypoplastic but he 
had no further signs of endocrine failure. 
C. RADIOLOGICAL FINDINGS 
The bones were generally demineralized and osteoporotic, with 
I 
broad traveculations and some defective modelling. These changes 
were particularly evident in the lumbar spine, femur and pelvis, 
while his hands and feet were more mildly affected (Figs. 20 - 9 
and 20 - 10). Radiographs of the skull revealed that the outer 
table of the calvarium was thin with trabeculations lying at 
right angles to the inner table (Fig. 20 - 11). The skeleton was 
i1T111ature as evidenced by the fact that the bone age was that of 
an individual of 16 years when he was 22 years of age. 
D. LABORATORY FINDINGS 
Haematological 
Hb 8,9 g per 100 ml 
PCV 27% 
MCHC 33% 
MCV 82 fl 
Reticulocyte count 2% 







Fig. 20 - 8 Patient 2. Lateral views showing protuberant 
abdomen as a result of massive hepatosplenomegaly. 
- 191 -
Fig. 20 - 9 Roentgenological findings in patient 2. Gross 
demineralization and rarefaction of femur, lumbar vertebrae 
and pelvis. 
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Fig. 20 - 10 Patient 2. View demonstrating rarefaction of 
small bones of hands and feet. 
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Fig. 20 - 11 Radiological findings of patient 2. 
Top: Skull shows thinning of outer table, widening of diploic 
space ~nd cross striations making up the characteristic 11 hair-
on-end" appearance. 
Bottom: Pelvis and femora, demonstrating rarefaction and some 
defective bone modelling. 
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Biochemistry Patient Normal 
Ca lei um 8,9 9 ,0-11,0 
Uric acid 7,4 2,0- 8,0 
Total bilirubin 2,3 0,1- 1,0 
Alkaline 101 30-85 
phosphatase 
Endocrine stress test indicated that his hypogonadism was 
probably due to pituitary hypofunction. 
E. TREATMENT 
The hypertransfusion regimen is followed in the patient. At 
intervals of approximately 2 weeks when his haemoglobin has 
dropped to about 8-9 g per 100 ml he receives 2-3 units (500 cc) 
of blood, which increases his haemoglobin to approximately -12 g 
per 100 ml. In addition, he receives the iron chelating agent 
desferrioxamine over 6 hours intravenously 2-3 times per week; 
and ascorbic acid 250 g 3 times per day. He also requires allo-
purinol 100 mg 3 times per day to maintain a normal serum uric 
acid level. Since being studied his therapy has been slightly 
altered. He now receives transfusions of frozen washed cells 







I.R., a 36-year-old male, initially offered no history suggestive 
of G-6-PD deficiency. However, on taking a more detailed history 
it became apparent that following the ingestion of fava beans or 
of aspirin he had had episodes of feeling ill, abdominal pain and 
dizziness. On examination he was neither anaemic nor jaundiced 
and the only significant feature was a spleen palpable 2 cm below 
the left costal margin with no hepatomegaly. 
SPECIAL INVESTIGATIONS 
Hb 15,5 g per 100 ml 
PCV 48% 
MCHC 32% 
Reticulocyte count 2,8% 
MCV 96 fl 
Motulsky 5 hours 
Osmotic fragility normal 
Blood group 0 positive 
In su11111ary the only stigmata are a grossly abnormal Motulsky test 
together with a mildly elevated reticulocyte count. 
C. MANAGEMENT 
He was given a list of potentially haemolytic drugs to avoid and 
recommended to wear a Medic-Alert disc indicating that he is 
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G-6-PD deficient. 
2. I. V. 
A. HISTORY 
I.V., a female, was born in 1911 and originated from the island 
of Lesbos. 
At the age of 61 years she presented with an attack of rigors, 
vomiting, backache and urine becoming dark following the ingestion 
of 8 aspirin tablets over 2 days for a cold. In the past she had 
had similar episodes and had been anaemic when pregnant. 
Hospital admission was necessary during this episode and she was 
found to have signs of anaemia and jaundice; no signs of chronic 
liver disease or hepatosplenomegaly were present. During this 
admission laboratory investigations revealed the following and a 




























Intravenous pyelogram and cholecystogram 
both normal 
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Although her Motulsky test was nonnal, the methaemoglobin 
reductase test enabled a diagnosis of G-6-PD deficiency to be 
made. In addition, her son was found to have the disorder. 
When seen by the author in 1976 she was neither jaundiced nor 





The cases presented here are both those in which a 
diagnosis was definitely made, as well as those in 
which a final diagnosis could not be made with cer-
tainty. The reasons are given in each instance. 
Case 1 (see Chapter 18) was noted on routine testing to have a raised 
osmotic fragility. On obtaining a more detailed history it was 
ascertained that his son had been found to have a splenomegaly of un-
known origin 2 years previously. Autohaemolytic studies revealed a 
value of 4% (the upper limit of normal) with no additives, corrected 
to 1,1% with glucose in Case 1 and a value of 7,8% corrected to 0,3% 
in the case of his son. Peripheral blood smear showed slight aniso-
cytosis. 
On the basis of the splenomegaly, increased osmotic fragility, the 
enhanced autohaemolysis and the hereditary nature of the disorder, a 
diagnosis of hereditary spherocytosis (HS) was made. The variable 
expression of the dominantly inherited gene is well demonstrated in 
this particular kindred. 
CASE 4 
Case 4 gave a history of having had a cholecystectomy for gallstones, 
and on examination she was found to have a 3 cm firm splenomegaly. 
Osmotic fragility was increased and autohaemolytic studies revealed a 
value of 16,3% with no additives, corrected to 0,6% with the addition 
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of glucose. A few spherocytes were seen on peripheral blood smear. 
On performing limited family studies, her 14-year-old daughter was 
found to have an autohaemolysis value of 10,6% corrected to 0,4% on 
addition of glucose. 
A diagnosis of hereditary spherocytosis was made on the basis of the 
patient's cholecystectomy, splenomegaly, raised osmotic fragility, 
abnormal autohaemolytic studies, and the demonstration of the typical 
hereditary pattern of the disorder. 
CASE 7 
Case 7 gave a history of vague abdominal pain which was not suggestive 
of any specific pathological process. Physical examination revealed 
no abnormal signs but haematological examination revealed an abnormal 
brilliant cresyl blue dye reaction {for G-6-PD deficiency) and an 
increased osmotic fragility. As his osmotic fragility was increased 
to a greater extent than would be expected from G-6-PD deficiency alone, 
autohaemolytic studies were undertaken and the results (14,9% with no 
additives, and 1,8% with glucose) indicated hereditary spherocytosis. 
In addition, he had a moderate number of spherocytes on his peripheral 
blood smear and his reticulocyte count was 3,5%. 
Later, it was discovered that his family had been investigated in the 
past for an inherited anaemia and that both his father and sister had 
been shown to have hereditary spherocytosis, while his deceased mother 
ha~ carried G-6-PD deficiency. 
EQUIVOCAL CASES 
The remaining cases - 2, 3, 5, 6 and 8 (see Chapter 18) provide a far 
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more difficult diagnostic problem. 
Respondent~ No. 2 and 8 gave n~ suggestive history and on clinical 
examination there were no findings to suggest a diagnosis of HS. 
Case 2 had no abnonnal haematological parameters while case 8 had a 
marginally raised reticulocyte count of 2,2% (peripheral blood smear 
in both cases was normal). The only significant abnormalities were 
that of osmotic fragilities of the red corpuscles of both were in-
creased and the results of autohaemolytic studies were abnonnal. 
Case 2 had a value of 5,1% corrected to 0,4% on glucose addition and 
case 8 had a value of 7,5% corrected to 0,2% by addition of glucose. 
Limited family studies in case 8 were non-contributory and a firm 
diagnosis of hereditary spherocytosis could not be substantiated. 
Case 3, who gave a history of vague abdominal pain, was found to 
carry G-6-PD deficiency in addition to having an increased osmotic 
fragility. Because of this latter finding, autohaemolytic studies 
were undertaken and these showed result of 6,4% corrected to 0,4% on 
addition of glucose. Peripheral blood smear revealed occasional poly-
chromatophilic red cells while the reticulocyte count was 2,6%. The 
patient's daughter was found to carry G-6-PD deficiency but her 
osmotic fragility was nonnal. 
Respondent 5, who had had a cholecystectomy in the past for gallstones, 
had an increased osmotic fragility and autohaemolysis of 5,7% corrected 
to 1,7% with glucose. No clinical abnonnalities were found and peri-
pheral blood smear was nonnal. He had a brother who was nonnal but 
no other relatives on whom family studies could be undertaken. 
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The only available record on case 6 stated that she had an increased 
osmotic fragility and an autohaemolysis of 4,6% corrected to 0,6% on 





Family 1 (Fig. 23 - 1) illustrates the inheritance of thalassaemia, 
which is a recessive disorder, although the heterozygotes sometimes 
have symptoms and signs of varying severity. The proband (111 i) has 
thalassaemia major and is therefore homozygous for the disorder as he 
has received a thalassaemia gene from each of his parents. He has the 
clinically severe disorder and required freque~t blood transfusions, 
while his parents are mildly affected. His mother has symptoms of a 
mild anaemia and his father is asymptomatic. 
The proband has 3 uncles, 11-6, 11-8 -and 11-10, 2 of whom, 11-6 and 
11-10, have heterozygous beta-thalassaemia. One of them, 11-~0, has 
passed on the thalassaemia trait to his daughter 111-9. The siblings 
of the proband's mother 11-1, 11-2 and 11-3 are not in South Africa 
and it is not known whether or not they have the thalassaemia trait. 
The proband's maternal grandmother 1-2, was tested and found not to 
have the thalassaemia trait, but in fact to carry G-6-PD deficiency, 
which is irrelevant in this context. It is therefore reasonable to 
assume that the mother of the proband received the gene for thalas-
saemia from her deceased father, 1-1, who was never tested for 
thala~saemia. The paternal grandmother, 1-4, had been tested and 
found to have passed the beta thalassaemia gene on to her son. 
- 203 -
II 8 10 
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D Nonnal male 
0 Nonna l female 
• Homozygous male 
[1 Heterozygous male 
() Heterozygous female 
\ Pro band 
® Female with G-6-PD deficiency 
~ Deceased male 
Fig. 23 - l Pedigree of family l 
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FAMILY 2 
Family 2 (Fig. 23 - 3) (which is related to family 1) illustrates the 
inheritance and association of heterozygous beta-thalassaemia and 
G-6-PD deficiency in the same family. The proband 111-2, who had had 
an attack of favism when a child in Greece, was found to have both the 
thalassaemia trait and G-6-PD deficiency. The acute haemolytic attack 
he suffered following the ingestion of fava beans was so severe that 
he required a blood transfusion. 
The proband's mother, 11-2, also suffered a severe, acute haemolytic 
attack following the ingestion of acetyl salicylic acid, which suggests 
that this family have a particularly severe form of G-6-PD deficiency. 
However, G-6-PD deficiency had not been a problem in other members of 
the family. The diagnosis of the thalassaemic trait was made on com-
prehensive haematological investigations for a haemolytic anaemia and 
had, in fact, not been a problem in its own right. The occurrence of 
both disorders in the same person does not significantly increase the 
problems associated with each, though as each condition does predispose 
an affected individual to an anaemia, an anaemia due to one may be 
slightly exacerbated by the other. 
The pedigree also illustrates that thalassaemia and 'G~6-PD deficiency 
are inherited independently. Subjects 111-2 and 111-3, who both have 
G-6-PD deficiency and heterozygous beta-thalassaemia, received the 
gene for each disorder from each parent and subsequently only passed 
one of the abnormal genes on to their offspring. Subject 111-2 passed 
a G-6-PD deficiency gene on to his daughter, while 111-3 passed a beta-
thalassaemia gene on to his daughter. As the patterns of inheritance 
for these disorders are different, thalassaemia being recessive and 













Norma 1 f ema 1 e 
Male with G-6-PD deficiency and 
heterozygous beta-thalassaemia 
Female G-6-PD heterozygote 
Male with G-6-PD deficiency 
Female beta-thalassaemia heterozygote 
Deceased ma 1 e 
Deceased female 
Pro band 
Fig. 23 - 2 Pedigree of family 2 
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FAMILY 3 
Pedigree 3 (Fig. 23 - 3), the extended pedigree of families 1 and 2, 
who have conmon grandparents, and demonstrates a large family which 
has homozygous beta-thalassaemia, heterozygous beta-thalassaemia and 
G-6-PD deficiency. The family originates from the north-east Aegean 
island of Lesbos where the incidence for heterozygous beta-thalassaemia 
is approximately 10% (Fessas, 1976) and that for G-6-PD deficiency 
approximately 4% (Doxiadis, et al, 1964). It is therefore to be 
expected that there must be large families with both these disorders. 
As families 1 and 2 have been discussed in reasonable detail, this has 
not been repeated for family 3. 
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Fig. 23 - 3 Pedigree of family 3 
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FAMILY 4 
Family 4 (Fig. 23 - 4) illustrated the inheritance of G-6-PD deficiency. 
The family was initially investigated as the parents of the proband, 
who was 6 months of age, were worried about an anaemia which he had 
developed during an influenza-like illness. The proband (111-1) had a 
grossly abnormal brilliant cresyl blue test indicating that he had 
G-6-PD deficiency. The brilliant cresyl blue test of his mother (11-2), 
and maternal grandmother (1-4), were moderately increased and the met-
haemoglobin reductase test of his mother was grossly abnormal. 
The X-linked pattern of inheritance of G-6-PD deficiency is well 
illustrated in this kindred. On investigating the proband's father 
(11-1), he was found to also have G-6-PD deficiency although he had 
always been asymptomatic. His own parents (1-1 and 1-2) were not 
tested but as G-6-PD deficiency is an X-linked disorder it is reasonable 
to assume that he had inherited his G-6-PD deficiency from his mother. 
It is of interest to consider the possible genotypic expression in 
children of the proband's parents as the father has this X-linked dis-
order and the mother is heterozygous for it. There are 4 possibilities: 
i) that the offspring be a homozygous girl with full 
expression of the disorder; 
ii) a male with the disorder; 
iii) a heterozygous female carrying the disorder, or 
iv) a normal male. 
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0 Normal female 
II 2 • Affected male 
CD Heterozygous Female 
I I I " Pro band 
" 
Fig. 23 - 4 Pedigree of family 4 
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FAMILY 5 
Heterozygous beta-thalassaemia and G-6-PD deficiency occur together 
in family 5 (Fig. 23 - 5). The proband (111-1), a medical doctor, has 
heterozygous beta-thalassaemia and is asymptomatic. His father (11-1) 
was investigated for a haemolytic anaemia and it was discovered that 
he had both G-6-PD deficiency and the thalassaemic trait. On under-
taking family studies it was ascertained that he received both ab-
normal genes from his mother (1-2) and passed both to his daughter 
(111-3). This situation contrasts with family 2 where the individuals 
with both genes received them from separate parents and passed only 1 
abnormal gene on to the next generation. The wife (11-2) of 11-1 was 
also found to have heterozygous thalassaemia and the possibility 
therefore arose of an individual with thalassaemia major being born 
into this family. The brother of the proband (111-2) died as a young 
man in a motor vehicle accident, and although he was not tested, it is 
extremely unlikely that he had homozygous beta-thalassaemia, although 
it is possible that he had heterozygous beta-thalassaemia and/or G-6-PD 
deficiency. 111-3, the sister of the proband, who carries both G-6-PD 
deficiency and heterozygous beta-thalassaemia, suffers periodically 
from a symptomatic anaemia. 
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- 212 -
FAMILY 6 
Hereditary spherocytosis and G-6-PD deficiency occur together in 
family 6 (Fig. 26 - 6). The proband, 11-3, a male aged 32 years of 
age who, apart from complaining of vague abdominal symptoms, has 
always been in extremely good health. During the survey he was found 
to have both G-6-PD deficiency and HS, neither of which had caused him 
any problems. On perusing laboratory records it became evident that 
his family had previously been investigated extensively for an in-
herited anaemia, as his sister (11-2) had suffered from a significant 
anaemia. She was found to have hereditary spherocytosis, which she 
had inherited from her father (1-1). Both of her children (111-1 and 
111-2) have been tested and found to be normal. It was also discovered 
that his mother (1-2), now deceased from a heart ailment, had hetero-
zygous G-6-PD deficiency. Hereditary spherocytosis is inherited in a 
dominant pattern, whereas G-6-PD deficiency is X-linked and therefore 
the occurrence of the 2 in 1 family is pure chance. As both disorders 
result in a haemolytic anaemia, it is possible that the proband will 
suffer complications attributable to this and splenectomy may have to be 
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- 214 -
SECTION VI I 
DISCUSSION AND CONCLUSION 
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In this section subjects relevant to the survey and disorders 
found in it which have not been fully elucidated earlier are discussed. 
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CHAPTER 24 
SURVEY ORGANISATION AND GENERAL COMMENTS 
INITIAL ORGANISATION 
Once the basic aims of the survey had been formulated, the 
initial organisation proved to be remarkably straightforward. Probably 
the most ~evere problem was the characteristic Greek tendency to pro-
crastinate! The Greek authorities, particularly the diplomatic corps, 
corrmunity office bearers and local teachers were appreciative of the 
aims of the study and its potential benefit for Greek individuals and 
the corrmunity as a whole. As a result demographic information was 
willingly and plentifully given and introduction was facilitated to 
the Greek community at all social levels. 
The establishment of the laboratory facet of the investigation was 
fortunately without any significant problems. Dr. ~1.C. Botha, head of 
the Cape Provincial Blood Grouping Laboratories, co-operated fully, 
placinq his facilities at the author's disposal. The Blood Grouping 
Laboratories routinely perform the tests which were required for the 
purposes of the study and thus no time had to be spent in the prior 
evaluation and reassessment of techniques. 
BLOOD SAMPLING 
The first snag, and one which continued for some time, was to persuade 
potential respondents to donate blood samoles. Their reluctance was 
based upon initial fear, wariness and suspicion of the aims on the 
survey. especially on the part of the less well-educated individuals. 
However, the more intelligent and better educated subjects were 
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generally approachable and co-operative, probably because they were 
better able to understand the aims of this study. 
With the passaqe of time it became apparent that the survey was being 
discussed extensively amongst members of the conmunity. and individuals 
became more conversant with the aims of the study and increasingly 
willing to participate. It nevertheless took approximately 6 months to 
overcome this initial reluctance and at this staqe the greater part of 
the author's time was spent in seeking respondents. 
A further rate limiting factor was that the laboratory could only 
handle 5 blood specimens per day. Furthermore, the blood specimens had 
to be fresh, as certain of the tests r.ad to be performed within 6 hours 
of venepuncture. The practical implications were that the blood could 
only be taken on week-days and during the mornings. For this reason 
advantaqe could not be taken of the fact that the Greek community met 
in siqnificant numbers regularly on Sundays. 
As many members of the conmunity had small businesses which they could 
not leave during the week, and as blood could not be sampled during the 
week-end, much of the author's time was spent travelling to visit 
individuals in their homes or work places in order to sample their 
blood and obtain a family history. 
Once the tests revealed that a respondent had an inherited haemato-
logical disorder, furttier time would then have to be spent by the 
author visiting these individuals to obtain a more complete clinical 
history, perform a comprehensive physical examination and, where 
possible, to study the relatives. 
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The author estimates that he undertook more than 1500 kilometres of 
local trav~l during the project for these reasons. 
RANDOM SAMPLING OF SUBJECTS 
After the survey was completed, the question arose as to whether or 
not the sample was truly random. On statistical analysis (by a 
qualified statistician) on the distribution of the Duffy blood group 
in the respondents, it appeared that this might not have been adequately 
random. However, it was subsequently demonstrated that the Duffy anti-
seruw. used was at fault and on proceeding to analyse the ABC blood group 
system it was demonstrated that the sample was indeed random. 
The Greek conmunity of Cape Town is relatively small and. as has been 
previously notec, members tend to come mostly from one small island. 
Therefcre, one would expect there to be some bias in the sample wher, 
analysed by the above means. To ensure that the survey population was 
as random as possible, no first degree relatives were included in the 
survey. Neverthele~s, as the Greek conmunity is a relatively close-knit 
one aDd the tendency is not only to marry persons of the same island but 
even of the same town, it is to be expected that there is a deoree of in-
breeding within this community and. therefore, bv definition the sample 
could not be truly random. 
LABORATORY TECHNIQUE 
The tests performed on the blood were highly sophisticated and as such 
required specialized equipment and personnel. These criteria were met 
by the Cape Provincial Blood Grouping Laboratories who routinely per-
formed these tests. The personnel were medical technicians who had 
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be€n especially trained in this field and were extremely competent. 
For these reasons there were no problems w th experimental techniques 
and nonna l values for the laboratory were we 11 established. Neve rt he-
less, in a minority of borderline cases clear interpretation of results 
was difficult. In the same way there were initially slight problems 
with the apparatus and techniques involved in estimating alpha/beta 
chain ratios in the diagnosis of the alpha-thalassaemia heterozygous 
state, a diagnosis which can be extremely difficult to establish. 
I 
Althouqh the greatest bulk of the experiments were performed by ex-
perienced laboratory technicians. the author familiarized himself with 
the techniques involved and became fully conversant with all aspects 
of the equipment and execution of the analyses. More time could not 
be spent on this aspect of the study as so much of the author's time 
had to be employed in obtaining the subjects and their blood samples. 
FAMILY STUDIES 
In certain of the patients, detailed family studies are extremely use-
ful in substantiating or neqating a diagncsis. Situations where this 
is particularly relevant is in the diagnosis of alpha-thalassaemia 
carriers. hereditary spheroc.vtos is, borderline cases of beta-th al assaemi a 
and in certain females heterozygous for G-6-PD deficiency. In alpha-
thalassaemia heterozygotes where only one or two of the genes are in-
valved, the stigmata may be minimal. In this situation family studies 
are extremely important and the abnormality may only show up in the cord 
blood of a neonate. 
The pattern of inheritance of the hereditary spherocytosis should by 
definition be demonstrated in w.aking the diagnosis. In equivocal cases 
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of beta-thalassaemia heterozygotes where abnormalities are only of a 
minor degree, family studies may provide the diaqnostic answer. In 
G-6-PD deficiency which is inherited as an X-linked trait, signs of 
the disease in female carriers may vary from nothing to the full blown 
disorder. The reason for this is clarified by the Lyon hypothesis 
which suggests that random inactivation of the X-chromosome occurs. 
Thus in female carriers of G-6-PD deficiency a greater or lesser 
number of cells which are G-6-PD deficient may be inactivated and if 
normal cells that are inactivated the individual may have the stigmata 
of the disorder and vice versa {Lyon, 1961, 1962). In the former 
situation it may again only be family studies which would clarify the 
situation and allow a diagnosis to be made by demonstrating that 
either the son or father of the subject have the condition or that the 
mother carries it. 
At certain periods during the investigation one of the difficulties 
that arose was that it was impossible to undertake adequate family 
studies. The reason for this appeared to be that, especially in the 
cases of the younger immigrants, they had few if any relatives in Cape 
' I ' 
Town. In particularly difficult diagnostic situations, the fact that 
responden~s had 9nly a limited number of relatives in Cape Town con-
tinued to be a problem of some consequences. 
GENETIC CONTROL AND COUNSELLING 
BETA-THALASSAEMIA 
The theoretical data as well as the cases that have been presented in 
this study amply demonstrate the severity of thalassaemia ~ajor. The 
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treatment cf the condition is limited, does not cure, only partially 
alleviates and contributes its own problems and side effects. It is 
clear for these reasons that prevention is most important. This is 
best achieved through genetic control which will now be discussed at 
greater length. 
For genetic control one needs to be aware of the condition itself, its 
severity, the mode of inheritance and whether antenatal screening and 
diagnosis are possib.le. The severity of the condition has been dis-
cussed and demonstrated at length earlier. The pattern of inheritance, 
as mentioned before. is autosomal recessive although the heterozygotes 
may manifest the symptoms and signs of the disorder to a greater or 
lesser extent. However, the heterozygotes are usually asymptomatic. 
In Cape Town (and South Africa) at present, antenatal screening is not 
possible in certain centres elsewhere. Therefore when counselling a 
couple who are both heterozyqotes one would have to recommend that 
they do not procreate at present. However, during the past 3 years 
antenatal diaqnosis has been made possible. In order to achieve this, 
fetal blood sampling needs to be performed. This may be done either 
by blind puncturing of the placenta after its ultrasonic localization 
and then collecting red blood cells mixed with amniotic fluid, or by 
doing fetoscopy and then by aspirating blood from the large super-
ficial placental blood vessels. This blood which has a mixture of 
maternal and fetal red blood cells is then analysed. Mixtures con-
taining as little as 5% of fetal red blood are sufficient (Fairweather, 
et al, 1978). The f~tal cells are then examined for presence or ab-
sence of beta-chain production. 
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Fetal blood sampling has a high mortality rate and is only indicated 
in 'at risk couples' who agree to the tennination of the pregnancy 
should the fetus have thalassaemia major. This procedure is now being 
done tn certain larqe European and American hospitals. 
ALPHA-THALASSAEMIA 
Alpha-thalassaemia in the homozygous state results in a hydrops fetalis 
and stillbirth, whereas haemoqlobin H disease, the next severest fonn 
of the disorder, usually causes a moderate anaemia. The social and · 
economic implications, therefore. differ from homozygous beta-thallas-
saemia. Hcwever. it is not reasonable for a female to carry an 
affected pregnancy to term if it can be prevented. 
Antenatal diagnosis is now po~sible by analysinq copy desoxyribo-
senucleic acid (cDNA) prepared from cultured fibroblasts and demon-
strating the number of alpha-globin genes which are missing (Wong, et al, 
1978). Pmniocentesis, which is within the capacity of most obstetric 
units, is all that is required to obtain fibroblasts from the am~iotic 
fluid. However, the DNA analysis can only be done in highly special-
ized units. Wong, et al (1978) have also demonstrated that the amniotic 
fluid can be transported over long distances fer the accurate analysis 
to be made. 
Therefore. if an at risk pregnancy presented we could offer antenatal 
diagnosis after arranging transport of the amniotic fluid to the 
relevant laboratorv. Amniocentesis would be undertaken at 15 weeks 
gestation. Thereafter. fibroblast culture and DNA analysis would 
require approximately 5 weeks. In the case of a fetus with homozygous 
alpha-thalassaemia, tennination of the pregnancy would therefore have 
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to be undertaken at about 21 weeks gestation. 
In summary. genetic counsellinQ of persons carrying either of the 
thalassaemias involves informing them of their usually very mild dis-
order and of the possible risks for their offspring. When both husband 
and wife are carriers of the condition, it is important that they be 
informed of the seriousness of the disorder in its homozygotic forms 
and thereafter giving information as regards the possibility of ante-
natal diagnosis and the risks attached to these procedures. Finally, 
parents of a severely affected child should be informed cf the severity 
of the disorder, progress in treatment and prognosis. They need also 
to be told of the risks attached to future pregnancies and of the status 
of antenatal diagnosis. 
Groote Schuur Hospital. recently acquired a fetoscope and it is hoped 
that in the near future fetoscopy and fetal blood sampling will be 
possible and that antenatal diagnosis of thalassaemia be offered at 
this institution. At the time of writing. as far as is known, no other 
institutions in South Africa have a fetoscope or are able to offer this 
service. Therefore at present the best that we can offer to parents 
with 'at risk' preqnancy is referral to an overseas centre which has 
the necessary expertise and facilities to diagnose thalasseemia major. 
GLUCOSE 6-PHOSPHATE DEHYDROGENASE DEFICIENCY 
G-6-PD deficiency is not a disorder of the same severity as thalassaemia 
major and therefore different genetic counselling and control is 
required. Nevertheless, knowledge of the disorder within the population 
\ ' 
at risk is necessary. It is important that the medical profession be 
aware of the communities with a hiah prevalence so that a rapid diagnosis 
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can be made. This is of particular concern in the case of pregnant 
females who normally have the tendency to anaemia antenatallv and 
which is exacerbated by the condition, and for neonates who may 
present with a severe bil i rubi naemi a. Thus, although G-6-PD deficiency 
is important in the perinatal oeriod. it is never necessary to con-
sider te.nnination of pregnancy in the disorder. 
G-6-PD deficiencv mav also result in a specific illness at any time in 
persons having or carrying the disease. For these reasons it is im-
portant that the physician be awarf.· of the population at risk so that 
rapid diagnosis be made and adequate management qiven. Thereafter it 
is necessary that patients with the disturbance be infonned of the 
medicines and foodstuffs to be avoided so as to prevent the haemolytic 
complications from occurring. ·it is also recommended that persons 
with the condition wear a medic-alert disc and that relatives of 
affected individuals be tested to ascertain whether or not they are 
carrvinq the disorder. The above steos were carried out on affected 
subjects in the survey. 
HEREDITARY SPHEROCYTOSIS 
As with G-6-PD deficiency it is usually not necessary to consider 
tennination of a pregnancy in a family in which there is HS. However, 
it is imvortant that the diagnosis be confinned in an affected indi-
vidual and that relatives be tested to ascertain who does indeed have 
the condition. 
HS is inherited in an autosomal dominant fashion and thus persons with 
the abnonnal gene may suffer from the disturbance. The usual treatment 
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of a patient with symptoms and signs of the disorder, especially 
anaemia. splenomegal.v and gallstones, is splenectomy. Persons 
presenting with attacks of cholecystitis and who have HS should not 
only .und~rgo a cholecystectomy, but also a splenectomy to decreqse 
haemolysis. Thus the diagnosis of the condition is important in order 
that the correct operation be performed. 
One subject with HS in the survey was incorrectly treated for gall-
stones only, as the underlying cause (HS) was not diagnosed. As a 
result she o~ly underwent a chol~cystectomy. The accepted correct 
I 
treatw.ent would have been the removal of both the spleen and gall 
bladder at the same operation. 
The diagnosis within a family is important so that they can be 
adequately counselled about the mode of inheritance, informed who is 
affected and given necessary details about the disorder. This 
knowledge is also important for t he attending physician or surgeon in 




In this chapter, pertinent points of discussion of alpha-
thalassaemia which have not yet been dealt with are examined. 
UNDERDIAGNOSIS OF ALPHA-THALASSAEMIA 
The difficult_y in diagnosing alpha-thalassaemia heterozygotes 
has previously been discussed. In surrmary, there are 4 genes for 
alpha-thalassaemia and if all are involved (i.e. homozygozity}, it is 
incompatible with life and still birth with hydrops fetalis results. 
If 3 of the 4 genes are abnormal, the result is haemog.lcobin H disease 
in which the patient has a disease of medium severity. This is diag-
nosable on clinical grounds together with red cell parameters, red 
cell inclusion bodies and haemoqlobin electrophoresis, where a 
characteristic H band is obtained. Persons with only one or two genes 
involved and who have the alpha- thalassaemia trait may or may not have 
abnonnal clinical and haematological findings and thus be very difficult, 
if not impossible to diagnose. Diagnosis in these cases depends on 
analysis of the relative rates of synthesis of the alpha and beta chains. 
The problems associated with the diaqnosis of alpha-thalassaemia are 
well demonstrated by the survey. Because of the relative cost and time 
involved. c,r,ly a certain number of persons were able to have alpha/beta 
chain ratios undertaken. These persons (as .discussed in Chapter 15) were 
selected because they either had numerous red cell inclusion bodies or 
because they had red cell anomalies (e.g. decreased MCV and MCH), as well 
as a few inclusion bodies. 
Three of the 6 so selected were finally diagnosed as having the alpha-
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thalassaemia trait. None of these 3 were anaemic and all the red cell 
parameters of one respon~ent (Case 3) ~ere nonnal. She did, however, 
have 10 g~0 red cell inclusion bodies. Of the other 2 subjects, 1 had 
a moderate number of red cell inclusion bodies and abnormalities of 
his red cell indices, while the other also had red cell parameter 
anomalies with a small number of red cell incl~sion bodies (10 doo)· 
Of the remaining 3 who were not diagnosed as having the alpha-thalas-
saemia trait, it is seen that all had numerous red cell inclusion 
bodies and 1 had aberrant red cell indices. It is felt by the author 
that this latter individual may yet be found to carry alpha-thalas-
saemia, as her alpha/beta chain ratios were borderline. One of the 
remainder appears to have the beta-thalassaemia trait while the other 
patient is normal. These 3 cases are discussed in greater detail later 
in this chapter. 
From the above. it can be seen that a diagnosis of the alpha-thalas-
saemia trait cannot be made where either both or one of these findings 
is abnormal and alpha/beta chain rate of synthesis must be measured. 
Thirty-five subjects remain who had either one or the other of the 
above abnonnalities (red cell parameter anomalies or haemoglobin H red 
cell inclusion bodies) but whom it was not possible for logistic 
reasons to investigate further. This group is made up of 20 with red 
cell inclusion bodies but no abnonnalities of red cell indices, and 15 
with anomalous red c~ll parameters (namely decreased MCV and MCH} but 
no red cell inclusion bodies. Of the latter group, 2 can be discarded 
as their decreased MCV and MCH can be explained on the basis of an 
iron deficiency anaemia. Of the former group, 1 subject had 10 5g0 
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red cell inclusion bodies but ·no further red cell anomalies. He was 
not studied further as he was not contactable. His results are 
similar to Case No. 3 who was found to have alpha-thalassaemia and it 
is quite possible that he too had the alpha-thalassaemia trait. 
It is recognized, and in fact illustrated by the survey, that normal 
per,sons may have some inclusion bodies in their peripheral blood 
smears. Nevertheless, it seems quite probable that of the remaining 
19 with red cell inclusion bodies some, if investigated further, would 
be found to carry alpha-thalassaemia. Similarly. in the remaining 13 
subjects with no red cell inclusion bodies but definitely decreased 
levels of MCH and MCV, it is very possible that a certain proportion 
do carry alpha-thalassaemia and that this is responsible for these 
alterations. This situation could only be clarified by undertaking 
alpha/beta chain synthetic rate ratios to ascertain whether these sub-
jects carry either of the thalassaemias. 
For the above reasons, it seems likely that the prevalence of hetero-
zygous alpha-thalassaemia is significantly higher than the 1,2% quoted 
in the survey. 
Alpha/Beta Chain Ratios 
The results of alpha/beta chain ratios performed in the other 3 persons 
not diagnosed as having the alpha-thalassaemia trait are worth examining 
further. 
M.J., a female aged 35 years, gave a histor.y of an anaemia, the cause of 
which was not established. At the time of investigation, she had no 
clinical signs and her red cell indices ' and haemoglobin electrophoresis 
- 229 -
were within nonnal limits. However, she did have Io B~o red cell in-
clusion bodies and for this reason alpha/beta chain synthetic rates 
were measured. The result was 1,09 which is in keeping with normality. 
M.D .• a male aged 27 years, gave no medical history of an anaemia. His 
red cell parameters were all nonnal and haemoglobin electrophoresis and 
quantitation exhibited an A.A. pattern, HbF 0,1% and HbA2 2,6%. How-
20 ever. on incubation with brilliant cresyl blue Io 000 red cells had 
haemoglobin H inclusion bodies and it was, therefore, felt that he may 
carry heteroz.vgous alpha-thalassaemia. Alpha/beta chain ratios were 
perfonned and gave a result of 1,38 which was repeated and found to be 
1,47. This result is characteristic of beta-thalassaemia. 
I.M., a female aged 26 years, gave a history of anaemia during pregnancy. 
Physical examination revealed a mild anaemia which we confirmed by 
laboratory examination. Her haemoglobin {Hb) level was 11,2 g per 100 
ml, MCV 75 fl and MCH 24 pg. All these 3 parameters are decreased and 
in addition~she had IO ~OO haemoglobin H red cell inclusion bodies which 
made the picture highly sugqestive of the alpha-thalassaemia trait, ~s 
her haemoglobin electrophoresis and quantitation were both nonnal. How-
ever, her alpha/beta chain synthesis rate was 0,92. which falls just 
within the lower limit of nonnal and thus a diagnosis of the alpha-
thalassaemia carrier state was not made. Nevertheless. it is the 
opinion of the author that this individual may yet be proved to have 
the alpha-thalassaemia trait and this is further evidence of the 
difficulty in diaqnosing alpha-thalassaemia. This position could 







Thalassaemia major is a severe disabling disorder with important 
short and long term implications. Problems are those specific to the 
condition itself as well as those applicable to most chronic illnesses. 
1. MEDICAL ASPECTS 
In sunmary, these are problems arising from the disease itself, 
as well as its complications. These have previously been enumerated 
in the discussion of the disease in Chapters 7 and 8. These include 
the anaemia and its immediate effects, growth retardation, skeletal 
maldevelopment, endocrine failure, increased infections and hyper-
splenism. 
2. HOSPITALISATION 
Frequent hospitalisation is necessary from the time of diagnosis. 
a) Initial Hospitalisation 
This is usually to establish the diagnosis. If the clinician 
has a high index of suspicion this diagnosis is usually made 
shortly after 6 months of age. However, if the diagnosis is not 
apparent, hospitalisation may be prolonged while extensive in-
vestigations are undertaken. Implications now include cost and 
p~ycholo~ic~l factors which will be enlarged upon later. 
b) From the time the condition i~ diagnosed frequent hospital-
isation is required, mainly for treatment but also for follow-up 
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purposes. As the front line of treatment is blood transfusion, 
which is required frequently - initially approximately 1 monthly 
and thereafter 1 to 2 weekly, this has to be supervised in 
hospital. This, too, has important cost and psychological im-
plications. 
c) Due to the numerous complications that patients are prone to, 
hospitalisation is often necessary. · These include infections, 
often due to unusual organisms, pericarditis, nephropathy and 
cardiac failure, all of which have occurred in the subjects in-
cluded in the survey. 
3. TREATMENT 
Management consisting mainly of hypertransfusion plus chelation 
and supportive therapy which is frequent and lifelong. In addition to 
this it is also unpleasant and painful especially for the young who 
require regular and frequent intravenous infusion. 
The other major disadvantage of treatment is that it has its own set 
of complications. As discussed earlier these are mainly iron overload 
and resultantrhaemochromatosis which is also a complication of the 
disease itself. The outcome includes cardiac failure, endocrine 
failure and hepatic cirrhosis. 
4. SCHOOLING AND EDUCATION 
Absenteeism occurs often as numerous hospitalisations are required 
for treatment and complications of the illness. This may contribute 
toward academic failure even though mental retardation is not an 
associated problem of the condition or in the 2 cases in this study. 
- 232 -
Sport is an integral part of life in most South African schools. 
Patients with thalassaemia major, even if they feel physically 
capable of participating are advised not to due to possible problems 
such as traumatic rupture of the spleen. This can lead to a feeling 
of inferiority and abnormality. This was a problem with the younger 
of the 2 investigation subjects who was particularly keen to play 
rugby football and judo. 
5. PSYCHOLOGY 
a) Parents 
It is important that the parents of an affected individual 
be fully informed about the disorder, its inheritance, treatment 
and prognosis. They must firstly not be made to feel guilty that 
they carry a recessive gene and must therefore be supported in 
adjusting to an offspring who is going to require frequent and 
lifelong treatment and will probably have a limited lifespan. 
It is important that they be informed of the latest developments 
as regards antenatal diagnosis and prevention in future preg-
nancies and any new therapy which might be of benefit to their 
child. 
It is known that parents carrying a disorder may feel tainted and 
have powerful guilt feelings. This may create significant ten-
sions within the individual and result in neurotic reactions as 
well as psychosomatic illnesses. This in turn leads to the 
pa~ents being overprotective towards the affected child and over-
indulging him or her thereby creating further problems. 
If there are siblings they too will be affected by the abnormal 
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family situation. With more attention being lavished on the 
pati en~ s i b 1 i ng rivalry and resentment often arises. 
Education, understanding and support are the most important ways 
in which doctors can be of assistance to the parents of an 
affected individual. They should also be guided in their relation-
ship with normal offspring. 
b) Patient 
Psychological problems can complicate the whole life of one 
suffering from thalassaemia major. The first problems are en-
countered during initial hospitalisations when the parent and 
child are separated. The patient finds himself in unfamiliar 
surroundings and being cared for by strangers, which results in 
'separation anxiety', an entity well recognized when children are 
hospitalised. 
During hospitalisation, nursing care often entails control of 
bodily functions, such as washing and feeding which the child may 
have already mastered and he is treated in an inappropriate way 
for his age. This loss of ego control usually results in regres-
sive behaviour such -as bedwetting which may persist after dis-
charge from hospital. However, as defence against this regression 
the child may become a difficult, intractible patient, not 
reverting to or accepting helpless infancy. It may be necessary 
that the child be reweaned. 
In chronic illnesses such as thalassaemia major the child may feel 
discriminated against, passively deprived and thus lose confidence 
in himself. This is often a problem during convalescent periods 
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when neurotic disorders may manifest. Typical reactions are mood 
swings, temper tantrums, bedwetting, phobias and sleeping problems. 
These do not necessarily occur as a result of hospitalisation. In 
addition, feelings of abnormality and thus inferiority and rejection 
may be present for life. 
The need to take medicines on a long term basis has been recog-
nized as a cause of repressed ideas of the patient being attacked 
by the mother. When motor restraint is placed on a child the 
reasons may not be apparent to him and result in behavioural 
problems such as irritability, bad language and temper tantrums. 
Schooling difficulties, although not presenting as a problem in 
the 2 cases in the survey, may occur. This is especially so in a 
child who is average or below average intellectually and who has 
to miss lessons because of the illness. The patient's peers may 
consider him 'not normal' and reject him because of the frequent 
absenteeism, his inability to participate in all the normal school 
activities such as sport and possibly because of the characteristic 
appearance. This may result in depression even to the extent of 
severe withdrawal (Mi nde, et al, 1972). V. P., who wanted to play 
'body contact' sport but was not allowed to, has been mentioned 
previously. 
The child might quite understandably hav~ ampivalent feelings 
towards his parents. On the one hand there is the natural love 
bond between child and parent, while on the other hand he may 
resent his parents for 'giving' him his ailment and then in 
addition curbing his activities. Feelings of abnormality, in-
feriority and rejection may all play a part in the development of 
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the character of the patient and result in lifelong neuroses. 
V.P., the younger patient with thalassaemia major in the survey, 
has manifested certain of these behaviour patterns. While at a 
young age he blamed his parents for his condition and asked why 
it had happened to him. Later on he presented with a pnoblem of 
temper tantrums and aggressive behaviour at home. Enuresis is 
still an intermittent problem with him. 
Problems of a sexual nature may develop. According to Freudian 
thought, boys in the oedipal stage may be unable to cope. They 
may react passively (as do females) to the bodily pain they are 
forced to suffer and not with expected masculine contempt (Freud, 
1960). This may result in lifelong sexual identity confusion. 
Further difficulties can be envisaged especially in boys at 
puberty and further into life. These would be due chiefly to the 
delayed physical developmen t of the individual. Disturbed endo-
crine function is a well recognised complication of thalassaemia 
major. This includes malfunction at the level of the pituitary 
and gonads, with resultant inadequate production of the testerones 
in males and oestrogens in females. The overall outcome is 
delayed and possible absence of normal puberty. Decreased secon-
dary sexual characteristics are common. In fact, they were 
illustrated by the older of the 2 patients with thalassaemia in 
the survey. In this milieu sexual identity problems may be a 
feature of the person. This may resul~, in addition, in neurotic 
reactions. 
Logothetis, et al (1971), after evaluating 138 patients with 
tha l assaemi a major, reported that there \'Jas no apparent difference 
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in the I.Q. mean and distribution of their patients and the nonnal 
population. However, they did note a positive correlation between 
I.Q. and total blood transfused since birth and a negative 
correlation between I.Q. and parameters that characterize the 
severe stigmata of the disease. 
In this series, 96 of the subjects had behavioural problems mani-
fest as impulsiveness, capriciousness and uncontrolled temper or 
withdrawal, dependence and seclusiveness. In addition, 67 had 
abnormalities of affect,usually depression and floating anxiety. 
It was found that patients whose parents were very anxious and 
overly protective were more likely to have psychological problems. 
6. ECONOMICS 
Thalassaemia major, by virtue of the high cost of treatment and 
frequent hospitalisation, has important economic considerations. 
These may have to be initially borne by the parent of the affected child 
but after diagnosis the financial burden is carried by the state. 
As an example of the high costs involved, P.C., the older of the 2 
Greek patients with thalassaemia major in Cape Town, will be quoted. 
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TABLE 26 - 1 
TREATMENT COST OF SUBJECT WITH THALASSAEMIA MAJOR 
SERVICE COST/UNIT TOTAL ANNUAL COST 
Blood {frozen washed R32.00 R2,400,00 
cells) 
Desferrioxamine R70,91 R4,350,00 
Hospital admission R53,68 R 500,00 
R7,250,00 
These costs, which are approximate, have been calculated for the state. 
A private individual would have to pay about 50% more. These figures 
will now be explained. The blood is given in the form of frozen 
washed cells and the patient being discussed receives about 5 units 
every 3 to 4 weeks. He takes about 20 g of desferrioxamine, the iron 
chelating agent, per week. This costs R20,91 for 5 g. Hospital ad-
mission for blood transfusion is necessitated approximately once per 
month for 1 day, and furthermore about 10 days annually for compli~ 
cations of the disorder. The cost per bed per day at Groote Schuur 
Hospital is R53,68. However, this includes treatment and investi-
gations which the subject does not always need. Therefore, when 
calculating the above, an approximate estimate of his true cost to the 
state was made. 
The final annual total cost in this individual, though possibly 
slightly higher than most, is representative of the relative costs to 
the state of maintaining management of a patient with thalassaemia 
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major. In Cape Town, there are 2 Greek and 3 patients of other 
population groups suffering from this severe fonn of the disorder. 
Thus the probable cost to the state in Cape Town to treat these 
patients is approximately R30 000 per annum. From knowledge of the 
Greek population in Cape Town and that of the rest of South Africa, 
especially considering origins and size, there are probably a minimum 
of another 5-10 individuals with thalassaemia major. The cost of main-
taining them is thus in the region of R30 OOO-R70 000 per annum. 
As a result the total cost of maintaining patients with thalassaemia 
major in South Africa, where there are relatively few of these cases, 
is in the region of RlOO 000 per annum. 
Greece has a population of about 9 000 000. The prevalence of beta-
thalassaemia heterozygotes varies from 4% in certain areas of the main-
land to 6%-15% on Cyprus and 20% on certain islands, with an overall 
prevalence of probably about 10%. Therefore, a large number of new 
cases must be born annually. Greece is a poor country and is not able 
to treat as intensively as would be ideal. Nevertheless, extrapolating 
from the costs in South Africa, it is clear that Greece must spend a 
large amount of her health budget on treating patients with thalassaemia 
major. 
To rectify this situation, it is most necessary to prevent the birth of 
patients with thalassaemia major. This is currently being done in 
Greece by compulsory premarital screening of each couple intending to 
marry. The cost of screening is insignificant compared to the heavy 
financial burden to the state of new cases. 
I 
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SCREENING PROCEDURES FOR BETA-THALASSAEMIA 
In this survey persons tested were screened fully for any inherited 
haematological disorder. When making a diagnosis of beta-thalassaemia 
cognisance was taken of all the red cell parameters, the osmotic 
fragilities, peripheral blood smear and haemoglobin electrophoresis. 
In the literature reports have appeared discussing the efficacy of 
various parameters for use in large scale surveys. Tests which have 
been suggested for population screening include MCV, MCH, osmotic 
fragilities and haemoglobin electrophoresis. The ascertainment of the 
MCV and MCH can either be done by a fairly lengthy method such as 
followed in this investigation or by automatic measuring on a large 
counter. Using this latter method it would be possible to investigate 
a large number of blood specimens per day. However, for economic 
reasons this could only be done at a large centre which would have a 
large counter. 
In evaluating the results produced by the author's laboratory it is 
apparent that the MCV and MCH are most reliably correlated with an 
increase in HbF and/or HbA2 and thus beta-thalassaemia. The MCV was 
decreased in all but 3 and the MCH in all but 2 persons with hetero-
zygous beta-thalassaemia. Thus in screening the Greek population of 
C~pe 7own, 2 respondents with beta-thalassaemia would have been missed 
if only th~ MCH ard ~CV were measured. On the other hand, another 18 
individuals had a decreased MCH and MCV without an increase in HbF or 
HbA2. Two of these persons had iron deficiency anaemia from another 
cause, while 3 patients had inclusion bodies on their peripheral 
smears and were further investigated for alpha-thalassaemia. 
A pool of 13 persons who had a decreased MCV and MCH with no apparent 
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cause, still remains. One of these had an HbA2 of 2,8% and possibly 
could have a mild form of beta-thalassaemia. The -remainder can only 
be accounted for as possibly having a mild form of heterozygous alpha-
thalassaemia or possibly delta-beta-thalassaemia. They might also be 
at one end of the spectrum for the normal population or there may have 
been minor experimental errors. 
The osmotic fragility has previously been used in large scale screening 
procedures tn Greece and elsewhere with apparent success (Rucknagel, 
1966). This method has been perfected and simplified to enable large 
scale screenings to be undertaken on one drop of blood obtained by 
finger puncture (Silvestrone and Bianco, 1975). In this survey, of the 
22 persons found to have the thalassaemic trait, only 6 had a decreased 
osmotic fragility. The remainder, although within normal limits 
appeared at the lower end of the scale for normality. On this basis it 
appears that osmotic fragility studies alone, as undertaken in the 
author 1 s study, are inadequate for use in large population surveys. 
The probable reason for this is that the normal distribution curve 
which was used was shifted too far to the left. If the curve was to be 
shifted further to the right the majority of the respondents carrying 
the thalassaemia trait would be found to have a decreased osmotic 
fragility. However, were this to be done there would be a further body 
of persons with a decreased osmotic fragility and no other abnormalities 
such as has also occurred with the MCV and MCH. 
Taking a broad viewpoint, it is apparent that the most efficient tests 
in large population screenings are the MCH together with the MCV which 
would pick up the majority of thalassaemia carriers. Persons with 
decreased MCH and/or MCV would subsequently have to be fully screened 
- 241 -
by electrophoresis and in certain situations by alpha-beta-chain 
ratios to determine if the abnormalities of MCV and/or MCH were 
actually due to the thalassaemia trait. 
METHOD USED FOR ESTIMATION OF HAEMOGLOBIN A2 
After the survey had been completed and the results formulated it was 
suggested that the method of Black, et al (1960), which was used for 
estimating haemoglobin A2, was antiquated. This method was used for 
economy and to ensure that the experimental technique was indeed 
accurate,a random 10% of all specimens as we l l as all abnormal speci-
mens were retested by elution from cellulose acetate. There were no 
discrepancies and the author is confident that the method used and the 
results obtained were accurate. 
PREVALENCE OF THE BETA-THALASSAEMIA GENE IN THE GREEK PEOPLE 
The prevalence of heterozygous beta-thalassaemia in the Greek popu-
lation of Cape Town is relatively high (9,2%). From existing knowledge 
of the gene frequency of beta-thalassaemia in various regions in Greece, 
this result is much as expected, as the overall prevalence in Greece is 
in the region of 10%. 
At present it is generally accepted that heterozygous beta-thalassaemia 
protects against malaria. Recent research has produced findings to 
suggest that the high HbF found in thalassaemia heterozygotes in the 
first year of life confers resistence against falciparum malaria 
(Pasvol, Weatherall and Wilson, 1977). During this period the infant 
is particularly susceptible to Plasmodium falciparum which results in a 
high mortality and thus ·a selective advantage at this stage would in-
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fluence the prevalence of the carrier state of thalassaemia. This 
probable selective advantage has resulted in a high incidence of 
heterozygous beta-thalassaemia in areas of malarial and former malarial 
endemicity, such as Greece. In Cape Town where malaria is not endemic, 
individuals with heterozygous beta-thalassaemia are no longer at a 
selective advantage and it is therefore to be expected that the gene 
frequency of beta-thalassaemia will decrease in Cape Town. However, as 
the detrimental effects of heterozygous beta-thalassaemia are so mild, 
the disadvantage of having the disorder are insignificant and the 
decline in the gene frequency of the disorder will take very many 
generations. 
There are regions, such as the north-eastern Transvaal in South Africa, 
where malaria is still endemic. Individuals with heterozygous beta-
thalassaemia living in these regions might be expected to have a 
selective advantage against malaria and the incidence of beta-thalas-
saemia would therefore be expected to remain static or increase. How-
ever, with modern medicinal therapy and public health regulations there 
should no longer be a significant mortality or morbidity from malaria. 
For these reasons the gene frequency of beta-thalassaemia would be 
expected to remain relatively static. 
HETEROGENEITY OF THE THALASSAEMIAS 
The great heterogeneity of the thalassaemias is well illustrated by the 
findings of the survey and significant variations in clinical, haemato-
logical and electrophoretic manifestations were found. Certain indi-
viduals with heterozygous beta-thalassaemia had symptoms referrable to 
an anaemia, while others were asymptomatic. Likewise, certain beta-
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thalassaemia heterozygotes had marked haematological abnormalities 
while others had only mild stigmata of the disorder. 
In addition, the severity of the clinical manifestations did not 
necessarily correlate with the degree of the haematological or electro-
phoretic abnormalities. Similarly, the magnitude of the haematological 
findings was not proportional to those of the electrophoretic findings. 
Certain subjects with symptomatic anaemia had only minor elevations of 
their haemoglobin F or A2 whereas other s w.ith more significantly 
elevated levels of haemoglobin A2 or F were totally asymptomatic. In a 
similar manner, persons with significantly decreased haematolo~ical 
parameters and highly abnormal red cell morphology did not necessarily 
have a symptomatic anaemia, while certain persons with minor red cell 
changes and haematological parameters were found with a symptomatic 
anaemia~ Lastly, the degree of elevation of haemoglobins A2 and Fare 
not matched by a similar reduction in MCV and MCH or an alteration in 
red cell morphology. 
Further evidence for the heterogeneity of the thalassaemias is that 
individuals with beta-thalassaemia have elevated levels of both haemo-
globin A2 and F, whereas others have only an elevation of haemoglobin A2. 
A certain group have elevated levels of haemoglobin F with normal 
haemoglobin A2. The diagnosis in this latter category, who form a sub-
division under the broad heading of thalassaemias, is delta-beta-
thalassaemia. These levels of haemoglobins A2 and F tend to be constant 
within families. Further examples of the heterogeneity of the condition 
will be pres~nted in the following discussion. 
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INTRA-FAMILIAL SEGREGATION OF HAEMOGLOBIN A2 AND F 
It has been previously noted that there is significant intra-familial 
segregation of haemoglobin F and A2 values (Weatherall, 1964). 
Presented below are the haemoglobin A2 and F levels of 1 of the 
respondents included in the survey, as well as his or her sibling or 
child. 
FAMILY HbF % Hb A2 % 
1. 0 .. T. 4,8 2,5 
c. T. 2,5 2,4 
2. A.K. 1,8 3,9 
G.K. 2,2 5,3 
V .K. 2,1 3,6 
3. G.P. 1,0 5,8 
S.P. 1,3 3,9 
4. S.S. 0,8 4,8 
G.S. 3,6 5,0 
5. G.P. 0,4 4,8 
M.C. 0,9 3,6 
Family 1 demonstrates a raised haemoglobin F with a normal haemoglobin 
A2 value in both subjects and is probably an example of delta-beta-
thalassaemia. 
Families 3 and 5 have a heterozygous beta-thalassaemia with a normal 
haemoglobin F and a raised haemoglobin A2 level. 
Family 2 has a form of beta-thalassaemia with raised both haemoglobin F 
and A2 values. 
In family 4 the father's haemoglobin Fis normal, while his son's is 
raised. The haemoglobin A2 is increased in both father and son. The 
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explanation for the son's raised haemoglobin Fis probably that the 
child was 18 months old at the time of testing and had not decreased 
his gamma-chain production to normal adult levels. It can be inter-
preted that his haemoglobin F would be within normal limits by adult-
hood. It is thus demonstrated that members of families with the 
thalassaemia trait tend to have similar levels of haemoglobin F and 
haemoglobin A2 which may differ from other families. This illustrates 
intra-familial segregation of haemoglobin F and haemoglobin A2. It is 
also further proof of the heterogeneity of the thalassaemias. 
HEREDITARY PERSISTENCE OF FETAL HAEMOGLOBIN (HPFH} 
As defined earlier (Chapter 8), HPFH occurs where a raised haemoglobin 
Fis found in the absence of other abnormal haematological parameters, 
and it is diagnosed incidently during screening procedures and family 
studies. 
It is possible that subject 21 (see Chapter 16) falls into this category. 
His complaints of the symptoms of anaemia were not borne out by the 
findings of a haemoglobin of 16,1 g/100 ml. His MCV was normal, but the 
MCH was minimally decreased, the value being 26 pg. The only abnormality 
of his peripheral blood smear was anisopoikilocytosis, a minimal defect. 
Finally, his ~aemoglobin F was 2,7% on consecutive occasions. 
The haemoglobin Fin HPFH is usually in the region of 20-30%, whereas 
that of heterozygous beta-thalassaemia varies from normal to 6% 
(Weatherall and Clegg, 1972). This is further eviqence for respondent 
21 having the thalassaemia trait and not HPFH, if one were to differen-
tiate between the two. His diagnosis of thalassaemia heterozygosity 
hinged on his abnormal haemoglobin F, plus the 2 other minor haemato-
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logical abnormalities and this gives further credence to Clegg and 
Weatherall 's (1976) theory th~t the HPFH syndromes are in fact a mild 
form of thalassaemia. This further illustrates the wide heterogeneity 
of the thalassaemia. 
DELTA-BETA-THALASSAEMIA 
Three of the 23 respondents documented as having heterozygous beta-
thalassaemia had a raised haemoglobin F but a normal haemoglobin A2. 
Subjects 1 and 4 (see Chapter 16) had clinical and haematological 
findings which were typical of the thalassaemia trait. They were not 
anaemic but had low MCVs and MCHs. Examination of the peripheral 
blood smear revealed microcytosis, anisopoikilocytosis and target cells 
in subject 1. The haemoglobin A2 in both was 2,4% (normal). The 
haemoglobin Fin respondent 1 was 7,9%, while that in subject 4 was 
2,5%. 
The son of case 4 also had a normal haemoglobin A2 and the haemoglobin 
F of 4,8%. These individuals in fact do not have beta-thalassaemia but 
delta-beta-thalassaemia where there is a defect in delta- as well as 
beta-chain production. The haemoglobin levels of 13 g and 12,3 g per 
100 ml and the MCH of 21 pg in the 2 subjects are very similar to the 
mean haemoglobin level of 12,4 g per 100 ml and the mean MCH of 22,4 pg 
found by Stamatoyannopoulos, Fessas and Papayannopoulos (1969) in their 
series of 68 cases of delta-beta-thalassaemia. However, their mean 
haemoglobin F value of 10,9% is higher than that of the subjects studied 
in this series. 
Subject 21 had minor red cell abnormalities consisting of a marginal 
decrease in MCH (26 pg) and anisopoikilocytosis and probably falls into 
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this category. His haemoglobin A2 level was 2,4% and his haemoglobin 
F 2,7%, which is definitely elevated. The mildness of his stigmata 
suggest the possible diagnosis of hereditary persistence of fetal 
haemoglobin (HPFH). However, as he does have some red cell abnormalities 
and as it is now thought that the HPFH is probably a mild expression of 
the thalassaemic gene (Clegg and ~eatherall, 1976), it is reasonable to 
classify him as having the thalassaemia trait. As he has a normal 
haemoglobin A2 but a raised haemoglobin F, he probably has delta-beta-
thalassaemia, with a very mild expression of the gene. 
A fourth subject, patient 23, was diagnosed on alpha/beta-chain syn-
thetic rates as having delta-beta-thalassaemia. He is discussed in 
detail later in this chapter under the heading "Heterozygous beta-
I 
thalassaemia with normal haemoglobin pattern". 
The source of the abnormality in delta-beta-thalassaemia is that there 
is not only a quantitative defect in beta-chain, but also of delta-
chain synthesis. The depression of delta-chain production is not 
significant or important and as seen from the investigated subjects, 
the clinical abnormalities are no more severe than in mild heterozygous 
thalassaemia. 
HETEROZYGOUS BETA-THALASSAEMIA WITH A NORMAL HAEMOGLOBIN PATTERN 
Subject 23 (see Chapter 16) of the cases with heterozygous beta-
th~lassaemia was a late addition to this group as the results of the 
alpha/beta chain synthetic rate studies were only made available to the 
author 6 months after the rest of the laboratory work had been com-
pleted. He presented in an interesting fashion. He had normal red 
cell parameters but as he had 10 o68 haemoglobin H inclusion bodies, 
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it was felt that he may carry the alpha-thalassaemia trait. Alpha/beta 
chain synthetic rates were undertaken and the result was 1,47, which 
signifies a defect in betq-chain production. As this was unexpected, 
this latter investigation was repeated with an outcome of 1,38, which 
is within keeping with a diagnosis of beta~thalassaemia. 
On examining his red cell indices, he was not anaemic and his MCV and 
MCH were within normal limits. These 2 parameters are the most 
reliable simple indicators of the beta-thalassaemia trait. In this 
study, when considering both, they are accurate in 92% of cases. His 
other red cell indices were also normal. Haemoglobin electrophoresis 
and analysis reveal a HbA2 of 2,6% and a HbF level of 0,1%. These 
results are also normal. 
Thalassaemia with a normal haemoglobin pattern has previously been 
recognized (Silvestroni, et al, 1978). This may be the phenotypic 
manifestation of the alpha-thalassaemia carrier state, beta-thalassaemia 
with severe iron deficiency or the association of beta- with delta-
thalassaemia in the same individual. 
Case 23 was clearly not iron deficient and alpha/beta chain synthetic 
rates excluded the diagnosis of alpha-thalassaemia and in fact sub-
stantiated the diagnosis of the beta-thalassaemia trait. 
Subjects with normal haemoglobin levels and delta-beta-thalassaemia 
have usually been diagnosed on investigating the parents of a patient 
with thalassaemia major (Stammaloyanopoulos, Fessas and Papayannopoulos, 
1969; Weatherall and Clegg, 1972; Fessas and Loukopoulous, 1974, and 
Weatherall, et al, 1974). The diagnosis of delta-beta-thalassaemia has 
then been made and confirmed by alpha-beta chain synthetic rates and on 
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this basis the author has diagnosed the delta-beta-thalassaemia trait 
in respondent 23. 
The subject who has nonnal red cel l indices was only diagnosed as 
having the thalassaemia trait on alpha/beta chain synthetic rates and 
it is therefore possible that other subjects in the survey who were 
considered normal may actually also have the thalassaemic trait. This 
particularly applies to those persons who had abnormal red cell para-
meters such as a decreased MCV and/or MCH. This matter could only be 
clarified by measuring alpha/beta chain synthetic rates to exclude a 
defect in beta chain production (or, in the case of the alpha-
thalassaemia trait, a defect in alpha chain production as discussed 
earlier). This was not possible in this survey for logistic reasons 
and can, iri fact, only be done in highly specialized laboratories. 
A particular source of concern, as illustrated by this data, is that 
persons can remain undiagnosed fo llowing routine screening for the 
thalassaemia trait. The unpleasant implications are that a child with 
thalassaemia major may be born after the parents have been assured 
antenatally that this will not occur. 
RATIO OF THE BETA TO THE DELTA-BETA-THALASSAEMIA TRAIT 
The ratio of the beta-thalassaemia trait to the delta-beta-thalassaemia 
trait is 10: 1 in Greece when calculated from the data of Malamos, et 
al (1962) and Kattamis, et al (1978). The ratio in this series is of 
the order of 5 : 1, which is higher than expected. Reasons for this 
include the relatively small size of the sample as well as the fact 
that 2 of the subjects diagnosed as having the delta-beta-thalassaemia 
trait would possibly not have been diagnosed in the fonner series 




DIFFICULTY IN DIAGNOSING THE FEMALE HETEROZYGOTE 
As G-6-PD deficiency is inherite_d in an X-linked manner, female 
carriers may manifest the disorder to a greater or lesser extent, 
dependin~ on the proportions of the two X chromosomes which are in-
activated. · If a large proportion of the X chromosomes directing the 
synthesis of normal G-6-PD is inactivated, and thus more of the X 
chromosomes directing abnormal qualitative or quantitative G-6-PD are 
operative, the person will be G-6-PD deficient to a greater extent than 
in the opposite set of circumstances. This situation will also be 
mirrored in the tests for G-6-PD deficiency and thus the Motulsky 
(brilliant cresyl blue dye) tests will be grossly abnonnal in some 
carrier females, whereas completely normal in others. In the latter 
situation, it is possible to mis s the diagnosis of the carrier state in 
certain females and thus figures of the gene frequency of the disorder 
might be erroneous to a certain extent where females are taken into 
account. In this surve.Y, females were included and thus the results 
may be slightly inaccurate. In persons where the Motulsky test was 
equivocal, the position was clarified in a number of cases by using the 
more specific methaemoglobin reduction test. This particular problem 
is illustrated in two of our respondents, Nos. 3 and 10 (sEe Chapter 17). 
Subject 3 was demonstrated to be grossly G-6-PD deficient, his Motulsky 
test being more than 5 hours. On testing his daughter, who is by 
definition an obligatory carrier, her Motulsky test was 39 minutes. 
which is considered normal. Respondent 10 had a Motulsky test of 65 
- 251 -
minutes, which is not grossly elevated and is more characteristic of 
the Negro than the Greek variety of G-6-PD deficiency. His daughter 
had a Motulsky of 49 minutes, which is abnormal, but when her methaemo-
globin reduction was estimated it was found to be nonnal. 
This illustrates that neither of the tests used in this survey are in-
fallib~e in the case of women, and it is quite conceivable that certain 
of the female respondents were reported as nonnal whereas. in fact, they 
carried G-6-PD deficiency. The overall prevalence was 6% with that of 
women being 5% and that of men 6,7%. It is quite possible that the dis-
crepanc.v between the sexes is due to some females being missed in the 
screening and that the true prevalence of G-6-PD deficiency in the 
Greek population of Cape Town is 6,7% (with a gene frequency of 0,067) 
and not 6%. 
A SEVERE FORM OF G-6-PD DEFICIENCY IN LESBOS 
During the Second World War, subject 10 (see Chapter 17) and a brother 
ate fava beans in Greece and, as a result. had what was probably an 
acute haemolytic attack. C.V. received a blood transfusion, his father 
having donated the blood, whereas for reasons unknown to the author, 
his brother did not receive a transfusion and subsequently died. In 
South Africa, 25 years later, respondent lO's mother. after taking 
salicylates for an influenca-like illness, suffered from an attack of 
haemol.vsis which necessitated hospital admission. It therefore seems 
that this family. who originate from Lesbos, suffer from a particularly 
severe fonn of G-6-PD deficiency. Doxiadis, et al (1964) have pre-
viously noted that G-6-PD deficiency neonates on Lesbos have a par-
ticularly severe form of jaundice and that the non-G-6-PD deficient 
- 252 -
newborn infants suffer from a more marked form of neonatal jaundice 
than those in other areas of Greece. They thus postulated a second 
icteroqenic factor which worsens the jaundice when occurring with 
G-6-PD deficiency. 
This factor might be environmental or genetic. From this one family, 
no final conclusions could be drawn. However, it would support the 
concept that the additional icterogenic factor is genetic and not 
environmental. 
HETEROGENEITY OF G-6-PD DEFICIENCY 
The heterogeneity of G-6-PD deficiency has been well recognized and 
documented. There are clinical differences with certain population 
groups having a more noted deficiency than others, e.g. the Mediter-
ranean type results in a more severe condition than the Negro variety. 
There are also differences in electrophoretic mobility and other 
laboratory parameters which have been discussed earlier. These are 
all examples of the heterogeneity of the disorder. Heterogeneity not 
only exists between the various population groups but also within the 
co111T1unities having the anomalous gene. 
There is evidence for this phenomenon in this study. Clinically, there 
were differences in how certain of the individuals with the condition 
reacted to it. Some of the subjects had genuine s_yrr.ptoms of a haemo-
lytic attack on taking a medicine, such as acetyl salicylic acid, known 
to precipitate haemolysis, while others could take the same preparation 
without any untoward effects. The reaction was so severe in two of the 
subjects that hospital admission was necessary and extensive special 
investigations were undertaken to enable the diagnosis to be made. 
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Similarly, 4 of the cases in the study had the physical sign of 
splenomegaly, while others did not. However, this would depend on the 
rate of haemolysis, which in turn would depend on the frequency with 
which the drugs inducinq haemolysis were ingested. Therefore, this 
sign could be stimulated by the persons themselves by, for example, 
regularly taking acetyl salicylic acid on getting headaches. 
The lacoratory results also illustrate this heteroqeneity (see Table 
17 - 5). The brilliant cresyl blue test is a measure of the activity 
of the enzyme G-6-PD. The results in the males varied from 59 minutes 
to more than 5 hours. In the majority of the men studied, the results 
were grossly abnormal. However, in 2 of the men the results were 59 
and 65 minutes, which is only slightly abnormal. In subject 9, electro-
phoresis was undertaken to typify the enzyme. The result was that the 
G-6-PD was of the B variety, i.e. the Mediterranean type which is what 
one would expect in an individ ua l of Greek origin. There is, therefore, 
evidence that there is also heterogeneity within this large group. 
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CHAPTER 28 
THALASSAEMIA IN ASSOCIATION WITH GLUCOSE-6-PHOSPHATE 
DEAYDROGENASE DEFIGIE~CV 
THALASSAEMIA AND G-6-PD DEFfCIENCY IN NON-GREEK CAPE TOWN RESIDENTS 
Thalassaemia is encountered reasonably commonly amongst the Cape 
Coloured population of Cape Town. This population group has a mixed 
gene pool, with Caucasian, African Negro, Bushman, Nama (Hottentot) 
and Asian contributions. 
Caucasians of Mediterranean origin and individuals from south east 
Asia have a high prevalence of beta-thalassaemia while the beta-
thalassaemia gene is found to a lesser extent in the West African 
negro. The beta-thalassaemia gene in the Cape Coloured population 
therefore possibly has origin from these 3 sources. Non-Greek patients 
with beta-thalassaemia who were encountered in Cape Town were pre-
dominantly of Malay stock and it is therefore reasonable to assume that 
their beta-thalassaemia gene came mainly from south-east Asia. There 
are in addition a few Cape Coloured families with south Mediterranean 
antecedents who possibly contributed the beta-thalassaemic gene to this 
population's gene pool. 
There are Caucasian individuals of non-Greek stock in Cape Town with 
heterozygous beta-thalassaemia. These people are mainly Italian in 
origin and to a lesser extent, Portuguese. Caucasian individuals are 
also present in Cape Town who have English names and heterozygous beta-
thalassaemia. However, on more detailed examination it is now evident 
there is an arltecedent of southern Mediterranean origin in these 
families. It is reasonable to assume that the beta-thalassaemia in 
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these individuals came from this source. 
There have been reports of individuals of English/Dutch stock in South 
Africa with sickle-cell haemoglobin C disease and haemoglobin S beta1 
thalassaemia (Dunston, et al. 1972). Gene flow from populations con-
taining the beta-thalassaemic as well as HbS and HbC genes to the 
English and Dutch during colonial times has been suggested as a source 
of these genes 
G-6-PD deficiency is also found in Cape Town in the same population 
groups discussed above and for the similar reasons. The incidence of 
G-6-PD deficienc} in the African Negro of South Africa ranges from 0-10% 
(Tobias, 1974). This is significantly higher than that for beta-thalas-
saemia in the same people. The result is that there is a higher inci-
dence of G-6-PD deficiency than beta-thalassaemia in the Coloured 
population in Cape Town as there is an added source for the G-6-PD 
deficiency gene, which is typical of the Negro variety. 
THALASSAEMIA, G-6-PD DEFICIENCY, GEOGRAPHY AND MALARIA 
Previous mention has been made concerning the relationship between 
malaria and G-6-PD deficiency and thalassaemia. The selective advantage 
of G-6-PD deficiency against malaria has been well established and al-
though it has not been proven in the case of thalassaemia, the background 
of the disorder strongly suggests that thalassaemia also protects against 
malaria. 
Examining the places of origin in Greece of the respondents with hetero-
zygous beta-thalassaemia, it is evident that all except one originates 
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from a low-lying town where it is reasonable to assume that malaria was 
endemic in the past. However, taking note of the place of origin of 
all the respondents it becomes obvious that most of the subjects in-
cluded in the survey come from low-lying areas. For this reason it 
would Qe fala~ious to state that from the figures obtained in this 
survey there is a direct relationship between the low-lying areas, 
malarial endemicity in the past and thalassaemia. 
It is possible, however. to compare the incidences in the various areas 
in Greece with those found amongst respondents living in Cape Town. 
The Greek subjects in Cape Town with the highest incidence of the beta-
thalassaemia gene are those from Cyprus, who have a prevalence of 30%. 
The comparative figure for Greek Cypriots in Cyprus is 15% (Ashiotis, 
et al, 1973). The discrepancy is probably the result of the small 
number of subjects. who numbered 15, from Cyprus who were included in 
this survey. The prevalence of 10,5% in persons from Lesbcs obtained 
in the survey compares well with t he 10% incidence found on Lesbos 
(Fessas, 1976). The good correlation is probably due to the relatively 
large number of subjects sampled from Lesbos. The prevalence of 9.5% 
in persons from the Peloponnese is somewhat higher than the 6% found 
there (Rucknagel, 1966}, whereas no subjects from the Dorian Islands 
were found with the beta-thalassaemia gene. However, this finding is 
probably also spurious due to the relatively small number of persons 
tested from these latter areas. 
Whereas the relationship betweeP low-lying areas, malarial endemicity 
and incidence of t.halassaemia has not been clearly demonstrated 
(Stamatoyannopoulos and Fessas, 1964), the relationship between the 
above factcrs· and the G-6-PD deficiency has been we 11 es tab 1 i shed 
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(Plato. Rucknagel and Gershowitz, 1964; Siniscalco, et al, 1964). It 
has been demonstrated by the above authors that the incidence of G-6-PD 
deficiency is significantly hi~her in coastal areas where malaria was 
endemic than in higher mountainous regions where malaria was not found. 
Thus, in an area such as the Arta are& of central Greece, there is a 
striking difference in the incidence of G-6-PD deficiency between non-
malarial endemic region~ (2,8%) and places where malaria was endemic 
(16,4%) (Stamatoyannopoulos and Fessas, 1964). 
In examining the figures of the survey, the regions of origin of 
respondents with the highest incidence of G-6-PD deficiency are the 
various Greek islands, in particular Lemnos (20%) and Cephalonia, an 
Ionian island (11,8%). Due to the geographical structure of the 
islands, malaria was endemic there to a greater extent than on the 
mainland and one could therefore expect there to be a high incidence 
of G-6-PD deficiency. The 4,3% prevalence found in subjects originating 
from Lesbos compares favourably with the: va 1 ues 4 ,6% and 3 ,9% found on 
Lesbos (Doxiadis, et al, 1964). Due to the relatively small number of 
respondents tested from so~e regions the seemingly high incidence may be 
somewhat misleading as it is possible that the true incidence in these 
areas is in reality lower. 
INTERACTION OF THALASSAEMIA AND G-6-PD DEFICIENCY 
As thalassaemia and G-6-PD deficiency are both very common in Greece and 
in people of Greek origin, it is likely that the two conditions will 
sometin;es occur in the same individual. 
It is known that there is no direct genetic relationship between G-6-PD 
deficiency, which is X-linked, and the thalassaemia gene which is auto-
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. 
somal. Thus they occur independently and by multiplying the preva-
lence of each, the number of persons expected to have both disorders 
can be calculated. In the survey it would be expected that there would 
be one such individual (as discussed earlier) while there are in fact 
two. As the numbers are relatively small, such a discrepancy is not 
totally unexpected. The two respondents in the survey with both beta-
thalassaemia and G-6-PD deficiency illustrate the point that the one 
disorder has no deleterious effect on the other (see Chapter 17). 
A.P. (see Chapter 17), who was aged 65 at the time of diagnosis, had 
never had any symptoms referable to G-6-PD deficiency or thalassaemia 
and would probably never have been diagnosed had it not been for the 
survey. He has subsequently demised from carcinoma of the bladder. 
A second patient, O.V. (see Chapter 17), had previously been diagnosed 
as having both disorders as he had been investigated fully following 
an attack of favism. He suffers f rom a particularly severe form of 
G-6-PD deficiency and has had a cholecystectomy for gall stones, which 
were conceivably the result of increased haemolysis on the basis of his 
G-6-PD deficiency. Apart from previous attacks of acute haemolysis and 




DIFFICULTY IN THE DIAGNOSIS 
McKusick, in his classical work on Mendelian inheritance, quotes 
the prevalence of hereditary spherocytosis as 2,2 per 10 000. In the 
population included in the survey, the prevalence has a minimum 
frequency of 1,2 per 100 and occurs possibly as frequently as 3,2 per 
100. The diagnosis of HS is usually initially made on clinical and 
haematological grounds. Presenting features include a history of 
cholecystitis, an anaemia and an _unexplained splenomegaly. Contri-
butory laboratory evidence is a possible decreased haemoglobin value, 
typical spherocytic red blood cells on the peripheral blood smear, and 
an increased reticulocyte count. Finally, the diagnosis is made when 
an increased osmotic fragility of the red blood cells is found and 
autohaemolytic studies reveal characteristic abnormalities. However, 
in this study the initial abnormality found in most cases was an in-
creased osmotic fragility. Thereafter. other distinctive features of 
the disorder were sought. In a significant proportion of these 
individuals typical clinical and haematological features were absent, 
which further complicated their diagnosis of HS. Experimental tech-
niques were checked in an attempt to explain the paucity of cQn-
tributing evidence. However, no experimental error was found and the 
results were considered to be in order. Therefore, it appears probable 
that these subjects have HS but with a very mild expression of the gene. 
Family studie~ were done where possible to elucidate the situation but 
this was unfortunately not possible in a number of these patients. 
McKusick maintains that an increased osmotic fragility of the red blood 
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cells is the most characteristic abnon:nalit_y in this disorder and this 
too lends weiqht to the diagnosis of HS in these cases. These findings 
are increased evidence for the heterogeneity of the disorder. 
HIGH PREVALENCE OF HEREDITARY SPEROCYTOSIS IN THE GREEK 
POPULATION OF CAPE TOWN 
The prevalence of hereqitary spherocytosis is quoted as 2,2 per 10 000. 
No data is available for southern Europe and more specifically Greece. 
The gene frequency found in the Greek population of Cape Town in this 
survey is far in excess of this figure (see Chapter 18). It is 
reasonable to suqgest that the founder effect has been responsible for 
these figures in Cape Town. It is known that the HS gene is present in 
Greece. However, no population survey has been undertaken to determine 
the frequency of the gene (Fessas, 1978) and therefore we do not know 
whether the high frequency found in the Greek community of Cape Town is 
representative of that in Greece. 
If these findings are a reflection of the situation in Greece, there 
are important implications. The characteristic abnormalities of the 
red blood cell in G~6-PD deficiency, sickle cell trait and probably 
thalassaemia minor have been considered to confer resistance to malaria. 
The important question which now arises is whether persons with HS also 
have a decreased susceptibility to malaria and hence a selective 
advantage. 
The primary defect in HS appears to lie in the red cell membrane which 
has been found to have an increased permeability to sodium ions (Jacob 
and Jandl, 1964). In addition, an abnormal red cell membrane protein 
- 261 -
has been reported (Amsden and White, 1971). If the primary defect is 
indeed in the red cell membrane, it is possibly reasonable to hypo-
thesize that this defect may render the red cell membrane resistant to 
the malarial parasite. However, at present there is no evidenc~ to 
refute or confirm this suggestion. 
These early findings are therefore of great interest and would bear 
further exhaustive investigation to clarify the position completely. 
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CHAPTER 30 
CONCLUSION AND RECOMMENDATIONS 
The prevalence of certain of the inherited haemato 1 ogi ca 1 dis-
orders in the Greek population of Cape Town were found to be as 
follows:-
1. Alpha-thalassaemia trait 1,2% 
2. Beta-thalassaemia trait 9,2% 
3. G-6-PD deficiency 6,7% 
4. Heredittr_y spherocytosis 1,2% 
5. Sickle cell trait 0.4% 
From our knowledge of the gene frequency of these disturbances in 
Greece and by extrapolating to the situation in Greeks in Cape Town, 
the prevalence of the thalassaemia and G-6-PD deficiency is much as 
expected. However, the prevalence of hereditary spherocytosis is 
unexpectedly high. 
The gene frequencies for these haematological conditions are significant 
and justify further thought and action. G-6-PD deficiency and heredi-
tary spherocytosis, as encountered in the survey, were relatively mild 
conditions and do not warrant any prophylactic action. However, the 
thalassaemias in the homozygous state, result in a severe, crippling 
disease with important socio-economic implications. This form of the 
disorder should be prevented from occurring where possible. 
This survey did indeed start this process. The first important step is 
education. Firstly. the medical profession should be aware of the 
I 
danqers of the disorders for the population at risk. In addition the 
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Greek population should be aware that they are prone to certain con-
ditions which are preventable. 
A circular was sent to members of the Greek community infonning them of 
the disorders and their implications and giving basic infonnation as to 
current medical treatment. The author also spoke to groups at social 
gatherings as well as to individuals requesting information and advice. 
Persons v9lunteerin~ to participate in the survey were, without excep-
tion, told exactly why the study was being done. 
Further education is still necessary. It is important that persons do 
not feel it a stigma to be a carrier of the disorder and to come for-
ward of their own accord to have their blood screened for these distur-
bances. This is particularly important premaritally in order that 
persons know whether they are heterozygotes for thalassaemia. If both 
the man and the woman are carriers they can be informed of tr.e possible 
outcome of any pregnancy. In appropriate circumstances they can be 
referred to an overseas clinic where antenatal diagnosis is perfonned 
and have the pregnancy tested. 
While undertakinq the survey the author attempted to set up a service 
whereby persons could be voluntarily tested. The laboratory and 
hospital side of this was organized but volunteers were not forthcoming. 
The author then ccntacted the ecclesiastical authorities and requested 
; 
that they inform couples premaritally of the service to be offered. 
Unfortunately. although appreciation of the work was expressed, the 
authorities f~lt that they could not be part of it. However, because 
of the risks of the severe disease it is nevertheless imperative that 
such a service be offered. 
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This testing can be justified from an economic point of view if one 
considers that it costs the State over R7000 per annum to maintain one 
patient with thalassaemia major. It is thus obviously worthwhile for 
the State to provide a service to prevent the recurrence of this dis-
order. 
It is compulsory in Greece for couples to be tested premaritally for 
any haemoglobinopathy and the thalassaemias. This is because of the 
severity of the disorders and their harsh economic consequences. This 
problem has also been realized in other countries to which large num-
bers of Greeks have emigrated, such as Australia {Editorial,1974) and 
it has been suggested that comprehensive voluntary screening programmes 
be instituted in these countries. 
However, as opposed to Greece where premarital testing is compulsory, 
it is preferable that the public at risk be an informed, enlightened 
one, seeking testing of their own free will. To attain this, education 
is most important as there is the tendency for anxieties, fears and 
guilt feelings to be raised as well as possible interference with moral, 
personal and religious beliefs. In order not to invade the rights of 
the individual it is important that the results of the tests be con-
fidential. Thereafter it is necessary that individual advice and coun-
selling be given where requested. 
Probably the next most important group who should be screened are 
mothers in early pregnancy. 
With the present organization of the South African health services only 
a few indivuals would be screened at Provincial hospitals. The majority 
of persons are seen and treated privately. In these circumstances 
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screening would have to be offered by the general practitioner or 
obstetrician. Arrangements would then have to be made for the testing 
to be done by the Provincial Laboratories. The importance that the 
public be informed ,and enlightened to minimize anxieties and guilt 
feelings and that confidentiality be maintained is emphasized here. 
The choice of possibilities for an at-risk pregnancy found in this 
manner in Cape Town are, if the patients can afford transport overseas, 
referral to a large, specialized unit which can undertake antenatal 
diagnosis with the understanding that an affected pregnancy be ter-
minated; that the pregnancy be terminated locally, or that the preg-
nancy qo to term if the parents so wish. 
In the case of G-6-PD deficiency the anomaly is not quite as severe. 
However, it is nevertheless important that the medical fraternity be 
aware of the population at risk in order that rapid diagnosis may be 
made when a patient presents with the side effects of the disorder. 
Although the condition is usually mild it may necessitate hospital 
admission. It is thus recognised that where possible, the communities 
that have a high prevalence of this disorder be tested for it. Such 
arrangements have been made for the Greek community in Cape Town. It 
is thereafter advisable that persons with the disorder wear a medic-
alert disc. Antenatal diagnosis of the disorder is not indicated in 
utero, but maternal prenatal and neonatal testing is advisable in 
certain instances and ideally should be undertaken in all possible 
carriers of the disorder. 
Finally, the gene frequency of hereditary spherocytosis far exceeded 
that expected. This is felt to be reasonably high as a result of the 
founder effect and may not be representative of the true picture of 
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the Greek people. It is recolTITlended that further study be undertaken 
to clarify this matter as the implications are far reaching. These 
' 
include the possibility of a selective advantaqe against malaria. 
Antenatal diagnosis ·is not indicated in HS although knowledge of the 
presence of the disorder is important as it might occur in the Greek 
conmunity with a significant prevalence. Diagnosis is important in 
order that the correct treatment may be given. Essentially. this is 
splenectomy. This surgical procedure ought to have been done in one 
of the survey subjects in addition to a cholecystectomy, but as the 
correct diagnosis of the underlying disorder was not made, it was not 
performed. 
It is also important that there be awareness of the possibility of 
haemoglobinopathies in persons of Greek origin. One person with the 
sickle cell trait was found in Cape Town. 
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APPENDIX A 
Unless otherwise indicated the laboratory techniques are based on 
those as described by Dacie and Lewis (1975). 
1. PERIPHERAL BLOOD SMEARS 
a) Red Cell Morphology 
A drop of well-mixed, fresh E.D.T.A. blood is smeared onto 
2 clean slides and then rapidly air dried. 
Staining procedure: 
0,5 ml Wright's stain is added to the slide and after 1 minute 
1 ml of Wright's buffer at pH 6,8 is added. This is well mixed 
on the smear and left on the slide for 12 minutes before being 
washed off with distilled water and air dried. The slide is now 
ready to be examined under an oil immersion lens under 40 objective 
magnification for red cell morphology. 
2. SUPRAVITALLY STAINED PREPARATIONS 
a) Reticulocytes 
0,2 ml of brilliant cresyl blue and an equal quantity of blood 
are well mixed and then incubated at 37°C in a waterbath for 30 
minutes. Two smears are then made from this solution. Five hun-
dred cells are counted from each slide and note is taken of the 
number of reticulocytes under 100 objective magnification. Thus a 
total of 1000 cells are counted. The total number of reticulocytes 
is then divided by 10 to allow the reticulocyte count to be ex-
pressed as a percentage. To obtain the corrected reticulocyte 
count the following formula is used:-
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Observed reticulocyte count x patient's PCV 
nonnal PCV 
The PCV is sex-dependent and the normal reticulocyte count ranges 
from 0,5 to 2%. 
b) Haemoglobin H inclusion bodies 
0,2 ml brilliant cresyl blue is added to 3 drops of blood and 
mixed well. This is then incubated for 30, 60, 90 and 120 minutes 
at 37°c in a waterbath. Two smears are made of each at 30, 60, 90 
and 120 minutes. 
The smears are then examined under 100 objective magnification and 
5000 cells counted on each slide, noting the number of red cell in-
clusion bodies. Thus, 10 000 cells are counted and the final result 
is expressed as number of inclusion bodies per 10 000 cells. 
The above method was employed for the first half of the survey. 
During the second half of the survey a similar procedure was 
followed, with the exception that the solution was incubated for 4 
hours and only 1 set of smears was made. 
3. BLOOD GROUPING 
a) ABO 
b) Rhesus 
c) Duffy blood grouping was performed. (Routine methods were 
used and will not be discussed further.) 
4. RED CELL PARAMETERS 
a) Haemo~lobin 
The cyanmethaemoglobin method as described by Dacie and Lewis 
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(1975) was used. 
PRINCIPLE 
By diluting the blood in a solution containing potassium cyanide and 
potassium ferricyanide, haemoglobin, methaemoglobin and carboxyhaemo-
globin are all .converted to the stable compound cyanmethaemoglobin. 
The optical density of this solution is then measured in a photo-
electric colorimeter and compared to that of a known standard. 
REAGENTS 
Drabkin's cyanide ferricyanide : KCN 0,05 g, K3 FE (CN) 6 
0,20 g and distilled water to 1 litre. 
Standard of concentration 15,2 per 100 ml. 
PROCEDURE 
0,02 ml of blood is added to 4 ml of modified Drabkin's cyanide-ferri-
cyanide solution in a tube which is then inverted several times. The 
solution is then compared with the standard in a Klett-Sommerson photo-
electric colorimeter. 
Calculation: 
Haemoglobin (g per 100 ml)= Test Standard 
b) PACKED CELL VOLUME (PCV) 
I 
x concentration of STD x dilution factor 
1000 
The microhaematocrit method was followed. 
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A microhaematocrit tube has well mixed E.D.T.A. blood added to 
two-thirds of its capacity. One end of the tube is sealed with 
plasticine or by flame and the tube is spun from 3 to 5 minutes 
at 12 000 gravs on a Hawksley centrifuge. The result is read off 
directly as a percentage on a Hawksley microhaematocrit reader. 
Nonnal value for a male is 45% while for a female 40%. 
c) RED CELL COUNT 
0,05 ml of well mixed blood is added to 25 ml isoton, a 
balanced isotonic modified medium wbich maintains the integrity 
of the cell for at least 30 minutes. 0,1 ml of this solution is 
then added to 10 ml isoton giving a 1 50 000 strength. This 
solution is now used to measure the red cell count. The model F 
Coulter counter, a particle counter, then automatically counts 
the number of red cells in the solution. 
Where the red cell count is high there is an increased possibility 
of 2 cells being counted as one. To compensate for this an inci-
dence chart is supplied for correction of the red cell count. 
Caution must be exercised to ensure that the blood is well mixed 
and that the system is dust-free. If these precautions are not 
taken the counts will be erroneous. 
d) MEAN CORPUSCULAR HAEMOGLOBIN CONCENTRATION (MCHC) 
The MCHC is calculated by dividing the haemoglobin by the 
PCV and multiplying by 100 (~ x ~). The result is expressed 
as a percentage with nonnal values ranging from 32 to 36 per cent. 
e) MEAN CORPUSCULAR VOLUME (MCV) 
The MCV is calculated by dividing the PCV by the red cell 
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count and multiplying by 10. The result is recorded in femto-





f) MEAN CORPUSCULAR HAEMOGLOBIN (MCH) 
The MCH is obtained by dividing the haemoglobin by the red 
cell count and multiplying by 10. 
(~ x l{) 
The result is expressed in picograms (pg) and the normal range is 
27 to 32 pg. 
5. OSMOTIC FRAGILITY 
Basis 
The method followed is slightly modified from that described by 
Dacie and Lewis (1975) and based on that of Parpart, et al (1947). 
Blood is added to hypotonic saline buffered to pH 7,4 in the proportion 
of 1 to 100 . The test is carried out at room temperature and lysis is 
measured photoelectrically. 
Reagents 
A stock solution of buffered sodium chloride, osmotically equivalent 
to 100 g/1 Nacl is made up as follows:-
NaCl - 90 g, Na2HP04 - 13,6 g and NaH2Po4, 2H 20 - 2,43 g are 
dissolved in w~ter and the final volume is adjusted to 1 
litre. It is stored as a 10 g/1 stock solution at 4°c. 
This is titrated to 1 g/1 accurately for use when needed. 
Serial dilutions of 8,5 are convenient concentrations. In 
,I 
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addition a 13 g/1 dilution is used after incubation. 
METHOD 
The test is performed within 2 hours of collection of the blood. 
0,02 ml volumes of the well mixed blood to be tested are added to 5 ml 
volumes of the range of hypotonic solutions and immediately mixed by 
inverting several times. The tubes are allowed to stand at room 
temperature from 30 minutes to 2 hours, then remixed and centrifuged 
for 5 minutes at 1200-1500 g. The amount of lysis in each tube is 
then compared with that in the 100% lysis tube (1,0 g/1 NaCl) using a 
photoelectric colorimeter with a yellow-green filter or at a wavelength 
setting of 540 nm. The supernatant from the 9,0 g/1 NaCl tube is used 
as the blank or that from a 13 g/1 NaCl tube if there is lysis in the 
8,5 g/1 NaCl. 
6. ELECTROPHORESIS 
Although any method suitable for electrophoresis of serum proteins 
can be used for haemoglobins, paper electrophoresis by the vertical 
{hanging strip) method has been found to be most suitable for routine 
use, such as large scale screening procedures. 
a) DETECTION AND PRELIMINARY CLASSIFICATION OF ABNORMAL 
HAEMOGLOBINS 
The method followed is that described by Lehmann and Ager (1960). 
BUFFER 
Standard barbiturate buffer pH8,6: Ionic strength 
Sodium diethylbarbiturate 20,6 g and 
Diethylbarbituric acid 1,84 g 
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&re added to distilled water to make up 2 litres. This buffer has 
half the concentration of diethylbarbituric acid used routinely for 
serum protein electrophoresis as it gives wider separation in the 
region where the haemoglobins are found. 
PROCEDURE 
Whatman No. 3 mm filter paper cut to strips measuring 36,5 cm by 
8,7 cm are folded gently in midline and this is marked lightly with a 
pencil. The strip is hung dry in the tank and 10 to 15 ml samples of 
haemolysate are streaked with a saline pipette along the pencilled 
line, about 1 cm wide. Fresh buffer is now applied by pipette to the 
paper to about 0,3 cm below the haemolysate and electrophoresis is 
performed for 17 to 20 hours at 12 milliamperes. The papers are then 
removed and the heavily soaked unwanted ends cut off to produce more 
clearly defined zones. The papers are dried in an incubator at about 
120°c. The haemoglobin bands are clearly visible and any abnonnal 
bands will r~quire further investigation. A small amount of non-
haemoglobin protein may become visible between the line of application 
and the region where haemoglobin A2 is found: this is thought to be 
the enzyme methaemoglobin reductase. 
b) QUANTITATION OF HAEMOGLOBIN A2 
The method used is that described by Black, et al (1966). 
Buffer: 
1,2 g Barbituric acid 
6,8 g Sodium barbital 
40,4 Tris 
4,0 g Disodium EDTA 
3,0 g Boric acid 
with distilled water to make up a 2-litre solution. 
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Two Whatman 3 mm filter paper strips measuring 14! by 1! inches have 
a pencil line drawn 1! inches from the midline. 0,1 ml of haemolysate 
is pipetted to the line to form a band approximately 1 cm in breadth. 
The ends of the strip are dipped into buffer to within 1/8 inch of 
each edge of the haemolysate and excess buffer is removed by blotting. 
The strip is hung in the tank with the applied band toward the anode. 
The run is started at 12 milliamperes and allowed to proceed for 17 to 
20 hours. Filter papers should not touch each other and the box must 
be full. The A2 band and its tail are cut from the two strips and are 
placed in 5 ml of Drabkin's reagent for elution. The A band is cut 
from the 2 strips and placed in 5 ml Drabkin's solution for elution 
and left for 2 hours. After 2 hours, the elutes are centrifuged to 
pack the paper and the optical density (OD) measured on a Klett-
Sommerson photoelectric colorimeter with filter 540 nm. 
Percentage of haemoglobin A2 is determined by the formula: 
OD A 
OD A2 + 
2orfA x 
100 
1 = Percentage haemoglobin A2 
The range in non-thalassaemic individuals is l,Oto2,9per cent, with a 
+ mean of 2,03 - 0,37. 
7. THE ESTIMATION OF ALKALI-RESISTANT HAEMOGLOBIN-FETAL 
HAEMOGLOBIN 
A convenient method of haemoglobin F (HbF) estimation is the 
"one minute alkali denaturation test" of Singer, Chernoff and Singer 
(1951). However, this technique is not altogether reliable at low 
concentrations of HbF. 
Adult haemoglobin is denatured by alkalis whereas haemoglobin Fis 
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resistant to this process. The denatured haemoglobin is removed by 
precipitation with ammonium sulphate and the remaining haemoglobin is 
measured photometrically. 
REAGENTS 
1) Ammonium sulphate: 152 g is dissolved in distilled water to give 
a final volume of 400 ml with 1 ml 10 N HCL added. 
2) Nl2 NAOH: 20 ml IN NAOH is added to 220 ml distilled water to 
give a final volume of 240 ml. 
3) Pmnonium hydroxide: 4 ml of concentrated ammonia is added to 1 
litre of distilled water . 
, 
The reagents should be kept and the test should be performed at about 
20°c. 0,2 ml of the haemolysate is added to 3,2 ml Nl2 sodium hydroxide, 
mixed thoroughly and left for precisely 1 minute. 6,8 ml of the 
arrmonium sulphate reagent is then added and after inverting several 
times and waiting about a minute the mixture is filtered through No. 42 
Whatman filter paper and measured on the Klett-Summerson photoelectric 
colorimeter at 540 nm. If it is . colourless, no measurable amount of 
HbF is present. A solution which is tenned "total II is now made up by 
adding 0,05 ml of the original haemolysate to 5 ml of ammonium hydro-
xide solution and this solution is measured photometrically. A control 
solution is made up of 6,8 ml ammonium sulphate added to 3,2 ml sodium 
hydroxide. This solution is now filtered before being measured photo-
metrically. The Klett-Surrmerson colorimeter is zeroed on a 5 ml 
ammonium hydroxide solution. 
Calculation: 




Results of below 1,7 per cent alkali-resistant haemoglobin are not 
significant, whereas over 1,7 per cent are suggestive of some degree 
of red cell pathology. 
8. THE BRILLIANT CRESYL BLUE DYE TEST OR MOTULSKY TEST 
This test is for G-6-PD deficiency and is essentially that 
developed by Motulsky and Campbell-Kraut (1961). 
PRINCIPLE 
Haemolysates are incubated in the presence of excess glucose - 6-
phosphate (G6P) as substrate and NADP as coenzyme, together with 
brilliant cresyl blue dye. Dehydrogenation of G6P as a result of the 
presence of G-6-PD leads to reduction of NADP to NADPH. The added 
dye is reduced to a colourless compound in proportion to the amount of 
NAPPH formed. The dye also stimulates the activity of the shunt 
(oxidative) pathway so that decolourization occurs rapidly. Deficiency 
of the enzyme thus results in a prolonged dye-decolourization time. 
REAGENTS 
1) BUFFER DYE SOLUTION 
44,75 g Tris (2-amino-2-hydroxymethyl propane-1,3 diol) and 160 mg 
of brilliant cresyl blue are dissolved to form a solution of 400 ml. 
The pH is adjusted to 8,5 with concentrated hydrochloric acid. The 
solution is mixed, made up to a final volume of 500 ml divided into 
4,5 ml volumes and frozen. 
2) NADP 
50 g are dissolved in 100 ml distil~ed water. The solution is 
divided into 1 ml volumes and stored frozen. 
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3) SODIUM GLUCOSE-6-PHOSPHATE 
895 mg of the salt is dissolved in 100 ml of distilled water. 
This solution is also divided into 1 ml volumes and frozen. 
COMBINED REAGENT SOLUTION 
This is prepared fresh daily by mixing 4,5 ml buffer-dye solution, 1 ml 
of NADP solution and 1,0 ml of glucose-6-phosphate solution. 
PROCEDURE 
0,02 ml of fresh whole blood is added to 1,0 ml of distilled water. 
The suspension is well mixed in water to lyse the cells before mixing 
with 0,65 ml of the combined reagent solution. The whole is then 
covered with liquid paraffin and incubated at 37°c without agitation. 
After 30 minutes the solution is checked each minute for dye-decolori-
zation. The decolourization produces subtle changes in the appearance 
of the contents of the tube. The reddish colour of haemoglobin shows 
through the blue dye giving an appearance rather like a striped marble. 
RESULTS 
Normal for women 
Normal for men 
SUPPLEMENTARY TESTS 
30-40 minutes 
less than 45 minutes 
9. METHAEMOGLOBIN REDUCTION TEST 
This test for G-6-PD deficiency is used in the case of female 
carriers for G-6-PD deficiency where the results of the Motulsky test 




The test developed by Brewer, Tarlov and Alving (1962) involves the 
oxidation of haemoglobin to methaemoglobin by sodium nitrite and its 
subsequent enzymatic reconversion to haemoglobin in the presence of 
methylene blue. This redox dye affects the pentose phosphate shunt and 
activates reduced NADP-methaemoglobin reductase in normal, but not 
G-6-PD deficient erythrocytes. 
REAGENTS 
0,18 M sodium nitrite and 0,28 M dextrose solution 
0,0004 M methylene blue chloride solution 
TUBES 
1. Normal reference tube : has no reagent added. 
2. Positive reference tube: has exactly 0,1 ml of the combined 
sodium nitrite-dextrose reagent added. 
3. Unknown sample tube: has exactly 0,1 ml of the sodium nitrite-
dextrose reagent and 0,1 ml of the methylene blue reagent. 
PROCEDURE 
2 ml of blood (either normal, drug-sensitive or unknown) is added to 
both the positive reference and the normal reference tubes. The con-
tents are well mixed by inverting each tube about 15 times. Add 2 ml 
of blood from the individual under investigation to the unknown sample 
tube and mix. The tubes are incubated unstoppered in a waterbath at 
37°c for 3 hours. A 0,1 ml aliquot from each of the 3 tubes is then 
pipetted into separate clear glass test tubes, to each of which 10 ml 
of phosphate buffer has previously been added. The unknown tube is 
then compared spectrophotometrically to the positive and normal test 
- 279 -
tubes. In individuals showing full expression of the G-6-PD deficiency 
trait, more than 70% methaemoglobin remains, while in normal individuals 
less than 5% persists. In female heterozygotes the amount of methaemo-
globin persisting varies between 5 and 70%. 
10. SOLUBILITY TEST FOR HAEMOGLOBINS (ITANO, 1953) 
This is a test for haemoglobin S (HbS) and is based on the unique 
low solubility of HbS in its reduced form. 
BUFFER: (Concentrated phosphate) pH6,8 
KH 2P04 and K2HP04 are dried to constant weight at 100°c. Then 40,12 g 
KH2P04 and 70,479 K2HP04 are dissolved overnight in 200 ml water in a 
250 ml volumetric flask. Next morning the volume is made up to 250 ml 
and the solution filtered through Whatman 42 filter paper. 
TEST 
100 mg sodium hydrosulphite (Na 2s2o4) is weighed with a 10 ml cylinder 
and 8 ml of the buffer added. After shaking to dissolve, 0,8 ml 
distilled water is layered over this solution. A volume of the 
approximately 10 g/100 ml oxyhaemoglobin solution chosen to contain 
exactly 50 g haemoglobin is carefully pipetted into the water layer. 
The volume is made up to 10 ml with distilled water without mixing and 
the flask incubated for 15 minutes in a- 2s0 c water bath. If no HbS is 
present the solution will be clear. However, if HbS is present, a 
precipitate proportionate to the amount of HbS present will fonn. 
The following tests were not done routinely and were highly specialized. 
The author, therefore, did not familiarize himself with the techniques 
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used and thus the names and references of the tests are all the 
information given. 
11. AUTOHAEMOLYSIS STUDIES {Where hereditary spherocytosis was 
suspected) 
I 
(Dacie and Lewis, 1975) 
The method followed was a combination of 2 described by Dacie 
and Lewis in order that it be more sensitive. 
12. ALPHA/BETA CHAIN RATIOS 
To enable the diagnosis of the alpha-thalassaemia trait to be 
substantiated (Weatherall, .et al, 1969). 
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